GT,Diagnosis 1
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Methylmalonic acidemia: This is a genetic disorder in which the body is unable to properly break down certain proteins and fats. Symptoms can include death in infancy or childhood, metabolic acidosis, and decreased methylmalonyl-CoA mutase activity. However, not all patients with methylmalonic acidemia will have all of these symptoms.

+2. Propionic acidemia: This is a genetic disorder in which the body is unable to properly break down certain proteins and fats. Symptoms can include death in infancy or childhood, metabolic acidosis, and decreased methylmalonyl-CoA mutase activity. However, not all patients with propionic acidemia will have all of these symptoms.

+3. Isovaleric acidemia: This is a genetic disorder in which the body is unable to properly break down certain proteins. Symptoms can include metabolic acidosis and death in infancy or childhood. Decreased methylmalonyl-CoA mutase activity is not typically associated with this disorder.

+4. Multiple carboxylase deficiency: This is a genetic disorder that affects the body's ability to use certain vitamins. Symptoms can include metabolic acidosis and death in infancy or childhood. Decreased methylmalonyl-CoA mutase activity is not typically associated with this disorder.

It is important to note that this is not an exhaustive list of potential diagnoses, and that further testing and evaluation would be necessary to confirm any diagnosis. It is also important to note that some of these disorders can be managed with dietary changes and supplements, while others may require more intensive medical treatment. It is essential that the patient consult with a healthcare professional for an accurate diagnosis and treatment plan."
['Succinic semialdehyde dehydrogenase deficiency']," +1. Metabolic disorders: This category includes a wide range of conditions that affect the body's ability to convert food into energy. Some metabolic disorders can cause motor delay, generalized hypotonia, and elevated urinary carboxylic acid. However, not all metabolic disorders would present with these symptoms, and the presence of pneumonia and death in infancy may indicate a specific type of metabolic disorder.

+2. Mitochondrial disorders: These are genetic disorders that affect the mitochondria, the ""powerhouses"" of the cell. Mitochondrial disorders can cause motor delay, generalized hypotonia, and elevated urinary carboxylic acid. Pneumonia may also be a symptom of a mitochondrial disorder, as these conditions can affect the respiratory system. However, death in infancy is not a common feature of mitochondrial disorders.

+3. Neuromuscular disorders: This category includes conditions that affect the nerves and muscles. Neuromuscular disorders can cause motor delay and generalized hypotonia. Elevated urinary carboxylic acid is not a typical symptom of neuromuscular disorders, but it can be seen in some cases. Pneumonia may be a complication of a neuromuscular disorder, particularly if the condition affects the respiratory muscles. Death in infancy is not a common feature of neuromuscular disorders.

+4. Inborn errors of metabolism: This is a specific category of metabolic disorders that are present from birth. Inborn errors of metabolism can cause motor delay, generalized hypotonia, and elevated urinary carboxylic acid. Pneumonia may also be a symptom of an inborn error of metabolism, particularly if the condition affects the respiratory system. Death in infancy is a possible feature of some inborn errors of metabolism.

It is important to note that this is just a list of potential diagnoses based on the symptoms provided. The patient would need to undergo further testing to determine the specific cause of their symptoms."
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, PKU does not typically cause hypertyrosinemia or death in infancy.

+2. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, MSUD does not typically cause hypertyrosinemia or death in infancy.

+3. Homocystinuria: This is a genetic disorder that affects the body's ability to process the amino acid methionine. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, homocystinuria does not typically cause hypertyrosinemia or death in infancy.

+4. Tyrosinemia type I: This is a genetic disorder that affects the body's ability to break down the amino acid tyrosine. Symptoms include abnormality of prenatal development or birth, neonatal death, hypertyrosinemia, and hyperphenylalaninemia. However, tyrosinemia type I does not typically cause death in infancy.

+5. Tyrosinemia type II: This is a genetic disorder that affects the body's ability to process the amino acid tyrosine. Symptoms include abnormality of prenatal development or birth, hypertyrosinemia, and hyperphenylalaninemia. However, tyrosinemia type II does not typically cause neonatal death or death in infancy.

+6. Tyrosinemia type III: This is a genetic disorder that affects the body's ability to process the amino acid tyrosine. Symptoms include abnormality of prenatal development or birth, hypertyrosinemia, and hyperphenylalaninemia. However, tyrosinemia type III does not typically cause neonatal death or death in infancy.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing and evaluation would be necessary to confirm a diagnosis. Additionally, some of these conditions can be managed with dietary restrictions and supplements, so it is important to consult with a medical professional for appropriate treatment."
['PMM2-CDG']," Based on the symptoms you have provided, I will list some potential diseases that could match, along with a brief description of each:

+1. Congenital Diaphragmatic Hernia (CDH): A birth defect in which the diaphragm does not form properly, allowing abdominal organs to move into the chest cavity and compress the lungs. Symptoms: Congenital diaphragmatic hernia (patient has this symptom), failure to thrive, and possibly death in infancy. Symptoms not present: Motor delay, cerebellar atrophy, lipodystrophy, abnormal muscle physiology, and cerebellar agenesis.

+2. Prader-Willi Syndrome (PWS): A genetic disorder causing various physical, mental, and behavioral problems. Symptoms: Motor delay, failure to thrive, and sometimes death in infancy. Symptoms not present: Congenital diaphragmatic hernia, cerebellar atrophy, hiatus hernia, lipodystrophy, abnormal muscle physiology, and cerebellar agenesis.

+3. Joubert Syndrome: A genetic disorder affecting the cerebellum and brainstem. Symptoms: Motor delay, cerebellar atrophy, and sometimes cerebellar agenesis. Symptoms not present: Congenital diaphragmatic hernia, failure to thrive, death in infancy, hiatus hernia, lipodystrophy, and abnormal muscle physiology.

+4. Centronuclear Myopathy: A group of muscle disorders causing muscle weakness and wasting. Symptoms: Motor delay, abnormal muscle physiology. Symptoms not present: Congenital diaphragmatic hernia, failure to thrive, death in infancy, hiatus hernia, lipodystrophy, cerebellar atrophy, and cerebellar agenesis.

+5. Marfan Syndrome: A genetic disorder affecting connective tissue. Symptoms: Hiatus hernia. Symptoms not present: Congenital diaphragmatic hernia, failure to thrive, death in infancy, lipodystrophy, cerebellar atrophy, cerebellar agenesis, and abnormal muscle physiology.

+6. Lipodystrophy: A group of disorders characterized by abnormal distribution of body fat. Symptoms: Lipodystrophy. Symptoms not present: Congenital diaphragmatic hernia, failure to thrive, death in infancy, hiatus hernia, cerebellar atrophy, cerebellar agenesis, and abnormal muscle physiology.

Please note that this list is not exhaustive, and further examination and testing are necessary to reach an accurate diagnosis. Additionally, some symptoms may be shared among multiple conditions, and the absence of a symptom does not necessarily rule out a particular disease."
['Maple syrup urine disease']," +1. Hydronephrosis: This is a condition where there is a buildup of urine in the kidneys, causing them to swell. The patient has this symptom.

+2. Intellectual disability: This is a condition characterized by significant limitations in intellectual functioning and adaptive behavior. The patient has this symptom.

+3. Motor delay: This is a condition where a child does not reach motor milestones at the expected time. The patient has this symptom.

+4. Generalized hypotonia: This is a condition characterized by low muscle tone throughout the body. The patient has this symptom.

+5. Opisthotonus: This is a condition where the body is arched backwards, often due to muscle spasms. The patient has this symptom.

+6. Athetosis: This is a condition characterized by slow, writhing movements of the hands and feet. The patient has this symptom.

+7. Kyphoscoliosis: This is a condition characterized by an abnormal curvature of the spine. The patient has this symptom.

+8. Hypervalinemia: This is a condition characterized by an abnormally high level of the amino acid valine in the blood. The patient has this symptom.

+9. Hyperleucinemia: This is a condition characterized by an abnormally high level of the amino acid leucine in the blood. The patient has this symptom.

+10. Hyperisoleucinemia: This is a condition characterized by an abnormally high level of the amino acid isoleucine in the blood. The patient has this symptom.

The following symptoms are not present in the patient:

- Delayed speech and language development
- Abnormality of prenatal development or birth
- Fever
- Death in infancy
- Neonatal death
- Death in childhood
- Death in adolescence
- Feeding difficulties
- Elevated urinary carboxylic acid"
['Phenylketonuria']," +1. Atopic dermatitis: The patient has a skin rash, which is a common symptom of this condition. However, atopic dermatitis does not typically cause abnormalities of prenatal development or birth, obesity, death in infancy, diarrhea, or neonatal or childhood death.

+2. Congenital diaphragmatic hernia: The patient has a hernia, which is a common symptom of this condition. However, congenital diaphragmatic hernia does not typically cause skin rash, gastrointestinal inflammation, recurrent viral infections, hyperphenylalaninemia, or hypertyrosinemia.

+3. Cystic fibrosis: The patient does not have any symptoms that are typically associated with cystic fibrosis.

+4. Down syndrome: The patient does not have any symptoms that are typically associated with Down syndrome.

+5. Ehlers-Danlos syndrome: The patient does not have any symptoms that are typically associated with Ehlers-Danlos syndrome.

+6. Erythema multiforme: The patient has a skin rash, which is a common symptom of this condition. However, erythema multiforme does not typically cause abnormalities of prenatal development or birth, obesity, death in infancy, diarrhea, or neonatal or childhood death.

+7. Familial dysautonomia: The patient does not have any symptoms that are typically associated with familial dysautonomia.

+8. Fetal alcohol syndrome: The patient does not have any symptoms that are typically associated with fetal alcohol syndrome.

+9. Galactosemia: The patient does not have any symptoms that are typically associated with galactosemia.

+10. Gaucher disease: The patient does not have any symptoms that are typically associated with Gaucher disease.

+11. Hemophilia: The patient does not have any symptoms that are typically associated with hemophilia.

+12. Hirschsprung disease: The patient does not have any symptoms that are typically associated with Hirschsprung disease.

+13. Hunter syndrome: The patient does not have any symptoms that are typically associated with Hunter syndrome.

+14. Hypothyroidism: The patient does not have any symptoms that are typically associated with hypothyroidism.

+15. Incontinentia pigmenti: The patient has a skin rash, which is a common symptom of this condition. However, incontinentia pigmenti does not typically cause abnormalities of prenatal development or birth, obesity, death in infancy, diarrhea, or neonatal or childhood death.

+16. Klinefelter syndrome: The patient does not have any symptoms that are typically associated with Klinefelter syndrome.

+17. Lesch-Nyhan syndrome: The patient does not have any symptoms that are typically associated with Lesch-Nyhan syndrome.

+18. Maple syrup urine disease: The patient does not have any symptoms that are typically associated with maple syrup urine disease.

+19. Marfan syndrome: The patient does not have any symptoms that are typically associated with Marfan syndrome.

+20. Menkes disease: The patient does not have any symptoms that are typically associated with Menkes disease.

+21. Neurofibromatosis: The patient does not have any symptoms that are"
['Biotinidase deficiency']," +1. Obsolete Eczematoid Dermatitis: The patient has obsolete eczematoid dermatitis, which is a chronic skin condition characterized by inflammation, redness, and itching. However, the patient does not have symptoms such as death in infancy, alopecia, increased circulating lactate concentration, or increased CSF lactate.

+2. Skin Rash: The patient has a skin rash, which is a common symptom of many skin conditions. However, the patient does not have symptoms such as death in infancy, alopecia, increased circulating lactate concentration, or increased CSF lactate.

+3. Stillbirth or Death in Infancy: The patient does not have a history of stillbirth or death in infancy.

+4. Alopecia: The patient has alopecia, which is a condition that causes hair loss. However, the patient does not have symptoms such as death in infancy, increased circulating lactate concentration, or increased CSF lactate.

+5. Increased Circulating Lactate Concentration: The patient does not have increased circulating lactate concentration.

+6. Increased CSF Lactate: The patient does not have increased CSF lactate.

+7. Lactic Acidosis: The patient does not have lactic acidosis, which is a condition characterized by an increased lactate level in the blood.

+8. Maple Syrup Urine Disease: The patient does not have maple syrup urine disease, which is a genetic disorder that affects the metabolism of certain amino acids.

+9. Meningitis: The patient does not have meningitis, which is an inflammation of the membranes surrounding the brain and spinal cord.

+10. Encephalitis: The patient does not have encephalitis, which is an inflammation of the brain.

+11. Seborrheic Dermatitis: The patient has eczematoid dermatitis, which can be a symptom of seborrheic dermatitis. However, the patient does not have symptoms such as death in infancy, alopecia, increased circulating lactate concentration, or increased CSF lactate.

+12. Psoriasis: The patient does not have psoriasis, which is a chronic skin condition characterized by the formation of red, scaly patches.

+13. Atopic Dermatitis: The patient has eczematoid dermatitis, which can be a symptom of atopic dermatitis. However, the patient does not have symptoms such as death in infancy, alopecia, increased circulating lactate concentration, or increased CSF lactate.

+14. Contact Dermatitis: The patient has eczematoid dermatitis, which can be a symptom of contact dermatitis. However, the patient does not have symptoms such as death in infancy, alopecia, increased circulating lactate concentration, or increased CSF lactate.

+15. Staphylococcal Scalded Skin Syndrome: The patient does not have staphylococcal scalded skin syndrome, which is a bacterial skin infection that causes the top layer of skin to peel off.

+16. Toxic Shock Syndrome: The patient does not have toxic shock syndrome, which is a rare but life-th"
['PMM2-CDG']," Based on the symptoms you have provided, here are some potential diseases:

+1. Bardet-Biedl syndrome: This is a genetic disorder that affects many parts of the body, including the eyes, kidneys, and liver. Symptoms can include rod-cone dystrophy, intellectual disability, and obesity (which can lead to lipodystrophy). However, this syndrome does not typically cause cerebellar atrophy, thromboembolism, or abnormal facial shape.

+2. Joubert syndrome: This is a genetic disorder that affects the cerebellum and other parts of the brain. Symptoms can include cerebellar atrophy, intellectual disability, and abnormal facial shape. However, this syndrome does not typically cause rod-cone dystrophy, thromboembolism, or lipodystrophy.

+3. Cohen syndrome: This is a genetic disorder that affects many parts of the body, including the eyes, brain, and immune system. Symptoms can include intellectual disability, cerebellar atrophy, and abnormal facial shape. However, this syndrome does not typically cause rod-cone dystrophy, thromboembolism, or lipodystrophy.

+4. Zellweger syndrome: This is a genetic disorder that affects the body's ability to break down certain fats. Symptoms can include cerebellar atrophy, intellectual disability, and abnormal facial shape. However, this syndrome does not typically cause rod-cone dystrophy, thromboembolism, or lipodystrophy.

+5. Alagille syndrome: This is a genetic disorder that affects the liver, heart, and other parts of the body. Symptoms can include chronic hepatitis, cerebellar atrophy, and abnormal facial shape. However, this syndrome does not typically cause rod-cone dystrophy, thromboembolism, or lipodystrophy.

+6. Wilson's disease: This is a genetic disorder that affects the body's ability to process copper. Symptoms can include chronic hepatitis, cerebellar atrophy, and abnormal facial shape. However, this syndrome does not typically cause rod-cone dystrophy, thromboembolism, or lipodystrophy.

+7. Galactosemia: This is a genetic disorder that affects the body's ability to process galactose, a sugar found in milk and other dairy products. Symptoms can include intellectual disability, cerebellar atrophy, and abnormal calvaria morphology. However, this syndrome does not typically cause rod-cone dystrophy, thromboembolism, or lipodystrophy.

Please note that this is not an exhaustive list and that further testing and evaluation would be needed to confirm a diagnosis. It is important to consult with a healthcare professional for an accurate diagnosis and appropriate treatment."
['Glutaryl-CoA dehydrogenase deficiency']," +1. Macrocephaly: This is a condition where the head is larger than normal. The patient has this symptom.

+2. Cystic hygroma: This is a birth defect that causes a sac filled with fluid to form in the neck or armpit of a fetus or newborn baby. The patient has this symptom.

+3. Lethargy: This is a state of drowsiness or sluggishness. The patient has this symptom.

+4. Generalized hypotonia: This is a condition of low muscle tone. The patient has this symptom.

+5. Dystonia: This is a neurological movement disorder characterized by involuntary muscle contractions and spasms. The patient has this symptom.

+6. Death in infancy: This is a condition where the patient dies during the first year of life. The patient has this symptom.

+7. Fever: This is a body temperature that is higher than normal. The patient has this symptom.

+8. Vomiting: This is the forceful expulsion of stomach contents through the mouth and sometimes the nose. The patient has this symptom.

+9. Diarrhea: This is the passage of loose or watery stools. The patient has this symptom.

+10. Dyspnea: This is difficulty breathing. The patient has this symptom.

+11. Drowsiness: This is a state of being sleepy or lethargic. The patient has this symptom.

+12. Sleep abnormality: This is a condition where the patient's sleep patterns are disturbed. The patient has this symptom.

+13. Glutaric aciduria: This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient has this symptom.

+14. Neonatal death: This is a condition where the patient dies during the first 28 days of life. The patient has this symptom.

+15. Decreased plasma free carnitine: This is a condition where the level of free carnitine in the blood is low. The patient has this symptom.

+16. Dyskinesia: This is a condition characterized by involuntary muscle movements. The patient has this symptom.

The following diseases are potential diagnoses for the patient based on the symptoms provided:

+17. Canavan disease: This is a rare genetic disorder that affects the white matter in the brain. Symptoms include macrocephaly, lethargy, generalized hypotonia, and death in infancy.

+18. Alexander disease: This is a rare genetic disorder that affects the nervous system. Symptoms include macrocephaly, lethargy, generalized hypotonia, and death in infancy.

+19. Infantile neuroaxonal dystrophy: This is a rare genetic disorder that affects the nervous system. Symptoms include macrocephaly, lethargy, generalized hypotonia, and death in infancy.

+20. Glutaric acidemia type I: This is a rare genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include macrocephaly, lethargy, generalized hypotonia, and death in infancy.

+21. Nonketotic hyperglycinemia: This is a rare genetic disorder that affects the body's ability to break down the amino acid"
['Isovaleric acidemia']," Based on the symptoms you have provided, here are some potential diseases:

+1. Argininemia: This is a rare genetic disorder that affects the breakdown of the amino acid arginine. It can cause abnormal prenatal development or birth, lethargy, drowsiness, hyperammonemia, sleep abnormalities, neonatal death, and death in childhood. However, this disorder does not typically cause feeding difficulties or abnormal circulating carnitine concentration.

+2. Citrullinemia: This is another genetic disorder that affects the breakdown of amino acids. It can cause abnormal prenatal development or birth, lethargy, drowsiness, hyperammonemia, sleep abnormalities, neonatal death, and death in childhood. Similar to argininemia, citrullinemia does not typically cause feeding difficulties or abnormal circulating carnitine concentration.

+3. Maple Syrup Urine Disease: This is a genetic disorder that affects the breakdown of certain amino acids. It can cause abnormal prenatal development or birth, lethargy, drowsiness, hyperammonemia, sleep abnormalities, and neonatal death. However, this disorder typically causes a distinctive sweet odor in the urine, which is not listed among your symptoms.

+4. Carnitine Transporter Deficiency: This is a genetic disorder that affects the body's ability to transport carnitine, a nutrient that helps the body convert fat into energy. It can cause feeding difficulties, abnormal circulating carnitine concentration, and lethargy. However, this disorder does not typically cause abnormal prenatal development or birth, hyperammonemia, or neonatal death.

+5. Organic Acidemias: This is a group of genetic disorders that affect the body's ability to break down certain amino acids and other organic compounds. It can cause abnormal prenatal development or birth, lethargy, drowsiness, hyperammonemia, sleep abnormalities, and neonatal death. However, this disorder does not typically cause feeding difficulties or abnormal circulating carnitine concentration.

Please note that this is not an exhaustive list of potential diseases, and further testing would be needed to confirm a diagnosis. It is important to consult with a healthcare professional for an accurate diagnosis and treatment plan."
['PMM2-CDG']," Based on the symptoms you have provided, I can suggest several potential diseases. Please note that this is only a preliminary assessment and further testing would be needed to make a definitive diagnosis.

+1. Microcephaly with Simplified Gyri and Strabismus (MGS): This condition is characterized by microcephaly, strabismus, intellectual disability, and simplified gyri on brain imaging. However, MGS does not typically present with nystagmus, ataxia, hyporeflexia, or cerebellar agenesis.

+2. Joubert Syndrome: This disorder is associated with cerebellar vermis hypoplasia, leading to symptoms such as hypotonia, ataxia, and developmental delay. However, Joubert Syndrome does not typically present with microcephaly, strabismus, nystagmus, or cerebellar agenesis.

+3. Pontocerebellar Hypoplasia (PCH): PCH is a group of disorders characterized by underdevelopment of the cerebellum and brainstem. Symptoms can include hypotonia, ataxia, and intellectual disability. However, PCH does not typically present with microcephaly, strabismus, nystagmus, or cerebellar agenesis.

+4. Cerebello-Oculo-Renal Syndrome (CORS): CORS is a rare genetic disorder characterized by cerebellar atrophy, ocular abnormalities (such as strabismus and nystagmus), and kidney disease. However, CORS does not typically present with microcephaly, hyporeflexia, or cerebellar agenesis.

+5. Mitochondrial Disorders: Mitochondrial disorders can present with a wide range of symptoms, including hypotonia, ataxia, and intellectual disability. However, mitochondrial disorders do not typically present with microcephaly, strabismus, nystagmus, or cerebellar agenesis.

+6. Lissencephaly: This disorder is characterized by the absence of normal convolutions (gyri) in the cerebral cortex, leading to intellectual disability, seizures, and hypotonia. However, lissencephaly does not typically present with microcephaly, strabismus, nystagmus, or cerebellar agenesis.

+7. Aicardi Syndrome: This X-linked dominant disorder is characterized by agenesis of the corpus callosum, chorioretinal lacunae, and infantile spasms. However, Aicardi Syndrome does not typically present with microcephaly, hyporeflexia, or cerebellar agenesis.

+8. Zellweger Syndrome: This disorder is characterized by a defect in peroxisome biogenesis, leading to a wide range of symptoms including hypotonia, seizures, and developmental delay. However, Zellweger Syndrome does not typically present with microcephaly, strabismus, nystagmus, or cerebellar agenesis.

Based on the patient's symptoms, I would recommend further testing to rule out or confirm these potential diagnoses."
"['Methylmalonic acidemia with homocystinuria, type cblC']"," +1. Leigh Syndrome: The patient has motor delay and generalized hypotonia. However, the patient does not show symptoms of ataxia, weakness, or lactic acidosis which are common in Leigh Syndrome.

+2. Pelizaeus-Merzbacher Disease: The patient has nystagmus and abnormality of prenatal development or birth. However, the patient does not show symptoms of ataxia, spasticity, or developmental regression which are common in Pelizaeus-Merzbacher Disease.

+3. Neuroaxonal Dystrophy: The patient has nystagmus and abnormality of prenatal development or birth. However, the patient does not show symptoms of ataxia, spasticity, or developmental regression which are common in Neuroaxonal Dystrophy.

+4. Refsum Disease: The patient has nystagmus and abnormal circulating carnitine concentration. However, the patient does not show symptoms of retinitis pigmentosa, peripheral neuropathy, or ichthyosis which are common in Refsum Disease.

+5. Maple Syrup Urine Disease: The patient has hyperammonemia, hyperhomocystinemia, and elevated urinary carboxylic acid. However, the patient does not show symptoms of maple syrup odor in urine, vomiting, or seizures which are common in Maple Syrup Urine Disease.

+6. Homocystinuria: The patient has hyperhomocystinemia and elevated urinary carboxylic acid. However, the patient does not show symptoms of dislocation of the lens, Marfanoid habitus, or mental retardation which are common in Homocystinuria.

+7. Methylmalonic Acidemia: The patient has hyperhomocystinemia, methylmalonic aciduria, and elevated urinary carboxylic acid. However, the patient does not show symptoms of vomiting, lethargy, or metabolic acidosis which are common in Methylmalonic Acidemia.

+8. Propionic Acidemia: The patient has hyperammonemia, hyperhomocystinemia, and elevated urinary carboxylic acid. However, the patient does not show symptoms of vomiting, lethargy, or metabolic acidosis which are common in Propionic Acidemia.

+9. Isovaleric Acidemia: The patient has hyperammonemia, hyperhomocystinemia, and elevated urinary carboxylic acid. However, the patient does not show symptoms of vomiting, lethargy, or metabolic acidosis which are common in Isovaleric Acidemia.

+10. Glutaric Acidemia Type I: The patient has hyperammonemia, hyperhomocystinemia, and elevated urinary carboxylic acid. However, the patient does not show symptoms of macrocephaly, encephalopathy, or movement disorders which are common in Glutaric Acidemia Type I.

+11. Non-ketotic Hyperglycinemia: The patient has hyperammonemia and elevated urinary carboxylic acid. However, the patient does not show symptoms of seizures, lethargy, or hypotonia which are common in Non-ketotic Hyperglycinemia."
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Congenital Heart Defects: This condition is present at birth and can affect the structure and function of the heart. However, it does not seem to explain all the symptoms presented.

+2. Inborn Errors of Metabolism: This is a group of genetic disorders caused by defective enzymes. Some symptoms such as hypoglycemia, vomiting, diarrhea, and elevated circulating hepatic transaminase concentration can be associated with this. However, death in infancy and abnormal circulating carnitine concentration can also be seen in some types of these disorders.

+3. Galactosemia: This is an inherited disorder in which the body is unable to metabolize the sugar galactose, leading to toxic buildup. Symptoms can include vomiting, diarrhea, and jaundice. However, death in infancy, hypoglycemia, and abnormal circulating carnitine concentration are not typically associated with this disorder.

+4. Maple Syrup Urine Disease: This is an inherited metabolic disorder that affects the breakdown of certain amino acids. Symptoms can include vomiting, diarrhea, and abnormal circulating amino acids. However, death in infancy, hypoglycemia, and elevated circulating hepatic transaminase concentration are not typically associated with this disorder.

+5. Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): This is an inherited metabolic disorder that affects the breakdown of certain fats. Symptoms can include hypoglycemia, vomiting, and lethargy. However, death in infancy, diarrhea, and elevated circulating hepatic transaminase concentration are not typically associated with this disorder.

+6. Tyrosinemia: This is an inherited metabolic disorder that affects the breakdown of the amino acid tyrosine. Symptoms can include vomiting, diarrhea, and elevated circulating liver enzymes. However, death in infancy and abnormal circulating carnitine concentration are not typically associated with this disorder.

+7. Urea Cycle Disorders: This is a group of inherited metabolic disorders that affect the body's ability to remove ammonia from the blood. Symptoms can include vomiting, lethargy, and seizures. However, death in infancy, hypoglycemia, and elevated circulating hepatic transaminase concentration are not typically associated with this disorder.

Please note that this is not an exhaustive list and the symptoms presented can be associated with other medical conditions as well. It is important to consult with a healthcare professional for a proper diagnosis."
['Succinic semialdehyde dehydrogenase deficiency']," +1. Hyperkalemic Periodic Paralysis: The patient has hyperkalemia in common. However, this disease does not typically present with coma, death in infancy, neonatal death, respiratory acidosis, or elevated urinary carboxylic acid.

+2. Bartter Syndrome: The patient has hyperkalemia and hyponatremia in common. However, this disease does not typically present with coma, death in infancy, neonatal death, respiratory acidosis, or elevated urinary carboxylic acid.

+3. Gitelman Syndrome: The patient has hypokalemia and metabolic alkalosis in common. However, this disease does not typically present with coma, death in infancy, neonatal death, respiratory acidosis, or elevated urinary carboxylic acid.

+4. Primary Hyperaldosteronism: The patient has hyperkalemia in common. However, this disease does not typically present with coma, death in infancy, neonatal death, respiratory acidosis, or elevated urinary carboxylic acid.

+5. Liddle Syndrome: The patient has hyperkalemia and hypertension in common. However, this disease does not typically present with coma, death in infancy, neonatal death, respiratory acidosis, or elevated urinary carboxylic acid.

+6. Pseudohypoaldosteronism: The patient has hyperkalemia and hyponatremia in common. However, this disease does not typically present with coma, death in infancy, neonatal death, respiratory acidosis, or elevated urinary carboxylic acid.

+7. Type 4 Renal Tubular Acidosis: The patient has hyperkalemia and metabolic acidosis in common. However, this disease does not typically present with coma, death in infancy, neonatal death, or elevated urinary carboxylic acid.

+8. Organic Acidemias: The patient has elevated urinary carboxylic acid in common. However, this disease does not typically present with coma, death in infancy, neonatal death, or respiratory acidosis.

+9. Maple Syrup Urine Disease: The patient has elevated urinary carboxylic acid in common. However, this disease does not typically present with coma, death in infancy, neonatal death, or respiratory acidosis.

+10. Isovaleric Acidemia: The patient has elevated urinary carboxylic acid in common. However, this disease does not typically present with coma, death in infancy, neonatal death, or respiratory acidosis.

+11. Propionic Acidemia: The patient has elevated urinary carboxylic acid in common. However, this disease does not typically present with coma, death in infancy, neonatal death, or respiratory acidosis.

+12. Methylmalonic Acidemia: The patient has elevated urinary carboxylic acid in common. However, this disease does not typically present with coma, death in infancy, neonatal death, or respiratory acidosis.

+13. Glutaric Acidemia Type 1: The patient has elevated urinary carboxylic acid in common. However, this disease does"
['Classic homocystinuria']," Based on the symptoms you have provided, I have compiled a list of potential diseases that the patient may have. Please note that this is not a definitive diagnosis and further medical testing and evaluation is necessary.

+1. Marfan syndrome: This is a genetic disorder that affects the body's connective tissue. Symptoms may include tall stature, long fingers, curved spine, and lens dislocation. However, Marfan syndrome does not typically cause intellectual disability, motor delay, or hyperhomocystinemia.

+2. Homocystinuria: This is a genetic disorder that affects the body's ability to process the amino acid methionine. Symptoms may include intellectual disability, motor delay, ectopia lentis, and long limbs. However, Homocystinuria does not typically cause ptosis or hypermethioninemia.

+3. Ehlers-Danlos syndrome: This is a group of disorders that affect connective tissues that support the skin, bones, blood vessels, and other organs. Symptoms may include joint hypermobility, stretchy skin, and fragile skin. However, Ehlers-Danlos syndrome does not typically cause ectopia lentis, intellectual disability, or motor delay.

+4. Down syndrome: This is a genetic disorder caused when abnormal cell division results in an extra full or partial copy of chromosome 21. Symptoms may include intellectual disability, distinct facial features, and poor muscle tone. However, Down syndrome does not typically cause ptosis, ectopia lentis, or long limbs.

+5. Klinefelter syndrome: This is a genetic disorder in which a male is born with an extra X chromosome. Symptoms may include tall stature, long limbs, and small testes. However, Klinefelter syndrome does not typically cause ptosis, ectopia lentis, or intellectual disability.

+6. Weill-Marchesani syndrome: This is a genetic disorder that affects the body's connective tissue. Symptoms may include short stature, brachydactyly (short fingers and toes), and ectopia lentis. However, Weill-Marchesani syndrome does not typically cause intellectual disability, motor delay, or hyperhomocystinemia.

+7. Cerebral palsy: This is a group of disorders that affect muscle coordination and movement. Symptoms may include intellectual disability, motor delay, and fatigue. However, cerebral palsy does not typically cause ptosis, ectopia lentis, or long limbs.

Please consult with a healthcare professional for further evaluation and testing."
[]," +1. Marfan syndrome: The patient has wide mouth and possibly seizure, but does not have carious teeth, hyperinsulinemia, sparse hair, hypoglycemia, neonatal death, or death in childhood.

+2. Down syndrome: The patient has epicanthus and possibly feeding difficulties, but does not have carious teeth, hyperinsulinemia, sparse hair, seizure, hypoglycemia, neonatal death, or death in childhood.

+3. Early-onset diabetes: The patient has hyperinsulinemia and possibly wide mouth, but does not have carious teeth, sparse hair, seizure, hypoglycemia, neonatal death, or death in childhood.

+4. Hypothyroidism: The patient has wide mouth and possibly seizure, but does not have carious teeth, hyperinsulinemia, sparse hair, hypoglycemia, neonatal death, or death in childhood.

+5. Ehlers-Danlos syndrome: The patient has wide mouth and possibly seizure, but does not have carious teeth, hyperinsulinemia, sparse hair, hypoglycemia, neonatal death, or death in childhood.

+6. Phenylketonuria: The patient does not have any symptoms that match this disease.

+7. Cystic fibrosis: The patient does not have any symptoms that match this disease.

+8. Sickle cell anemia: The patient has abnormal hemoglobin and possibly feeding difficulties, but does not have wide mouth, epicanthus, carious teeth, hyperinsulinemia, seizure, hypoglycemia, neonatal death, or death in childhood.

+9. Turner syndrome: The patient does not have any symptoms that match this disease.

+10. Williams syndrome: The patient does not have any symptoms that match this disease.

+11. Tuberous sclerosis: The patient has seizure and possibly wide mouth, but does not have carious teeth, hyperinsulinemia, sparse hair, hypoglycemia, neonatal death, or death in childhood.

+12. Neurofibromatosis: The patient does not have any symptoms that match this disease.

+13. Noonan syndrome: The patient has wide mouth and possibly seizure, but does not have carious teeth, hyperinsulinemia, sparse hair, hypoglycemia, neonatal death, or death in childhood.

+14. Prader-Willi syndrome: The patient has feeding difficulties and possibly wide mouth, but does not have carious teeth, hyperinsulinemia, seizure, hypoglycemia, neonatal death, or death in childhood.

+15. Angelman syndrome: The patient does not have any symptoms that match this disease.

+16. Cornelia de Lange syndrome: The patient does not have any symptoms that match this disease.

+17. Rubinstein-Taybi syndrome: The patient does not have any symptoms that match this disease.

+18. Smith-Magenis syndrome: The patient does not have any symptoms that match this disease.

+19. Wolf-Hirschhorn syndrome: The patient does not have any symptoms that match this disease.

+20. 1p36 deletion syndrome: The patient does not have any symptoms that match this disease.

+21. DiGeorge syndrome"
['Propionic acidemia']," Based on the symptoms you have provided, here are some potential diseases:

+1. Maple Syrup Urine Disease: This is a genetic disorder that affects the way the body breaks down certain amino acids (proteins). Symptoms include abnormal circulating carnitine concentration, hyperammonemia, hyperglycinemia, and hypoglycinemia. However, this disease does not typically cause abnormalities of prenatal development or birth, intellectual disability, seizure, motor delay, anemia, hepatomegaly, neonatal death, or death in childhood.

+2. Non-ketotic Hyperglycinemia: This is a genetic disorder that affects the way the body processes the amino acid glycine. Symptoms include hypoglycinemia, seizure, and intellectual disability. However, this disease does not typically cause abnormalities of prenatal development or birth, motor delay, anemia, hepatomegaly, neonatal death, or death in childhood.

+3. Phenylketonuria (PKU): This is a genetic disorder that affects the way the body processes the amino acid phenylalanine. Symptoms can include intellectual disability, seizure, and motor delay. However, this disease does not typically cause abnormalities of prenatal development or birth, anemia, hepatomegaly, neonatal death, or death in childhood.

+4. Homocystinuria: This is a genetic disorder that affects the way the body processes the amino acid methionine. Symptoms can include intellectual disability, seizure, and motor delay. However, this disease does not typically cause abnormalities of prenatal development or birth, anemia, hepatomegaly, neonatal death, or death in childhood.

+5. Zellweger Syndrome: This is a genetic disorder that affects the way the body metabolizes fats. Symptoms can include abnormalities of prenatal development or birth, intellectual disability, seizure, motor delay, hepatomegaly, and neonatal death. However, this disease does not typically cause anemia, hyperammonemia, hyperglycinemia, hypoglycinemia, or death in childhood.

Please note that this is not an exhaustive list and further testing would be needed to confirm a diagnosis. It is important to consult with a healthcare professional for an accurate diagnosis and treatment plan."
['Vitamin B12-unresponsive methylmalonic acidemia']," Based on the symptoms you have provided, here are some potential diseases:

+1. Methylmalonic acidemia with homocystinuria,"
['Systemic primary carnitine deficiency']," +1. Coma: A state of deep unconsciousness in which a person is unable to respond to stimuli or communicate. The patient has this symptom.

+2. Death in infancy: The cessation of life during the first year of life. The patient does not have this symptom.

+3. Sudden death: The unexpected and sudden death of a person, often without any obvious cause. The patient has this symptom.

+4. Hypoglycemia: A condition characterized by abnormally low levels of glucose in the blood. The patient has this symptom.

+5. Vomiting: The forcible expulsion of stomach contents through the mouth. The patient has this symptom.

+6. Elevated circulating alkaline phosphatase concentration: A condition in which there are higher than normal levels of the enzyme alkaline phosphatase in the blood. The patient has this symptom.

+7. Decreased plasma free carnitine: A condition in which there are lower than normal levels of free carnitine in the blood. The patient has this symptom.

+8. Abnormal circulating aspartate family amino acid concentration: A condition in which there are abnormal levels of aspartate family amino acids in the blood. The patient has this symptom.

+9. Abnormal circulating alanine concentration: A condition in which there are abnormal levels of alanine in the blood. The patient has this symptom.

+10. Increased circulating lactate dehydrogenase concentration: A condition in which there are higher than normal levels of lactate dehydrogenase in the blood. The patient has this symptom.

These symptoms could be indicative of a number of different diseases, including metabolic disorders, infections, and neurological conditions. It is important to conduct further tests and evaluations to determine the specific cause of the patient's symptoms."
['3-methylcrotonyl-CoA carboxylase deficiency']," +1. Lethargy: This could be a symptom of many different diseases, but one potential cause is a metabolic disorder such as medium-chain acyl-CoA dehydrogenase deficiency (MCAD). MCAD is a genetic disorder that affects the body's ability to break down certain fats for energy, leading to symptoms such as lethargy, especially during periods of fasting or illness.

+2. Death in infancy: This is a serious symptom that could be caused by a number of different diseases. One possibility is sudden infant death syndrome (SIDS), which is the unexplained death of a seemingly healthy baby, usually during sleep. However, it's important to note that SIDS is a diagnosis of exclusion, meaning that other potential causes of death must be ruled out before SIDS can be diagnosed.

+3. Clumsiness and poor coordination: These symptoms could be indicative of a neurological disorder such as cerebral palsy. Cerebral palsy is a group of disorders that affect movement and muscle tone, and is usually caused by damage to the brain before or during birth.

+4. Drowsiness and sleep abnormality: These symptoms could be indicative of a sleep disorder such as narcolepsy. Narcolepsy is a neurological disorder that affects the brain's ability to regulate sleep-wake cycles, leading to excessive daytime sleepiness and sudden attacks of sleep.

+5. Decreased plasma free carnitine: This is a symptom that could indicate a metabolic disorder such as carnitine deficiency. Carnitine is a nutrient that helps the body convert fat into energy, and a deficiency can lead to symptoms such as lethargy, muscle weakness, and developmental delays.

+6. Feeding difficulties: This symptom could be indicative of a number of different diseases, including gastrointestinal disorders such as gastroesophageal reflux disease (GERD) or food allergies. It could also be a symptom of a neurological disorder such as cerebral palsy.

It's important to note that this is not an exhaustive list of potential diseases, and that further testing and evaluation would be necessary to make a definitive diagnosis. Additionally, some of these symptoms may overlap with multiple diseases, making it difficult to pinpoint a specific cause without further investigation."
[]," Based on the symptoms you have provided, I will list some potential diseases that could match the patient's condition. Please note that this list is not exhaustive, and a proper diagnosis should be made by a healthcare professional after a thorough examination and diagnostic testing.

1. +1 Pontocerebellar hypoplasia (PCH): Delayed speech and language development, hypotonia, and ataxia. However, PCH typically does not present with spasticity or hyperreflexia.

2. +2 Leigh syndrome: Delayed development, hypotonia, and encephalopathy. Some forms of Leigh syndrome can present with spasticity and hyperreflexia, but they usually do not cause dysarthria or spastic tetraplegia.

3. +3 Pelizaeus-Merzbacher disease (PMD): Delayed speech and language development, hypotonia, and ataxia. PMD can also cause spasticity, but it does not typically present with hyperreflexia or encephalopathy.

4. +4 Metachromatic leukodystrophy (MLD): Delayed development, hypotonia, and encephalopathy. MLD can also cause spasticity and hyperreflexia, but it does not typically present with dysarthria or spastic tetraplegia.

5. +5 Glutaric aciduria type 1: Delayed development, hypotonia, and encephalopathy. Glutaric aciduria type 1 can also cause dystonia and dysarthria, but it does not typically present with spasticity or hyperreflexia.

6. +6 Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS): Delayed development, encephalopathy, and recurrent viral infections. MELAS can also cause spasticity and hyperreflexia, but it does not typically present with dysarthria or spastic tetraplegia.

7. +7 Non-ketotic hyperglycinemia (NKH): Delayed development, encephalopathy, and abnormal circulating glycine concentration. NKH can also cause hypotonia and dysarthria, but it does not typically present with spasticity or hyperreflexia.

8. +8 Ethylmalonic encephalopathy (EE): Delayed development, encephalopathy, and ethylmalonic aciduria. EE can also cause spasticity and hyperreflexia, but it does not typically present with dysarthria or spastic tetraplegia.

9. +9 Cytochrome c oxidase deficiency: Delayed development, encephalopathy, and cytochrome C oxidase-negative muscle fibers. Cytochrome c oxidase deficiency can also cause hypotonia and spasticity, but it does not typically present with dysarthria or spastic tetraplegia.

10. +10 Spinal muscular atrophy (SMA): Delayed development, hypotonia, and recurrent viral infections. SMA does not typically present with spasticity, hyperreflexia, or encephalopathy.

Please note that some of these diseases can lead to death in adolescence or early adulthood, as mentioned in the provided symptoms. A proper diagnosis should be made by a healthcare professional to determine the underlying cause of the patient'"
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Smith-Lemli-Opitz syndrome: A genetic disorder affecting the metabolism of cholesterol, which can result in abnormal prenatal development or birth, and in some cases, death in infancy or neonatal death. However, this syndrome does not typically cause abnormal circulating carnitine concentration.

+2. Maple syrup urine disease: A genetic disorder affecting the metabolism of certain amino acids, which can result in abnormal prenatal development or birth, and in some cases, death in infancy or neonatal death. This disease does not typically cause abnormal circulating carnitine concentration.

+3. Carnitine transporter deficiency: A genetic disorder affecting the transport of carnitine in the body, which can result in abnormal circulating carnitine concentration. However, this disorder does not typically cause abnormal prenatal development or birth, or death in infancy or neonatal death.

+4. Carnitine palmitoyltransferase II deficiency: A genetic disorder affecting the metabolism of fatty acids, which can result in abnormal circulating carnitine concentration. However, this disorder does not typically cause abnormal prenatal development or birth, or death in infancy or neonatal death.

+5. 3-methylcrotonyl-CoA carboxylase deficiency: A genetic disorder affecting the metabolism of certain amino acids, which can result in abnormal prenatal development or birth, and in some cases, death in infancy or neonatal death. However, this disorder does not typically cause abnormal circulating carnitine concentration.

It is important to note that these are potential diagnoses based on the given symptoms, and further testing and evaluation would be necessary to confirm any diagnosis."
['Glutaryl-CoA dehydrogenase deficiency']," +1. Megalencephaly: Macrocephaly is a common symptom, while other symptoms such as cystic hygroma, hyperhidrosis, lethargy, generalized hypotonia, dystonia, metabolic acidosis, fever, vomiting, diarrhea, dyspnea, drowsiness, sleep abnormality, glutaric aciduria, elevated circulating glutaric acid concentration, neonatal death, death in childhood, decreased plasma free carnitine, and dyskinesia are not typically associated with this condition.

+2. Lymphatic malformation: Macrocephaly and cystic hygroma are common symptoms, while hyperhidrosis, lethargy, generalized hypotonia, dystonia, metabolic acidosis, fever, vomiting, diarrhea, dyspnea, drowsiness, sleep abnormality, glutaric aciduria, elevated circulating glutaric acid concentration, neonatal death, death in childhood, decreased plasma free carnitine, and dyskinesia are not typically associated with this condition.

+3. Hypohidrotic ectodermal dysplasia: Macrocephaly and hyperhidrosis are common symptoms, while cystic hygroma, lethargy, generalized hypotonia, dystonia, metabolic acidosis, fever, vomiting, diarrhea, dyspnea, drowsiness, sleep abnormality, glutaric aciduria, elevated circulating glutaric acid concentration, neonatal death, death in childhood, decreased plasma free carnitine, and dyskinesia are not typically associated with this condition.

+4. Congenital central hypoventilation syndrome: Lethargy, dyspnea, and drowsiness are common symptoms, while macrocephaly, cystic hygroma, hyperhidrosis, generalized hypotonia, dystonia, metabolic acidosis, fever, vomiting, diarrhea, sleep abnormality, glutaric aciduria, elevated circulating glutaric acid concentration, neonatal death, death in childhood, decreased plasma free carnitine, and dyskinesia are not typically associated with this condition.

+5. Prader-Willi syndrome: Macrocephaly, hypotonia, and drowsiness are common symptoms, while cystic hygroma, hyperhidrosis, dystonia, metabolic acidosis, fever, vomiting, diarrhea, dyspnea, sleep abnormality, glutaric aciduria, elevated circulating glutaric acid concentration, neonatal death, death in childhood, decreased plasma free carnitine, and dyskinesia are not typically associated with this condition.

+6. Glutaric acidemia type I: Macrocephaly, metabolic acidosis, glutaric aciduria, elevated circulating glutaric acid concentration, and dystonia are common symptoms, while cystic hygroma, hyperhidrosis, lethargy, generalized hypotonia, fever, vomiting, diarrhea, dyspnea, drowsiness, sleep abnormality, neonatal death, death in childhood, decreased plasma free carnitine, and dyskinesia are not typically associated with this condition.

+7. Maple syrup urine disease: Mac"
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder that causes an amino acid called phenylalanine to build up in the body. It can lead to abnormal prenatal development, neonatal death, and death in infancy or childhood if left untreated. Hyperphenylalaninemia is a common symptom of PKU. However, this disorder does not typically cause hypertyrosinemia or death in adolescence.

+2. Tyrosinemia type I: This is a rare genetic disorder that affects the breakdown of the amino acid tyrosine. It can cause abnormal prenatal development, neonatal death, and death in infancy or childhood if left untreated. Hypertyrosinemia is a common symptom of tyrosinemia type I. However, this disorder does not typically cause hyperphenylalaninemia or death in adolescence.

+3. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the breakdown of certain amino acids (leucine, isoleucine, and valine). It can cause abnormal prenatal development, neonatal death, and death in infancy or childhood if left untreated. Hyperphenylalaninemia is a common symptom of MSUD. However, this disorder does not typically cause hypertyrosinemia or death in adolescence.

+4. Homocystinuria: This is a genetic disorder that affects the breakdown of the amino acid methionine. It can cause abnormal prenatal development, neonatal death, and death in infancy or childhood if left untreated. Hyperhomocysteinemia is a common symptom of homocystinuria. However, this disorder does not typically cause hypertyrosinemia or hyperphenylalaninemia, and death in adolescence is uncommon.

+5. Nonketotic hyperglycinemia: This is a genetic disorder that affects the breakdown of the amino acid glycine. It can cause abnormal prenatal development, neonatal death, and death in infancy or childhood if left untreated. Elevated glycine levels in the blood and spinal fluid are common symptoms of nonketotic hyperglycinemia. However, this disorder does not typically cause hypertyrosinemia or hyperphenylalaninemia, and death in adolescence is uncommon.

It is important to note that the symptoms listed in the patient's history are non-specific and can be caused by a variety of different conditions. A definitive diagnosis can only be made through further testing and evaluation by a healthcare professional."
['L-2-hydroxyglutaric aciduria']," +1. Cerebral palsy: A group of disorders that affect movement and muscle tone or posture. The patient has delayed speech and language development, difficulty walking, and difficulty running in common. The patient does not have death in infancy or childhood as a symptom.

+2. Leukodystrophy: A group of genetic disorders that affect the white matter of the brain. The patient has abnormal cerebral white matter morphology in common. The patient does not have delayed speech and language development, intellectual disability, hyperreflexia, difficulty climbing stairs, or difficulty running as symptoms.

+3. Rett syndrome: A genetic disorder that affects brain development, primarily in females. The patient has delayed speech and language development, intellectual disability, and difficulty walking in common. The patient does not have death in infancy, hyperreflexia, difficulty climbing stairs, or difficulty running as symptoms.

+4. Duchenne muscular dystrophy: A genetic disorder characterized by progressive muscle degeneration and weakness. The patient does not have delayed speech and language development, intellectual disability, hyperreflexia, abnormal cerebral white matter morphology, difficulty climbing stairs, or difficulty running as symptoms.

+5. Spinal muscular atrophy: A genetic disorder that affects the motor neurons in the spinal cord, causing muscle weakness and atrophy. The patient does not have delayed speech and language development, intellectual disability, hyperreflexia, abnormal cerebral white matter morphology, difficulty climbing stairs, or difficulty running as symptoms.

+6. Phenylketonuria (PKU): A genetic disorder that affects the body's ability to break down an amino acid called phenylalanine. The patient does not have delayed speech and language development, intellectual disability, hyperreflexia, abnormal cerebral white matter morphology, difficulty climbing stairs, or difficulty running as symptoms.

+7. Fragile X syndrome: A genetic disorder that causes intellectual disability, behavioral and learning challenges, and various physical characteristics. The patient has delayed speech and language development and intellectual disability in common. The patient does not have hyperreflexia, abnormal cerebral white matter morphology, difficulty climbing stairs, or difficulty running as symptoms.

+8. Tuberous sclerosis complex: A genetic disorder that causes non-cancerous (benign) tumors to grow in many parts of the body. The patient does not have delayed speech and language development, intellectual disability, hyperreflexia, abnormal cerebral white matter morphology, difficulty climbing stairs, or difficulty running as symptoms.

+9. Neurofibromatosis type 1: A genetic disorder that causes tumors to grow on nerves throughout the body. The patient does not have delayed speech and language development, intellectual disability, hyperreflexia, abnormal cerebral white matter morphology, difficulty climbing stairs, or difficulty running as symptoms.

+10. Angelman syndrome: A genetic disorder that affects the nervous system and causes developmental delays and neurological problems. The patient has delayed speech and language development in common. The patient does not have intellectual disability, hyperreflexia, abnormal cerebral white matter morphology, difficulty climbing stairs, or difficulty running as symptoms.

It is important to note that this is not an exhaustive list of potential diagnoses, and further evaluation and testing would be necessary to determine the underlying cause of the patient's symptoms."
['Maple syrup urine disease']," +1. Maple Syrup Urine Disease (MSUD): The patient has hypervalinemia, hyperleucinemia, and hyperisoleucinemia, which are characteristic of MSUD. However, the patient does not have the sweet-smelling urine that gives this condition its name.

+2. Nonketotic Hyperglycinemia (NKH): The patient has hypoglycemia, which can be a symptom of NKH. However, NKH is typically characterized by developmental delay, seizures, and episodic apnea, which the patient does not have.

+3. Pompe Disease: The patient has generalized hypotonia, which can be a symptom of Pompe disease. However, Pompe disease is typically characterized by hypertrophic cardiomyopathy, which the patient does not have.

+4. Prader-Willi Syndrome (PWS): The patient has obesity and hypotonia, which are characteristic of PWS. However, PWS is typically characterized by hyperphagia, short stature, and distinctive facial features, which the patient does not have.

+5. Leigh Syndrome: The patient has hypotonia and death in infancy or early adulthood, which can be symptoms of Leigh syndrome. However, Leigh syndrome is typically characterized by progressive neurologic decline, including motor and intellectual regression, and characteristic brain MRI findings, which the patient does not have.

+6. Canavan Disease: The patient has spasticity and hypotonia, which can be symptoms of Canavan disease. However, Canavan disease is typically characterized by macrocephaly, which the patient does not have.

+7. Krabbe Disease: The patient has spasticity and death in early adulthood, which can be symptoms of Krabbe disease. However, Krabbe disease is typically characterized by global developmental delay, optic atrophy, and peripheral neuropathy, which the patient does not have.

+8. Niemann-Pick Disease Type C (NPC): The patient has spasticity and death in early adulthood, which can be symptoms of NPC. However, NPC is typically characterized by ataxia, vertical supranuclear gaze palsy, and gelastic cataplexy, which the patient does not have.

+9. Alexander Disease: The patient has spasticity and hypotonia, which can be symptoms of Alexander disease. However, Alexander disease is typically characterized by megalencephaly, bulbar symptoms, and characteristic MRI findings, which the patient does not have.

+10. Pelizaeus-Merzbacher Disease (PMD): The patient has spasticity and hypotonia, which can be symptoms of PMD. However, PMD is typically characterized by nystagmus, ataxia, and developmental delay, which the patient does not have.

It is important to note that this list is not exhaustive and that further diagnostic testing is necessary to confirm a diagnosis."
['Classic galactosemia']," Based on the symptoms you have provided, here are some potential diseases:

+1. Phenylketonuria (PKU): PKU is a genetic disorder characterized by the body's inability to break down an amino acid called phenylalanine. This can lead to brain damage, delayed speech and language development, and intellectual disability. However, PKU does not typically cause obesity, death in infancy or adolescence, or abnormal circulating tyrosine concentration.

+2. Maple Syrup Urine Disease (MSUD): MSUD is a genetic disorder that affects the body's ability to break down certain amino acids, including leucine, isoleucine, and valine. This can lead to delayed speech and language development, hyperalaninemia, aminoaciduria, and increased total bilirubin. However, MSUD does not typically cause obesity, death in infancy or adolescence, or abnormal circulating tyrosine concentration.

+3. Galactosemia: Galactosemia is a genetic disorder that affects the body's ability to break down the sugar galactose, which is found in milk and other dairy products. This can lead to increased total bilirubin, abnormality of galactoside metabolism, and abnormal circulating aspartate family amino acid concentration. However, galactosemia does not typically cause delayed speech and language development, obesity, death in infancy or adolescence, hyperalaninemia, or aminoaciduria.

+4. Tyrosinemia: Tyrosinemia is a genetic disorder that affects the body's ability to break down the amino acid tyrosine. This can lead to delayed speech and language development, obesity, hypergalactosemia, abnormal circulating tyrosine concentration, and death in adolescence. However, tyrosinemia does not typically cause increased total bilirubin or abnormal circulating aspartate family amino acid concentration.

It is important to note that these are just potential diagnoses based on the symptoms you have provided. Further testing and evaluation would be needed to confirm any diagnosis."
['3-hydroxy-3-methylglutaric aciduria']," Based on the symptoms you have provided, here are some potential diseases:

+1. Propionic Acidemia: This is a genetic disorder characterized by the buildup of harmful substances in the body due to the lack of an enzyme needed to break down certain proteins. Symptoms can include death in infancy, metabolic acidosis, fever, hyperammonemia, vomiting, dicarboxylic aciduria, and 3-methylglutaric aciduria. However, abnormal circulating glycine concentration is not typically associated with this disorder.

+2. Methylmalonic Acidemia: This is another genetic disorder that affects the body's ability to break down certain proteins. Symptoms can include metabolic acidosis, hyperammonemia, vomiting, dicarboxylic aciduria, and 3-methylglutaric aciduria. However, death in infancy, fever, and abnormal circulating glycine concentration are not typically associated with this disorder.

+3. Isovaleric Acidemia: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include metabolic acidosis, hyperammonemia, vomiting, and dicarboxylic aciduria. However, death in infancy, fever, 3-methylglutaric aciduria, and abnormal circulating glycine concentration are not typically associated with this disorder.

+4. Nonketotic Hyperglycinemia: This is a genetic disorder that affects the body's ability to break down the amino acid glycine. Symptoms can include abnormal circulating glycine concentration, seizures, lethargy, and developmental delays. However, death in infancy, metabolic acidosis, hyperammonemia, vomiting, dicarboxylic aciduria, and 3-methylglutaric aciduria are not typically associated with this disorder.

It is important to note that these are potential diagnoses based on the symptoms provided, and further testing would be needed to confirm any diagnosis. Additionally, it is possible that the patient's symptoms could be caused by a combination of factors, or by a different disorder entirely."
['Classic homocystinuria']," Based on the symptoms you have provided, here are some potential diseases that the patient may have:

+1. Hepatitis: This is an inflammation of the liver that can cause jaundice, anemia, and abnormal liver function tests. However, hepatitis does not typically cause generalized hypotonia, hyperhomocystinemia, hypomethioninemia, or death in childhood.

+2. Hemolytic anemia: This is a condition in which the red blood cells are destroyed faster than they can be replaced, leading to anemia. Hemolytic anemia can be caused by various factors, including infections, medications, and inherited disorders. However, hemolytic anemia does not typically cause jaundice, hyperhomocystinemia, hypomethioninemia, or death in childhood.

+3. Homocystinuria: This is an inherited disorder of methionine metabolism that can cause hyperhomocystinemia, hypomethioninemia, developmental delay, Marfan-like features, and thromboembolic events. However, homocystinuria does not typically cause jaundice, anemia, or recurrent viral infections.

+4. Porphyria: This is a group of disorders that affect the production of heme, a component of hemoglobin. Porphyria can cause abnormal circulating porphyrin concentrations, neurologic symptoms, and skin manifestations. However, porphyria does not typically cause jaundice, anemia, or hypomethioninemia.

+5. Folate deficiency: This is a condition in which there is a lack of folate, a B vitamin, in the body. Folate deficiency can cause anemia, neurologic symptoms, and abnormalities of folate metabolism. However, folate deficiency does not typically cause jaundice, hyperhomocystinemia, or hypomethioninemia.

+6."
['Phenylketonuria']," Based on the symptoms you have provided, I have compiled a list of potential diseases that the patient may have. Please note that this is not a definitive diagnosis and further testing would be needed to confirm.

+1. Tracheoesophageal Fistula: This is a congenital abnormality where the esophagus and trachea are abnormally connected, leading to upper airway obstruction. However, this condition does not typically result in death in infancy, childhood, adolescence, or early adulthood.

+2. Phenylketonuria (PKU): This is a metabolic disorder that results in an inability to break down the amino acid phenylalanine, leading to hyperphenylalaninemia and hypertyrosinemia. However, PKU does not typically cause prenatal developmental abnormalities, neonatal death, or chronic pulmonary obstruction.

+3. Cystic Fibrosis: This is a genetic disorder that affects the respiratory and digestive systems, leading to chronic pulmonary obstruction and upper airway obstruction. However, cystic fibrosis does not typically cause prenatal developmental abnormalities, neonatal death, or death in infancy, childhood, adolescence, or early adulthood.

+4. Congenital Diaphragmatic Hernia: This is a birth defect where the diaphragm does not form properly, leading to abnormalities of prenatal development and birth, as well as upper airway obstruction and neonatal death. However, this condition does not typically result in hypertyrosinemia, hyperphenylalaninemia, or death in infancy, childhood, adolescence, or early adulthood.

+5. Alpha-1 Antitrypsin Deficiency: This is a genetic disorder that affects the lungs and liver, leading to chronic pulmonary obstruction and death in early adulthood. However, this condition does not typically cause prenatal developmental abnormalities, neonatal death, or death in infancy, childhood, or adolescence.

Please consult with a healthcare professional for a definitive diagnosis."
['Biotinidase deficiency']," +1. Hypoxic-Ischemic Encephalopathy (HIE): The patient has seizure and dyspnea, which are common symptoms of HIE. However, the patient does not show symptoms such as coma or feeding difficulties, which are commonly associated with HIE.

+2. Leigh's Disease: The patient has seizure, dyspnea, and elevated urinary carboxylic acid, which are common symptoms of Leigh's Disease. However, the patient does not show symptoms such as vomiting or developmental delays, which are commonly associated with Leigh's Disease.

+3. Maple Syrup Urine Disease (MSUD): The patient has elevated urinary carboxylic acid, which is a common symptom of MSUD. However, the patient does not show symptoms such as sweet-smelling urine or maple syrup odor on the skin, which are commonly associated with MSUD.

+4. Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS): The patient has seizure, dyspnea, and elevated urinary carboxylic acid, which are common symptoms of MELAS. However, the patient does not show symptoms such as muscle weakness or headaches, which are commonly associated with MELAS.

+5. Neonatal Adrenoleukodystrophy (NALD): The patient has seizure, which is a common symptom of NALD. However, the patient does not show symptoms such as developmental delays or vision loss, which are commonly associated with NALD.

+6. Phenylketonuria (PKU): The patient has elevated urinary carboxylic acid, which is a common symptom of PKU. However, the patient does not show symptoms such as intellectual disability or eczema, which are commonly associated with PKU.

+7. Pyruvate Dehydrogenase Deficiency (PDHD): The patient has seizure, dyspnea, and elevated urinary carboxylic acid, which are common symptoms of PDHD. However, the patient does not show symptoms such as developmental delays or lactic acidosis, which are commonly associated with PDHD.

+8. Rett Syndrome: The patient has apathy, which is a common symptom of Rett Syndrome. However, the patient does not show symptoms such as repetitive hand movements or loss of speech, which are commonly associated with Rett Syndrome.

+9. Spinal Muscular Atrophy (SMA): The patient has spasticity, which is a common symptom of SMA. However, the patient does not show symptoms such as muscle weakness or tremors, which are commonly associated with SMA.

+10. Tuberous Sclerosis Complex (TSC): The patient has seizure, which is a common symptom of TSC. However, the patient does not show symptoms such as skin abnormalities or behavioral problems, which are commonly associated with TSC.

It is important to note that this list is not exhaustive and further diagnostic testing is necessary to confirm a diagnosis."
['Phenylketonuria']," +1. Obesity: The patient has obesity, which is a condition characterized by excessive body fat accumulation to the extent that it may have an adverse effect on health.

+2. Fever: The patient has a fever, which is an elevation of body temperature above the normal range of 36-37C (96.8-98.6F).

+3. Vomiting: The patient has vomiting, which is the forceful expulsion of stomach contents through the mouth.

+4. Hypertyrosinemia: The patient has hypertyrosinemia, which is an elevated level of tyrosine in the blood.

+5. Hyperphenylalaninemia: The patient has hyperphenylalaninemia, which is an elevated level of phenylalanine in the blood.

+6. Gastrointestinal inflammation: The patient has gastrointestinal inflammation, which is the swelling, irritation, and redness of the lining of the gastrointestinal tract.

The following diseases are not likely, as they are not consistent with the patient's symptoms:

+ Death in infancy
+ Neonatal death
+ Death in childhood
+ Death in adolescence

It is important to note that this is a hypothetical diagnosis and the patient should consult with a healthcare professional for an accurate diagnosis."
['Biotinidase deficiency']," +1. Lysinuric protein intolerance: This is a genetic disorder characterized by an inability to break down certain amino acids, leading to their accumulation in the body. Symptoms may include skin rash, aminoaciduria, and abnormal circulating glycine concentration. However, this condition does not typically cause death in infancy, alopecia, metabolic acidosis, increased CSF lactate, or erythematous plaques/macules/papules.

+2. Maple syrup urine disease: This is a genetic disorder caused by a deficiency of an enzyme needed to break down certain amino acids. Symptoms may include skin rash, metabolic acidosis, and elevated urinary carboxylic acid. However, this condition does not typically cause death in infancy, alopecia, increased CSF lactate, or erythematous plaques/macules/papules.

+3. Non-accidental injury: This is a term used to describe injuries that are intentionally inflicted on a person, often a child. Symptoms may include skin rash, erythematous plaques/macules/papules. However, this condition does not typically cause death in infancy, alopecia, metabolic acidosis, increased CSF lactate, aminoaciduria, or abnormal circulating glycine concentration.

+4. Ehlers-Danlos syndrome: This is a group of disorders that affect connective tissues, which support the skin, bones, blood vessels, and other organs. Symptoms may include skin rash. However, this condition does not typically cause death in infancy, alopecia, metabolic acidosis, increased CSF lactate, aminoaciduria, abnormal circulating glycine concentration, or erythematous plaques/macules/papules.

+5. Homocystinuria: This is a genetic disorder caused by a deficiency of an enzyme needed to metabolize the amino acid methionine. Symptoms may include skin rash, metabolic acidosis, and elevated urinary carboxylic acid. However, this condition does not typically cause death in infancy, alopecia, increased CSF lactate, or erythematous plaques/macules/papules.

It is important to note that this is not an exhaustive list of potential diagnoses, and additional information and testing would be necessary to make a definitive diagnosis. Additionally, some of the symptoms listed may be caused by multiple different conditions, and the presence of one or more symptoms does not necessarily indicate the presence of a specific disease."
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Metabolic Disorders: This category of diseases includes disorders that affect the body's metabolism, or the way it uses food to make energy. The patient's symptoms of death in infancy, dehydration, and feeding difficulties could indicate a metabolic disorder. However, decreased methylmalonyl-CoA mutase activity is a specific symptom that may indicate a specific type of metabolic disorder, such as methylmalonic acidemia.

+2. Inborn Errors of Metabolism: This is a subcategory of metabolic disorders and includes genetic disorders that affect the body's ability to metabolize certain substances. The patient's symptoms of death in infancy, dehydration, and feeding difficulties could indicate an inborn error of metabolism. Decreased methylmalonyl-CoA mutase activity is a specific symptom that may indicate a specific type of inborn error of metabolism, such as methylmalonic acidemia.

+3. Methylmalonic Acidemia: This is a specific type of inborn error of metabolism that affects the body's ability to break down certain amino acids. The patient's symptoms of death in infancy, dehydration, decreased methylmalonyl-CoA mutase activity, and feeding difficulties could indicate methylmalonic acidemia.

+4. Organic Acidemias: This is a group of genetic disorders that affect the body's ability to break down certain amino acids. The patient's symptoms of death in infancy, dehydration, and feeding difficulties could indicate an organic acidemia. Decreased methylmalonyl-CoA mutase activity is a specific symptom that may indicate a specific type of organic acidemia, such as methylmalonic acidemia.

+5. Maple Syrup Urine Disease: This is a genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of death in infancy, dehydration, and feeding difficulties could indicate maple syrup urine disease. However, this disorder is usually characterized by a sweet odor to the urine, which is not listed as a symptom in this case.

It is important to note that this is not an exhaustive list of potential diseases and that further testing and evaluation would be necessary to make a definitive diagnosis."
['Biotinidase deficiency']," +1. Sepsis: The patient has fever, which is a common symptom of sepsis. However, sepsis does not typically cause lethargy, generalized hypotonia, metabolic acidosis, increased circulating lactate concentration, drowsiness, sleep abnormality, decreased pyruvate carboxylase activity, propionyl-CoA carboxylase deficiency, aminoaciduria, stomatitis, stridor, abnormal circulating glycine concentration, fatigue, elevated urinary carboxylic acid, or gangrene.

+2. Meningitis: The patient has lethargy and fever, which are common symptoms of meningitis. However, meningitis does not typically cause generalized hypotonia, metabolic acidosis, increased circulating lactate concentration, drowsiness, sleep abnormality, decreased pyruvate carboxylase activity, propionyl-CoA carboxylase deficiency, aminoaciduria, stomatitis, stridor, abnormal circulating glycine concentration, fatigue, elevated urinary carboxylic acid, or gangrene.

+3. Encephalitis: The patient has lethargy, which is a common symptom of encephalitis. However, encephalitis does not typically cause generalized hypotonia, metabolic acidosis, increased circulating lactate concentration, drowsiness, sleep abnormality, decreased pyruvate carboxylase activity, propionyl-CoA carboxylase deficiency, aminoaciduria, stomatitis, stridor, abnormal circulating glycine concentration, fatigue, elevated urinary carboxylic acid, or gangrene.

+4. Maple syrup urine disease: The patient has elevated urinary carboxylic acid, which is a common symptom of maple syrup urine disease. However, maple syrup urine disease does not typically cause lethargy, generalized hypotonia, death in infancy, metabolic acidosis, fever, increased circulating lactate concentration, drowsiness, sleep abnormality, decreased pyruvate carboxylase activity, propionyl-CoA carboxylase deficiency, aminoaciduria, stomatitis, stridor, abnormal circulating glycine concentration, fatigue, or gangrene.

+5. Propionic acidemia: The patient has propionyl-CoA carboxylase deficiency, which is a characteristic symptom of propionic acidemia. However, propionic acidemia does not typically cause lethargy, generalized hypotonia, death in infancy, metabolic acidosis, fever, increased circulating lactate concentration, drowsiness, sleep abnormality, decreased pyruvate carboxylase activity, aminoaciduria, stomatitis, stridor, abnormal circulating glycine concentration, fatigue, or gangrene.

+6. Pyruvate carboxylase deficiency: The patient has decreased pyruvate carboxylase activity, which is a characteristic symptom of pyruvate carboxylase deficiency. However, pyruvate carboxylase deficiency does not typically cause lethargy, generalized hypotonia, death in infancy, metabolic acidosis, fever, increased circulating la"
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, PKU does not typically cause death in infancy or childhood.

+2. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, MSUD does not typically cause death in infancy or childhood.

+3. Homocystinuria: This is a genetic disorder that affects the body's ability to process the amino acid methionine. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, homocystinuria does not typically cause death in infancy or childhood.

+4. Tyrosinemia type I: This is a genetic disorder that affects the body's ability to break down the amino acid tyrosine. Symptoms include abnormality of prenatal development or birth, neonatal death, hyperphenylalaninemia, and hypertyrosinemia. However, tyrosinemia type I does not typically cause death in childhood.

+5. Isovaleric acidemia: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, isovaleric acidemia does not typically cause hypertyrosinemia or death in infancy or childhood.

It is important to note that these are just potential diagnoses based on the symptoms provided. Further testing and evaluation would be necessary to confirm any diagnosis."
['3-hydroxy-3-methylglutaric aciduria']," +1. Sudden Infant Death Syndrome (SIDS): This is a diagnosis of exclusion, which means that it is considered only after all other possible causes of death in infancy have been ruled out. In this case, the patient has one symptom in common (Death in infancy) and three symptoms not in common.

+2. Dicarboxylic Aciduria: This is a metabolic disorder characterized by an accumulation of dicarboxylic acids in the body due to a deficiency in the enzyme that breaks them down. The patient has one symptom in common (Dicarboxylic aciduria) and two symptoms not in common.

+3. 3-Methylglutaconic Aciduria: This is a metabolic disorder characterized by an accumulation of 3-methylglutaconic acid in the body due to a deficiency in the enzyme that breaks it down. The patient has one symptom in common (Elevated urinary carboxylic acid) and two symptoms not in common.

+4. Organic Acidemias: This is a group of metabolic disorders characterized by an accumulation of organic acids in the body due to a deficiency in the enzymes that break them down. The patient has one symptom in common (Elevated urinary carboxylic acid) and two symptoms not in common.

+5. Maple Syrup Urine Disease: This is a metabolic disorder characterized by an accumulation of certain amino acids in the body due to a deficiency in the enzyme that breaks them down. The patient does not have any symptoms in common with this disease.

+6. Propionic Acidemia: This is a metabolic disorder characterized by an accumulation of propionic acid in the body due to a deficiency in the enzyme that breaks it down. The patient does not have any symptoms in common with this disease.

+7. Methylmalonic Acidemia: This is a metabolic disorder characterized by an accumulation of methylmalonic acid in the body due to a deficiency in the enzyme that breaks it down. The patient does not have any symptoms in common with this disease.

+8. Isovaleric Acidemia: This is a metabolic disorder characterized by an accumulation of isovaleric acid in the body due to a deficiency in the enzyme that breaks it down. The patient does not have any symptoms in common with this disease.

+9. Glutaric Acidemia Type I: This is a metabolic disorder characterized by an accumulation of glutaric acid in the body due to a deficiency in the enzyme that breaks it down. The patient does not have any symptoms in common with this disease.

+10. Multiple Carboxylase Deficiency: This is a metabolic disorder characterized by an accumulation of carboxylic acids in the body due to a deficiency in multiple enzymes that break them down. The patient has one symptom in common (Elevated urinary carboxylic acid) and two symptoms not in common.

It is important to note that this list is not exhaustive and that further testing and evaluation would be necessary to confirm a diagnosis. Additionally, some of the diseases listed may have overlapping symptoms, and it is possible that the patient's symptoms could be caused by a combination of disorders."
['Wilson disease']," +1. Dental caries: The patient has carious teeth, which is a common dental disease caused by bacteria.

+2. Obesity: The patient has obesity, which is a condition characterized by an excessive amount of body fat.

+3. Nonalcoholic fatty liver disease (NAFLD): The patient has elevated circulating hepatic transaminase concentration, which can be a sign of liver damage. NAFLD is a condition in which there is an abnormal accumulation of fat in the liver.

+4. Acute intermittent porphyria: The patient has abnormal circulating porphyrin concentration. This is a rare genetic disorder that affects the production of heme, a component of hemoglobin.

+5. Wilson's disease: The patient has decreased circulating ceruloplasmin concentration, increased urinary copper concentration, and decreased circulating copper concentration. Wilson's disease is a genetic disorder that affects copper metabolism.

+6. Hypoaminoacidemia: The patient has abnormal circulating aspartate family amino acid concentration and abnormal circulating alanine concentration. Hypoaminoacidemia is a condition characterized by low levels of amino acids in the blood.

+7. Iron deficiency anemia: The patient has decreased serum iron. This is a condition in which the body does not have enough iron to produce hemoglobin, the protein in red blood cells that carries oxygen.

The following diseases have been ruled out based on the patient's symptoms:

- Death in childhood: The patient is alive, so this condition has been ruled out.
- Hemochromatosis: This is a condition characterized by increased iron absorption and iron overload. However, the patient has decreased serum iron, so this condition has been ruled out.
- Porphyria cutanea tarda: This is a type of porphyria that is characterized by skin symptoms such as blisters and scarring. The patient does not have any skin symptoms, so this condition has been ruled out.
- Menkes disease: This is a rare genetic disorder that affects copper metabolism. However, the patient does not have the characteristic kinky hair and developmental delays associated with this condition, so it has been ruled out."
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Smith-Lemli-Opitz syndrome: A genetic disorder affecting the metabolism of cholesterol, which can result in abnormal prenatal development or birth, and in some cases, death in infancy or neonatal death. However, this syndrome does not typically cause abnormal circulating carnitine concentration.

+2. Carnitine transporter deficiency: A genetic disorder affecting the transport of carnitine in the body, which can result in abnormal circulating carnitine concentration. This disorder is not typically associated with abnormal prenatal development or birth, or death in infancy or neonatal death.

+3. Zellweger spectrum disorder: A group of genetic disorders affecting the metabolism of lipids, which can result in abnormal prenatal development or birth, and in some cases, death in infancy or neonatal death. However, this disorder is not typically associated with abnormal circulating carnitine concentration.

+4. Maple syrup urine disease: A genetic disorder affecting the metabolism of certain amino acids, which can result in abnormal circulating amino acids and neurological symptoms. This disorder is not typically associated with abnormal prenatal development or birth, or death in infancy or neonatal death.

+5. Homocystinuria: A genetic disorder affecting the metabolism of the amino acid methionine, which can result in abnormal circulating amino acids and neurological symptoms. This disorder is not typically associated with abnormal prenatal development or birth, or death in infancy or neonatal death.

It is important to note that these are potential diagnoses based on the given symptoms, and further testing and evaluation would be necessary to confirm any diagnosis. Additionally, the patient's medical history, physical examination, and other diagnostic tests would also be taken into consideration when making a diagnosis."
['Phenylketonuria']," Based on the symptoms you have provided, here are some potential diseases:

+1. Tyrosinemia type I: This is a genetic disorder caused by a deficiency of the enzyme fumarylacetoacetase, which is needed to break down the amino acid tyrosine. Symptoms can include death in infancy or childhood, hypertyrosinemia, and hyperphenylalaninemia. However, recurrent viral infections are not typically associated with this condition.

+2. Phenylketonuria (PKU): This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, which is needed to break down the amino acid phenylalanine. Symptoms can include hyperphenylalaninemia, but death in infancy and recurrent viral infections are not typically associated with this condition. Hypertyrosinemia can occur in some cases of PKU, but it is not a primary symptom.

+3. Liver failure: This can be caused by a variety of factors, including genetic disorders, viral infections, and exposure to toxins. Symptoms can include death in infancy or childhood, but hypertyrosinemia and hyperphenylalaninemia are not typically associated with liver failure. Recurrent viral infections could be a symptom of liver failure, depending on the underlying cause.

+4. Immune deficiency: This can be caused by a variety of factors, including genetic disorders and exposure to toxins. Symptoms can include recurrent viral infections, but death in infancy, hypertyrosinemia, and hyperphenylalaninemia are not typically associated with immune deficiency.

Please note that this is not an exhaustive list of potential diagnoses, and further testing would be needed to confirm any diagnosis. It is important to consult with a healthcare professional for an accurate diagnosis and treatment plan."
['3-methylcrotonyl-CoA carboxylase deficiency']," Based on the symptoms you have provided, here are some potential diseases:

+1. Maple Syrup Urine Disease: This is a genetic disorder caused by a deficiency in one of the enzymes needed to break down certain amino acids. The disease gets its name from the sweet odor of the patient's urine. Aminoaciduria and elevated urinary carboxylic acid are common symptoms of this disease.

+2. Homocystinuria: This is a genetic disorder caused by a deficiency in the enzyme needed to metabolize the amino acid methionine. Aminoaciduria and elevated urinary carboxylic acid are common symptoms of this disease.

+3. Carnitine Transporter Deficiency: This is a genetic disorder that affects the body's ability to transport carnitine into cells. Abnormal circulating carnitine concentration is a common symptom of this disease.

+4. Isovaleric Acidemia: This is a genetic disorder caused by a deficiency in an enzyme needed to break down the amino acid leucine. Elevated urinary carboxylic acid is a common symptom of this disease.

+5. Glutaric Acidemia Type 1: This is a genetic disorder caused by a deficiency in an enzyme needed to break down certain amino acids. Elevated urinary carboxylic acid is a common symptom of this disease.

+6. Multiple Carboxylase Deficiency: This is a genetic disorder caused by a deficiency in an enzyme needed to activate several other enzymes. Elevated urinary carboxylic acid is a common symptom of this disease.

Please note that these are potential diagnoses based on the symptoms you have provided. Further testing would be needed to confirm any diagnosis. Also, it's important to note that some of these diseases can have overlapping symptoms, and that some symptoms may not appear in all patients with a given disease."
['Carbamoyl-phosphate synthetase 1 deficiency']," +1. 3-Methylglutaconic aciduria type VII (3-MGA VII, Barth syndrome): This X-linked recessive disorder is characterized by cardiomyopathy, skeletal myopathy, growth retardation, neutropenia, and organic aciduria. The patient's symptoms of generalized hypotonia, feeding difficulties, hepatomegaly, and 3-Methylglutaconic aciduria align with this condition. However, Barth syndrome typically does not present with neonatal death or tachypnea.

+2. Pompe disease (Glycogen storage disease type II): This autosomal recessive disorder is caused by a deficiency of acid alpha-glucosidase, leading to lysosomal glycogen accumulation. Symptoms include generalized hypotonia, feeding difficulties, and hepatomegaly. However, Pompe disease does not typically present with 3-Methylglutaconic aciduria, neonatal death, or tachypnea.

+3. Nonketotic hyperglycinemia (NKH): This autosomal recessive disorder is characterized by an accumulation of glycine in the body due to a deficiency of the glycine cleavage system. Symptoms include generalized hypotonia, feeding difficulties, and tachypnea. However, NKH does not typically present with 3-Methylglutaconic aciduria, neonatal death, or hepatomegaly.

+4. Zellweger spectrum disorder (ZSD): This group of peroxisomal biogenesis disorders includes Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease. Symptoms include generalized hypotonia, feeding difficulties, hepatomegaly, and tachypnea. However, ZSD does not typically present with 3-Methylglutaconic aciduria or neonatal death.

+5. Mitochondrial disorders: Mitochondrial disorders are a group of genetic diseases caused by mutations in mitochondrial DNA or nuclear DNA. Symptoms can include generalized hypotonia, feeding difficulties, hepatomegaly, and tachypnea. However, mitochondrial disorders do not typically present with 3-Methylglutaconic aciduria or neonatal death.

It is important to note that these are potential diagnoses based on the provided symptoms, and further testing and evaluation are necessary to confirm a diagnosis."
['Citrullinemia type I']," +1. Down syndrome: Delayed speech and language development, abnormality of prenatal development or birth, motor delay, and often associated with hypotonia and characteristic facial features. However, this condition does not typically cause hyperhidrosis, hypoglycemia, respiratory alkalosis, hyperammonemia, hypothermia, or elevated plasma citrulline.

+2. Congenital hypothyroidism: Delayed speech and language development, lethargy, and hypotonia. However, this condition does not typically cause hyperhidrosis, hypoglycemia, respiratory alkalosis, hyperammonemia, hypothermia, or elevated plasma citrulline.

+3. Prader-Willi syndrome: Delayed speech and language development, hypotonia, motor delay, and obesity. However, this condition does not typically cause hyperhidrosis, hypoglycemia, respiratory alkalosis, hyperammonemia, or hypothermia.

+4. Phenylketonuria (PKU): Delayed speech and language development, motor delay, and often associated with intellectual disability. This condition can cause elevated plasma citrulline and oroticaciduria. However, PKU does not typically cause hyperhidrosis, hypoglycemia, respiratory alkalosis, hyperammonemia, hypothermia, or drowsiness.

+5. Maple syrup urine disease: Elevated plasma citrulline, oroticaciduria, and often associated with ketoacidosis, seizures, and maple syrup odor in urine. However, this condition does not typically cause hyperhidrosis, hypoglycemia, respiratory alkalosis, hyperammonemia, hypothermia, delayed speech and language development, or motor delay.

+6. Nonketotic hyperglycinemia: Elevated plasma citrulline, hypotonia, lethargy, and often associated with seizures and intellectual disability. However, this condition does not typically cause hyperhidrosis, hypoglycemia, respiratory alkalosis, hyperammonemia, or hypothermia.

+7. Urea cycle disorders: Hyperammonemia, lethargy, hypotonia, and often associated with seizures, vomiting, and coma. However, this condition does not typically cause hyperhidrosis, hypoglycemia, respiratory alkalosis, or hypothermia.

+8. Respiratory chain disorders: Respiratory alkalosis, hypotonia, lethargy, and often associated with lactic acidosis, seizures, and developmental delay. However, this condition does not typically cause hyperhidrosis, hypoglycemia, hyperammonemia, or hypothermia.

+9. Inborn errors of metabolism: Hyperammonemia, hypoglycemia, and often associated with metabolic acidosis, ketosis, and hyperlactatemia. However, this condition does not typically cause hyperhidrosis, respiratory alkalosis, or hypothermia.

+10. Congenital adrenal hyperplasia: Hyperhidrosis, lethargy, and often associated with ambiguous genitalia, virilization, and electrolyte imbalances. However, this condition does not typically cause hypog"
['Glutaryl-CoA dehydrogenase deficiency']," +1. Megalencephaly: The patient has macrocephaly (an abnormally large head) which is a common symptom of this condition. However, megalencephaly is a non-specific term that refers to an increase in the size of the brain, and not all cases are due to a disease.

+2. Neurodegeneration with brain iron accumulation (NBIA): The patient has abnormalities in visual evoked potentials, which can be seen in NBIA. However, NBIA is a group of rare genetic disorders that cause progressive degeneration and iron accumulation in the brain, and not all cases present with visual abnormalities.

+3. Infantile spasms: The patient has seizures, which can be a symptom of infantile spasms. This is a type of epilepsy that affects infants and young children, and is often characterized by clusters of sudden, repetitive muscle jerks.

+4. Hypoxic-ischemic encephalopathy: The patient has seizures and generalized hypotonia (low muscle tone), which can be seen in hypoxic-ischemic encephalopathy. This is a condition that occurs when the brain is deprived of oxygen and nutrients, often due to a lack of blood flow or respiratory problems.

+5. Mitochondrial disorders: The patient has seizures, hypotonia, and death in infancy, which can be seen in mitochondrial disorders. These are genetic disorders that affect the mitochondria, the energy-producing structures in cells.

+6. Leigh syndrome: The patient has seizures, hypotonia, and death in infancy, which can be seen in Leigh syndrome. This is a rare inherited disorder that affects the nervous system and causes progressive loss of mental and movement abilities.

+7. Glutaric aciduria type I: The patient has glutaric aciduria, which is a rare genetic disorder that affects the body's ability to break down certain amino acids. However, glutaric aciduria does not typically cause macrocephaly, abnormalities in visual evoked potentials, or irritability.

+8. Aicardi-Goutires syndrome: The patient has macrocephaly, seizures, and death in infancy, which can be seen in Aicardi-Goutires syndrome. This is a rare genetic disorder that affects the brain and immune system.

+9. Lysosomal storage disorders: The patient has macrocephaly, seizures, and death in infancy, which can be seen in lysosomal storage disorders. These are genetic disorders that affect the body's ability to break down and recycle waste products in cells.

+10. Neonatal lupus: The patient has neonatal death, which can be seen in neonatal lupus. This is a rare condition that affects newborns of mothers with lupus, an autoimmune disorder.

It is important to note that this list is not exhaustive and that further testing and evaluation is needed to make a definitive diagnosis."
['Tyrosinemia type 1']," Based on the symptoms you have provided, here are some potential diseases:

+1. Phenylketonuria (PKU): PKU is a genetic disorder characterized by an inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. This can result in delayed speech and language development, abnormal circulating phenylalanine concentration, and if left untreated, can lead to death in childhood. However, PKU does not typically cause 4-hydroxyphenylpyruvic aciduria or elevated urinary delta-aminolevulinic acid.

+2. Hypertyrosinemia type I: This is a genetic disorder that affects the metabolism of the amino acid tyrosine. Symptoms can include delayed speech and language development, elevated urinary delta-aminolevulinic acid, and abnormal circulating phenylalanine concentration. However, this condition does not typically cause 4-hydroxyphenylpyruvic aciduria or lead to death in childhood.

+3. Hereditary coproporphyria: This is a genetic disorder that affects the production of heme, a component of hemoglobin. Symptoms can include abdominal pain, neurological symptoms, and photosensitivity. Elevated urinary delta-aminolevulinic acid is a characteristic finding in this condition, but delayed speech and language development, 4-hydroxyphenylpyruvic aciduria, and hypertyrosinemia are not typically associated with this condition.

+4. Lead toxicity: Exposure to lead can cause a range of symptoms, including developmental delays, abnormal circulating phenylalanine concentration, and elevated urinary delta-aminolevulinic acid. However, lead toxicity does not typically cause 4-hydroxyphenylpyruvic aciduria or hypertyrosinemia.

+5. Hepatitis: Hepatitis is an inflammation of the liver that can be caused by a variety of viruses. Symptoms can include elevated liver enzymes, jaundice, and abnormal circulating phenylalanine concentration. However, hepatitis does not typically cause 4-hydroxyphenylpyruvic aciduria or hypertyrosinemia.

It is important to note that these are potential diagnoses based on the symptoms you have provided, and further testing would be needed to confirm any diagnosis. Additionally, it is possible that the patient's symptoms are caused by a combination of factors or an underlying condition that has not yet been identified."
['Phenylketonuria']," +1. Down Syndrome: Abnormality of prenatal development or birth. This genetic disorder causes developmental delays, intellectual disability, and distinct physical features. Obesity, hyperphenylalaninemia, and elevated urinary carboxylic acid are not typically associated with Down Syndrome.

+2. Phenylketonuria (PKU): Hyperphenylalaninemia and elevated urinary carboxylic acid. PKU is a metabolic disorder that affects the body's ability to process an amino acid called phenylalanine, leading to a buildup of toxic levels in the brain. Abnormality of prenatal development or birth, obesity, and death in infancy or childhood are not typically associated with PKU.

+3. Tyrosinemia type I: Hypertyrosinemia, neonatal death, and death in childhood. This rare genetic disorder affects the body's ability to metabolize the amino acid tyrosine, leading to liver and kidney damage, and neurological problems. Abnormality of prenatal development or birth, obesity, and elevated urinary carboxylic acid are not typically associated with Tyrosinemia type I.

+4. Maple Syrup Urine Disease (MSUD): Elevated urinary carboxylic acid. MSUD is a genetic disorder that affects the body's ability to break down certain amino acids, leading to a buildup of toxic levels in the body. Abnormality of prenatal development or birth, obesity, hyperphenylalaninemia, and death in infancy or childhood are not typically associated with MSUD.

+5. Obesity: Obesity is a complex disease that involves an excessive amount of body fat. Abnormality of prenatal development or birth, death in infancy, hypertyrosinemia, neonatal death, death in childhood, hyperphenylalaninemia, and elevated urinary carboxylic acid are not typically associated with obesity.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing and evaluation would be necessary to confirm a diagnosis. The symptoms presented may be indicative of other medical conditions, and a healthcare professional should be consulted for proper diagnosis and treatment."
['Phenylketonuria']," Based on the symptoms you have provided, I can suggest several potential diseases. Please note that this is only a preliminary assessment and further medical testing would be required to make a definitive diagnosis.

+1. Phenylketonuria (PKU): PKU is a genetic disorder characterized by an inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body. Symptoms can include intellectual disability, seizures, and hyperphenylalaninemia. However, PKU does not typically cause hyperactivity, obesity, or short stature.

+2. Tyrosinemia type I: This is a rare genetic disorder that affects the breakdown of the amino acid tyrosine. Symptoms can include intellectual disability, seizures, hypertyrosinemia, severe short stature, and elevated urinary carboxylic acid. However, PKU does not typically cause obesity or death in childhood.

+3. Mucopolysaccharidosis (MPS) I: MPS I is a genetic disorder caused by the absence or malfunction of an enzyme needed to break down certain complex carbohydrates. Symptoms can include intellectual disability, seizures, obesity, and severe short stature. However, MPS I does not typically cause hypertyrosinemia or elevated urinary carboxylic acid.

+4. Beta-Ketothiolase Deficiency: This is a genetic disorder that affects the body's ability to break down certain proteins and fats. Symptoms can include intellectual disability, seizures, elevated urinary carboxylic acid, and death in childhood. However, beta-ketothiolase deficiency does not typically cause hypertyrosinemia or obesity.

+5. Lafora Disease: Lafora disease is a rare genetic disorder that affects the brain and causes seizures, intellectual disability, and death in adolescence. However, Lafora disease does not typically cause hypertyrosinemia, obesity, or elevated urinary carboxylic acid.

+6. Prader-Willi Syndrome: Prader-Willi syndrome is a genetic disorder that affects appetite, growth, and behavior. Symptoms can include hyperactivity, intellectual disability, obesity, and severe short stature. However, Prader-Willi syndrome does not typically cause seizures, hypertyrosinemia, or elevated urinary carboxylic acid.

+7. Wilson's Disease: Wilson's disease is a genetic disorder that affects the body's ability to metabolize copper. Symptoms can include intellectual disability, seizures, and death in early adulthood. However, Wilson's disease does not typically cause hypertyrosinemia, obesity, or elevated urinary carboxylic acid.

These are just a few potential diagnoses based on the symptoms you have provided. It is important to consult with a medical professional for a definitive diagnosis and appropriate treatment."
['Vitamin B12-unresponsive methylmalonic acidemia']," Based on the symptoms you have provided, here are some potential diseases:

+1. Maple Syrup Urine Disease: This is a genetic disorder in which the body cannot break down certain amino acids (leucine, isoleucine, and valine). Symptoms include seizures, generalized hypotonia, vomiting, and metabolic acidosis. However, this disease does not typically cause thrombocytopenia, leukopenia, hyperammonemia, methylmalonic acidemia, methylmalonic aciduria, or neonatal death.

+2. Nonketotic Hyperglycinemia: This is a genetic disorder that affects the body's ability to break down the amino acid glycine. Symptoms include seizures, generalized hypotonia, and vomiting. However, this disease does not typically cause thrombocytopenia, leukopenia, metabolic acidosis, hyperammonemia, methylmalonic acidemia, methylmalonic aciduria, or neonatal death.

+3. Methylmalonic Acidemia: This is a genetic disorder in which the body cannot break down certain proteins and fats properly. Symptoms include seizures, generalized hypotonia, vomiting, metabolic acidosis, hyperammonemia, methylmalonic acidemia, and methylmalonic aciduria. However, this disease does not typically cause thrombocytopenia or leukopenia.

+4. Propionic Acidemia: This is a genetic disorder in which the body cannot break down certain proteins and fats properly. Symptoms include seizures, generalized hypotonia, vomiting, metabolic acidosis, hyperammonemia, and methylcitric aciduria. However, this disease does not typically cause thrombocytopenia, leukopenia, or methylmalonic acidemia.

+5. Isovaleric Acidemia: This is a genetic disorder in which the body cannot break down certain proteins properly. Symptoms include seizures, generalized hypotonia, vomiting, metabolic acidosis, and isovaleric acidemia. However, this disease does not typically cause thrombocytopenia, leukopenia, hyperammonemia, methylmalonic acidemia, or methylmalonic aciduria.

+6. Glutaric Acidemia Type I: This is a genetic disorder in which the body cannot break down certain amino acids properly. Symptoms include seizures, generalized hypotonia, vomiting, metabolic acidosis, and increased levels of glutaric acid in the urine. However, this disease does not typically cause thrombocytopenia, leukopenia, hyperammonemia, methylmalonic acidemia, or methylmalonic aciduria.

+7. Citrullinemia: This is a genetic disorder in which the body cannot break down certain amino acids properly. Symptoms include seizures, generalized hypotonia, vomiting, and hyperammonemia. However, this disease does not typically cause thrombocytopenia, leukopenia, metabolic acidosis, methylmalonic acidemia, or methylmalonic aciduria.

+8. Urea Cycle Disorders: This is a group of genetic disorders that affect the body's ability to remove ammonia"
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Smith-Lemli-Opitz syndrome: A genetic disorder affecting the metabolism of cholesterol, which can result in abnormal prenatal development or birth, and in some cases, death in infancy or neonatal death. However, this syndrome does not typically cause abnormal circulating carnitine concentration.

+2. Maple syrup urine disease: A genetic disorder affecting the metabolism of certain amino acids, which can result in abnormal prenatal development or birth, and in some cases, death in infancy or neonatal death. This disease does not typically cause abnormal circulating carnitine concentration.

+3. Carnitine transporter deficiency: A genetic disorder affecting the transport of carnitine in the body, which can result in abnormal circulating carnitine concentration. However, this disorder does not typically cause abnormal prenatal development or birth, or death in infancy or neonatal death.

+4. Carnitine palmitoyltransferase II deficiency: A genetic disorder affecting the metabolism of fatty acids, which can result in abnormal circulating carnitine concentration. However, this disorder does not typically cause abnormal prenatal development or birth, or death in infancy or neonatal death.

+5. 3-methylcrotonyl-CoA carboxylase deficiency: A genetic disorder affecting the metabolism of certain amino acids, which can result in abnormal prenatal development or birth, and in some cases, death in infancy or neonatal death. However, this disorder does not typically cause abnormal circulating carnitine concentration.

It is important to note that these are potential diagnoses based on the given symptoms, and further testing and evaluation would be necessary to confirm any diagnosis. Additionally, it is possible that the patient's symptoms may be caused by a combination of factors or a different underlying condition."
['Vitamin B12-unresponsive methylmalonic acidemia']," Based on the symptoms you have provided, here are some potential diseases:

+1. Propionic Acidemia: This is a genetic disorder that affects the body's ability to break down certain proteins and fats. It can cause metabolic acidosis, hyperammonemia, vomiting, and methylmalonic aciduria. However, death in infancy is not a typical symptom of this disease.

+2. Methylmalonic Acidemia: This is a genetic disorder that affects the body's ability to process certain amino acids. It can cause metabolic acidosis, hyperammonemia, vomiting, and methylmalonic aciduria. Death in infancy is not a typical symptom of this disease.

+3. Isovaleric Acidemia: This is a genetic disorder that affects the body's ability to break down certain proteins. It can cause metabolic acidosis, hyperammonemia, vomiting, and methylmalonic aciduria. Death in infancy is not a typical symptom of this disease.

+4. Maple Syrup Urine Disease: This is a genetic disorder that affects the body's ability to break down certain amino acids. It can cause metabolic acidosis, vomiting, and methylmalonic aciduria. However, hyperammonemia and death in infancy are not typical symptoms of this disease.

+5. Citrullinemia: This is a genetic disorder that affects the body's ability to process certain amino acids. It can cause hyperammonemia, vomiting, and methylmalonic aciduria. However, metabolic acidosis and death in infancy are not typical symptoms of this disease.

It is important to note that these are potential diagnoses based on the symptoms you have provided. Further testing and evaluation would be necessary to confirm any diagnosis. Additionally, it is possible that the patient's symptoms may be caused by a combination of factors, or by a different condition entirely."
['Ornithine transcarbamylase deficiency']," +1. Urea Cycle Disorders: This group of genetic disorders affects the body's ability to remove ammonia from the blood. Symptoms can include seizures, hyperammonemia, cerebral edema, and death in infancy or neonatal period. However, oroticaciduria is not typically associated with these disorders.

+2. Maple Syrup Urine Disease: This is an inherited metabolic disorder where the body cannot break down certain amino acids. Symptoms can include seizures, but death in infancy, hyperammonemia, cerebral edema, and oroticaciduria are not typically associated with this disorder.

+3. Nonketotic Hyperglycinemia: This is a genetic disorder that affects the body's ability to process the amino acid glycine. Symptoms can include seizures, hyperammonemia, and cerebral edema, but death in infancy and oroticaciduria are not typically associated with this disorder.

+4. Organic Acidemias: This is a group of genetic disorders that affect the body's ability to metabolize certain amino acids, carbohydrates, and fatty acids. Symptoms can include seizures, hyperammonemia, and cerebral edema, but death in infancy and oroticaciduria are not typically associated with these disorders.

+5. Mitochondrial Disorders: This is a group of disorders caused by genetic mutations that affect the energy-producing structures in cells. Symptoms can include seizures, but death in infancy, hyperammonemia, cerebral edema, and oroticaciduria are not typically associated with these disorders.

+6. Pyridoxine-Dependent Epilepsy: This is a rare genetic disorder that affects the body's ability to process the vitamin B6. Symptoms can include seizures, but death in infancy, hyperammonemia, cerebral edema, and oroticaciduria are not typically associated with this disorder.

It is important to note that this list is not exhaustive and that further testing and evaluation by a medical professional is necessary to make a definitive diagnosis."
['Biotinidase deficiency']," +1. Sialidosis: This is a rare genetic disorder that affects the metabolism of glycoproteins. Symptoms may include seizures, hypotonia, and developmental delay. However, growth delay, death in infancy, and alopecia are not typically associated with this disease.

+2. Nonketotic hyperglycinemia: This is a metabolic disorder that affects the breakdown of the amino acid glycine. Symptoms may include seizures, hypotonia, and developmental delay. Growth delay and death in infancy are possible, but alopecia and fasciculations are not typically associated with this disease.

+3. Methylmalonic acidemia: This is a genetic disorder that affects the metabolism of certain amino acids and fatty acids. Symptoms may include seizures, hypotonia, and developmental delay. Growth delay and death in infancy are possible, but alopecia and fasciculations are not typically associated with this disease.

+4. Propionic acidemia: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms may include seizures, hypotonia, and developmental delay. Growth delay and death in infancy are possible, but alopecia and fasciculations are not typically associated with this disease.

+5. Isovaleric acidemia: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms may include seizures, hypotonia, and developmental delay. Growth delay and death in infancy are possible, but alopecia and fasciculations are not typically associated with this disease.

+6. Glutaric acidemia type I: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms may include seizures, hypotonia, and developmental delay. Growth delay and death in infancy are possible, but alopecia and fasciculations are not typically associated with this disease.

+7. Maple syrup urine disease: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms may include seizures, hypotonia, and developmental delay. Growth delay and death in infancy are possible, but alopecia and fasciculations are not typically associated with this disease.

+8. Homocystinuria: This is a genetic disorder that affects the metabolism of the amino acid methionine. Symptoms may include seizures, hypotonia, and developmental delay. Growth delay and death in infancy are possible, but alopecia and fasciculations are not typically associated with this disease.

+9. Phenylketonuria: This is a genetic disorder that affects the metabolism of the amino acid phenylalanine. Symptoms may include seizures, hypotonia, and developmental delay. Growth delay and death in infancy are possible, but alopecia and fasciculations are not typically associated with this disease.

+10. Tyrosinemia type I: This is a genetic disorder that affects the metabolism of the amino acid tyrosine. Symptoms may include seizures, hypotonia, and developmental delay. Growth delay and death in infancy are possible, but alopecia and fasciculations are not typically associated with this disease.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing would be needed to confirm any of"
['Phenylketonuria']," +1. Obesity: The patient has obesity, which is a condition characterized by an excessive amount of body fat.

+2. Hypercholesterolemia: The patient has hypercholesterolemia, which is a condition characterized by high levels of cholesterol in the blood.

+3. Hyperthyroidism: The patient does not have hyperthyroidism, which is a condition characterized by an overactive thyroid gland that produces too much thyroid hormone.

+4. Hyperparathyroidism: The patient does not have hyperparathyroidism, which is a condition characterized by an overactive parathyroid gland that produces too much parathyroid hormone.

+5. Hyperglycemia: The patient does not have hyperglycemia, which is a condition characterized by high levels of glucose in the blood.

+6. Hypernatremia: The patient does not have hypernatremia, which is a condition characterized by high levels of sodium in the blood.

+7. Hyperkalemia: The patient does not have hyperkalemia, which is a condition characterized by high levels of potassium in the blood.

+8. Hypertension: The patient does not have hypertension, which is a condition characterized by high blood pressure.

+9. Hypothyroidism: The patient does not have hypothyroidism, which is a condition characterized by an underactive thyroid gland that produces too little thyroid hormone.

+10. Hypoparathyroidism: The patient does not have hypoparathyroidism, which is a condition characterized by an underactive parathyroid gland that produces too little parathyroid hormone.

+11. Hypoglycemia: The patient does not have hypoglycemia, which is a condition characterized by low levels of glucose in the blood.

+12. Hyponatremia: The patient does not have hyponatremia, which is a condition characterized by low levels of sodium in the blood.

+13. Hypokalemia: The patient does not have hypokalemia, which is a condition characterized by low levels of potassium in the blood.

+14. Hypotension: The patient does not have hypotension, which is a condition characterized by low blood pressure.

+15. Hyperuricemia: The patient does not have hyperuricemia, which is a condition characterized by high levels of uric acid in the blood.

+16. Hyperoxalemia: The patient does not have hyperoxalemia, which is a condition characterized by high levels of oxalate in the blood.

+17. Hypercalcemia: The patient does not have hypercalcemia, which is a condition characterized by high levels of calcium in the blood.

+18. Hypocalcemia: The patient does not have hypocalcemia, which is a condition characterized by low levels of calcium in the blood.

+19. Hyperphosphatemia: The patient does not have hyperphosphatemia, which is a condition characterized by high levels of phosphate in the blood.

+20. Hypophosphatemia: The patient does not have hypophosphatemia, which is a condition characterized by low levels of phosphate in the blood.

+21. Hypermagnesemia: The"
['Phenylketonuria'], +1
['Smith-Lemli-Opitz syndrome']," +1. Smith-Lemli-Opitz syndrome: This disorder is characterized by microcephaly, low-set ears, wide nasal bridge, strabismus, delayed speech and language development, syndactyly, intellectual disability, motor delay, and elevated 8-dehydrocholesterol.

+2. Chondrodysplasia punctata 2, X-linked: This disorder is characterized by microcephaly, wide nasal bridge, strabismus, motor delay, severe short stature, and elevated circulating 7-dehydrocholesterol concentration. However, it does not typically include low-set ears, syndactyly, or intellectual disability.

+3. Walker-Warburg syndrome: This disorder is characterized by microcephaly, strabismus, intellectual disability, motor delay, and difficulty walking. However, it does not typically include low-set ears, wide nasal bridge, syndactyly, or elevated 8-dehydrocholesterol.

+4. Meckel-Gruber syndrome: This disorder is characterized by microcephaly, motor delay, and neonatal death. However, it does not typically include low-set ears, wide nasal bridge, strabismus, syndactyly, or elevated 8-dehydrocholesterol.

+5. Jeune syndrome: This disorder is characterized by severe short stature, motor delay, difficulty walking, and difficulty climbing stairs. However, it does not typically include microcephaly, low-set ears, wide nasal bridge, strabismus, syndactyly, or elevated 8-dehydrocholesterol.

+6. Joubert syndrome: This disorder is characterized by delayed speech and language development, intellectual disability, and motor delay. However, it does not typically include microcephaly, low-set ears, wide nasal bridge, strabismus, syndactyly, or elevated 8-dehydrocholesterol.

+7. Cornelia de Lange syndrome: This disorder is characterized by microcephaly, low-set ears, wide nasal bridge, strabismus, intellectual disability, motor delay, and severe hearing impairment. However, it does not typically include syndactyly, elevated 8-dehydrocholesterol, or difficulty walking.

+8. Rubinstein-Taybi syndrome: This disorder is characterized by microcephaly, low-set ears, wide nasal bridge, intellectual disability, motor delay, and severe short stature. However, it does not typically include strabismus, syndactyly, or elevated 8-dehydrocholesterol.

+9. Aicardi-Goutieres syndrome: This disorder is characterized by microcephaly, intellectual disability, motor delay, and elevated circulating 7-dehydrocholesterol concentration. However, it does not typically include low-set ears, wide nasal bridge, strabismus, syndactyly, or difficulty walking.

+10. Cohen syndrome: This disorder is characterized by microcephaly, low-set ears, wide nasal bridge, intellectual disability, motor delay, severe short stature, and severe hearing impairment. However, it does not typically include strabismus, syndactyly, or elevated 8-dehydrocholesterol.

It is important to note that this is not an exhaustive list of potential diagnoses, and further evaluation and testing would be necessary to confirm a diagnosis."
['Glutaryl-CoA dehydrogenase deficiency']," Based on the symptoms you have provided, I will list some potential diseases that could match. Please note that this is not a definitive diagnosis and medical examination and testing are necessary to confirm.

1. +1. Ataxia-Telangiectasia: A genetic disorder characterized by progressive neurologic deterioration, ataxia, oculocutaneous telangiectasia, immunodeficiency, and increased risk of cancer. (Symptoms: Ataxia, Progressive neurologic deterioration)
2. +2. Canavan Disease: A genetic disorder that affects the breakdown and use of a fatty substance called myelin in the brain. Symptoms usually appear in the first year of life and may include poor head control, mental deterioration, weak muscle tone, and feeding difficulties. (Symptoms: Ataxia, Progressive neurologic deterioration)
3. +3. Glutaric Acidemia Type I: An inherited disorder that affects the metabolism of the amino acids lysine, hydroxylysine, and tryptophan. Symptoms include macrocephaly, hypotonia, seizures, and movement disorders. (Symptoms: Ataxia, Progressive neurologic deterioration, Glutaric aciduria, Elevated circulating glutaric acid concentration)
4. +4. Non-ketotic Hyperglycinemia: A genetic disorder that affects the breakdown of the amino acid glycine. Symptoms include lethargy, poor feeding, seizures, and developmental delays. (Symptoms: Dehydration, Fever, Diarrhea)
5. +5. Maple Syrup Urine Disease: An inherited disorder of metabolism that affects the breakdown of certain amino acids (leucine, isoleucine, and valine) and causes a maple syrup odor in urine, ear wax, and sweat. Symptoms include poor feeding, vomiting, lethargy, and developmental delays. (Symptoms: Dehydration, Fever, Diarrhea)
6. +6. Phenylketonuria (PKU): A genetic disorder that affects the metabolism of the amino acid phenylalanine. Symptoms include intellectual disability, behavioral problems, seizures, and skin rashes. (Symptoms: Dehydration, Fever, Diarrhea)
7. +7. Homocystinuria: A genetic disorder that affects the metabolism of the amino acid methionine. Symptoms include developmental delays, dislocation of the lens in the eye, and skeletal abnormalities. (Symptoms: Dehydration, Fever, Diarrhea)
8. +8. Mitochondrial Disorders: A group of genetic disorders that affect the energy production in cells. Symptoms can vary widely, but often include muscle weakness, developmental delays, and seizures. (Symptoms: Ataxia, Progressive neurologic deterioration, Dehydration, Fever, Diarrhea)
9. +9. Leigh Syndrome: A rare inherited neurometabolic disorder that affects the central nervous system. Symptoms include progressive neurologic deterioration, hypotonia, and lactic acidosis. (Symptoms: Ataxia, Progressive neurologic deterioration)
10. +10. Pelizaeus-Merzbacher Disease: A rare X-linked rec"
['Phenylketonuria']," +1. Down syndrome: Abnormality of prenatal development or birth and motor delay are common symptoms. Generalized hypotonia is also often present. Hip dysplasia can be a related issue, but not always present. Hypertyrosinemia and hyperphenylalaninemia are not typically associated with Down syndrome.

+2. Edward's syndrome: Abnormality of prenatal development or birth and death in infancy are common symptoms. Motor delay, generalized hypotonia, hip dysplasia, hypertyrosinemia, and hyperphenylalaninemia are not typically associated with Edward's syndrome.

+3. Phenylketonuria (PKU): Hyperphenylalaninemia is a common symptom. Abnormality of prenatal development or birth, motor delay, generalized hypotonia, hip dysplasia, and neonatal death are not typically associated with PKU.

+4. Tyrosinemia type I: Hypertyrosinemia is a common symptom. Abnormality of prenatal development or birth, motor delay, generalized hypotonia, hip dysplasia, and neonatal death are not typically associated with Tyrosinemia type I.

+5. Spinal muscular atrophy (SMA): Motor delay and generalized hypotonia are common symptoms. Abnormality of prenatal development or birth, hip dysplasia, hypertyrosinemia, and hyperphenylalaninemia are not typically associated with SMA.

+6. Osteogenesis imperfecta: Abnormality of prenatal development or birth and hip dysplasia are common symptoms. Motor delay, generalized hypotonia, hypertyrosinemia, and hyperphenylalaninemia are not typically associated with osteogenesis imperfecta.

+7. Congenital hip dysplasia: Hip dysplasia is a common symptom. Abnormality of prenatal development or birth, motor delay, generalized hypotonia, hypertyrosinemia, and hyperphenylalaninemia are not typically associated with congenital hip dysplasia.

+8. Prader-Willi syndrome: Abnormality of prenatal development or birth, motor delay, and generalized hypotonia are common symptoms. Hip dysplasia, hypertyrosinemia, and hyperphenylalaninemia are not typically associated with Prader-Willi syndrome.

+9. Achondroplasia: Abnormality of prenatal development or birth is a common symptom. Motor delay, generalized hypotonia, hip dysplasia, hypertyrosinemia, and hyperphenylalaninemia are not typically associated with achondroplasia.

+10. Cornelia de Lange syndrome: Abnormality of prenatal development or birth, motor delay, and generalized hypotonia are common symptoms. Hip dysplasia, hypertyrosinemia, and hyperphenylalaninemia are not typically associated with Cornelia de Lange syndrome.

It is important to note that this is not an exhaustive list and further diagnostic testing is necessary to confirm a diagnosis."
['Phenylketonuria']," Based on the symptoms you have provided, here are some potential diseases that the patient may have:

+1. Phenylketonuria (PKU): PKU is a genetic disorder characterized by an inability to break down the amino acid phenylalanine, leading to its accumulation in the body. Symptoms can include abnormal prenatal development or birth, seizures, generalized hypotonia, and death in infancy or childhood. However, PKU does not typically cause retrognathia, apnea, opisthotonus, or hypertyrosinemia.

+2. Nonketotic hyperglycinemia (NKH): NKH is a genetic disorder that affects the body's ability to break down the amino acid glycine. Symptoms can include abnormal prenatal development or birth, seizures, generalized hypotonia, and death in infancy or childhood. However, NKH does not typically cause retrognathia, apnea, opisthotonus, hypertyrosinemia, or hyperphenylalaninemia.

+3. Maple syrup urine disease (MSUD): MSUD is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include abnormal prenatal development or birth, seizures, generalized hypotonia, and death in infancy or childhood. However, MSUD does not typically cause retrognathia, apnea, opisthotonus, hypertyrosinemia, or hyperphenylalaninemia.

+4. Zellweger syndrome: Zellweger syndrome is a rare genetic disorder that affects the body's ability to produce peroxisomes, which are necessary for normal metabolic function. Symptoms can include abnormal prenatal development or birth, seizures, generalized hypotonia, and death in infancy or childhood. Additionally, Zellweger syndrome can cause retrognathia and opisthotonus, but it does not typically cause apnea, hypertyrosinemia, or hyperphenylalaninemia.

+5. Moebius syndrome: Moebius syndrome is a rare neurological disorder that affects the cranial nerves, causing facial paralysis and other symptoms. Symptoms can include abnormal prenatal development or birth and retrognathia. However, Moebius syndrome does not typically cause seizures, generalized hypotonia, apnea, opisthotonus, hypertyrosinemia, or hyperphenylalaninemia.

+6. Pierre Robin sequence: Pierre Robin sequence is a congenital condition characterized by a small lower jaw (micrognathia), a tongue that falls back in the throat (glossoptosis), and breathing difficulties. Symptoms can include abnormal prenatal development or birth, retrognathia, and apnea. However, Pierre Robin sequence does not typically cause seizures, generalized hypotonia, opisthotonus, hypertyrosinemia, or hyperphenylalaninemia.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing and evaluation would be necessary to confirm any diagnosis."
['Tyrosinemia type 1']," +1. Autism Spectrum Disorder: The patient exhibits autistic behavior, but does not have self-mutilation, hyperactivity, or intellectual disability.

+2. Epilepsy: The patient has seizures, but does not have neonatal death, death in infancy, or death in childhood.

+3. Phenylketonuria (PKU): The patient has hyperphenylalaninemia and elevated circulating alpha-fetoprotein concentration, but does not have neonatal death or death in infancy.

+4. Tyrosinemia Type I: The patient has hypertyrosinemia, elevated circulating alkaline phosphatase concentration, and elevated circulating alpha-fetoprotein concentration. However, the patient does not have neonatal death or death in infancy.

+5. Maple Syrup Urine Disease: The patient has abnormal circulating aspartate family amino acid concentration and abnormal circulating alanine concentration, but does not have neonatal death or death in infancy.

+6. Iron Deficiency Anemia: The patient has decreased serum iron, but does not have intellectual disability, hyperactivity, or seizures.

+7. Obesity: The patient has obesity, but does not have intellectual disability, hyperactivity, seizures, or motor delay.

+8. Cerebral Palsy: The patient has motor delay, but does not have intellectual disability, hyperactivity, seizures, or obesity.

+9. Down Syndrome: The patient does not have any of the symptoms listed, but intellectual disability is a common symptom of Down Syndrome.

+10. Fragile X Syndrome: The patient does not have any of the symptoms listed, but intellectual disability and autistic behavior are common symptoms of Fragile X Syndrome.

+11. Rett Syndrome: The patient exhibits autistic behavior, but does not have hyperactivity or intellectual disability. Rett Syndrome is a genetic disorder that affects the development of the brain and is more common in females.

+12. Angelman Syndrome: The patient exhibits autistic behavior, but does not have hyperactivity or intellectual disability. Angelman Syndrome is a genetic disorder that affects the nervous system and is characterized by developmental delay, intellectual disability, and speech impairment.

+13. Prader-Willi Syndrome: The patient does not have any of the symptoms listed, but obesity and intellectual disability are common symptoms of Prader-Willi Syndrome.

+14. Tuberous Sclerosis Complex: The patient does not have any of the symptoms listed, but intellectual disability and autistic behavior are common symptoms of Tuberous Sclerosis Complex.

+15. Neurofibromatosis Type 1: The patient does not have any of the symptoms listed, but intellectual disability and motor delay are common symptoms of Neurofibromatosis Type 1.

+16. Sturge-Weber Syndrome: The patient does not have any of the symptoms listed, but intellectual disability and seizures are common symptoms of Sturge-Weber Syndrome.

+17. Pelizaeus-Merzbacher Disease: The patient does not have any of the symptoms listed, but intellectual disability and motor delay are common symptoms of Pelizaeus-Merzbacher Disease.

+18. Alexander Disease: The patient does not have any of the symptoms listed"
['Classic galactosemia']," +1. Galactosemia: This is a metabolic disorder that affects the body's ability to metabolize the sugar galactose, leading to an accumulation of galactose in the blood. Symptoms include vomiting, increased total bilirubin, and hypergalactosemia. However, this condition does not typically cause death in infancy or neonatal death.

+2. Tyrosinemia: This is a genetic disorder that affects the breakdown of the amino acid tyrosine. Symptoms can include vomiting and increased total bilirubin. However, this condition does not typically cause death in infancy or neonatal death, and hypergalactosemia is not a symptom.

+3. Maple Syrup Urine Disease: This is a metabolic disorder that affects the breakdown of certain amino acids. Symptoms can include vomiting and increased total bilirubin. However, this condition does not typically cause death in infancy or neonatal death, and hypergalactosemia is not a symptom.

+4. Hepatitis: This is an inflammation of the liver that can be caused by a viral infection or other factors. Symptoms can include vomiting and increased total bilirubin. However, this condition does not typically cause death in infancy or neonatal death, and hypergalactosemia is not a symptom.

+5. Biliary Atresia: This is a condition in which the bile ducts inside or outside the liver do not have normal openings, leading to a buildup of bile in the liver and eventually causing scarring and damage. Symptoms can include increased total bilirubin and neonatal death. However, this condition does not typically cause death in infancy or vomiting, and hypergalactosemia is not a symptom.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing and evaluation would be necessary to confirm a diagnosis. Additionally, some of these conditions may have overlapping symptoms, and it is possible that the patient's symptoms could be caused by a combination of factors."
['Phenylketonuria']," +1. Phenylketonuria (PKU): PKU is a genetic disorder characterized by an inability to break down the amino acid phenylalanine, leading to its accumulation in the body. It can cause abnormal prenatal development or birth, death in infancy, neonatal death, hyperphenylalaninemia, and abnormal circulating tyrosine concentration.

+2. Tyrosinemia type I: This is a genetic disorder affecting the breakdown of the amino acid tyrosine. It can cause abnormal prenatal development or birth, death in infancy, neonatal death, hyperphenylalaninemia, and abnormal circulating tyrosine concentration.

+3. Alkaptonuria: This is a rare genetic disorder that affects the breakdown of tyrosine. It can cause abnormal prenatal development or birth, but it does not typically cause death in infancy, neonatal death, hyperphenylalaninemia, or abnormal circulating tyrosine concentration.

+4. Homocystinuria: This is a genetic disorder affecting the metabolism of the amino acid methionine. It can cause abnormal prenatal development or birth, but it does not typically cause death in infancy, neonatal death, hyperphenylalaninemia, or abnormal circulating tyrosine concentration.

+5. Maple syrup urine disease: This is a genetic disorder affecting the breakdown of certain amino acids. It can cause abnormal prenatal development or birth, but it does not typically cause death in infancy, neonatal death, hyperphenylalaninemia, or abnormal circulating tyrosine concentration.

Please note that this is not an exhaustive list and further diagnostic tests would be needed to confirm a diagnosis."
['Biotinidase deficiency'], +1
['Phenylketonuria']," +1. Down Syndrome: This condition is characterized by an abnormality of prenatal development, specifically an extra copy of chromosome 21. It can cause intellectual disability and may be associated with other health problems. However, it would not typically cause hyperphenylalaninemia, hypertyrosinemia, or death in infancy or adolescence.

+2. Tay-Sachs Disease: This is a genetic disorder that affects the nervous system and causes intellectual disability, progressive deterioration, and death in infancy or childhood. It is caused by a deficiency of the enzyme hexosaminidase A, which leads to the accumulation of a fatty substance called ganglioside GM2 in the brain. Tay-Sachs disease would not typically cause abnormalities of prenatal development or neonatal death.

+3. Phenylketonuria (PKU): This is a genetic disorder that affects the way the body processes phenylalanine, an amino acid found in proteins. If left untreated, PKU can cause intellectual disability, seizures, behavioral problems, and other neurological problems. It is characterized by hyperphenylalaninemia and can sometimes also cause hypertyrosinemia. However, PKU would not typically cause abnormalities of prenatal development, neonatal death, or death in infancy or adolescence.

+4. Tyrosinemia Type I: This is a rare genetic disorder that affects the way the body metabolizes the amino acid tyrosine. It can cause liver damage, kidney problems, and neurological symptoms such as intellectual disability and seizures. Tyrosinemia Type I is characterized by hypertyrosinemia and can sometimes also cause hyperphenylalaninemia. It can cause death in infancy or adolescence if left untreated.

+5. Maple Syrup Urine Disease (MSUD): This is a genetic disorder that affects the way the body breaks down certain amino acids (leucine, isoleucine, and valine). It is characterized by a distinctive sweet odor of the urine, hence the name. MSUD can cause intellectual disability, seizures, and other neurological problems if left untreated. It would not typically cause abnormalities of prenatal development or neonatal death.

+6. Homocystinuria: This is a genetic disorder that affects the way the body processes the amino acid methionine. It can cause intellectual disability, developmental delays, and other neurological problems. Homocystinuria is characterized by an elevated level of homocysteine in the blood and can sometimes also cause abnormalities of prenatal development or neonatal death.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing would be needed to confirm any of these possibilities. It is also possible that the patient's symptoms are caused by a combination of factors or by a different condition entirely. A healthcare professional would be able to provide more personalized information and guidance based on a thorough evaluation of the patient's medical history and current symptoms."
['Smith-Lemli-Opitz syndrome']," Based on the symptoms you have provided, I will list some potential diseases that the patient may have. Please note that this is not a definitive diagnosis and medical consultation is necessary for accurate diagnosis.

+1. Smith-Lemli-Opitz syndrome: This is a genetic disorder characterized by multiple congenital anomalies, including microcephaly, low-set ears, strabismus, ptosis, syndactyly, intellectual disability, and growth delay. Additionally, this syndrome is often associated with hypocholesterolemia, elevated 8-dehydrocholesterol, and elevated circulating 7-dehydrocholesterol concentration.

+2. Down syndrome: This is a genetic disorder caused by trisomy 21, which is characterized by intellectual disability, low-set ears, and hypotonia. Some individuals with Down syndrome may also have congenital heart defects, gastrointestinal abnormalities, and hearing impairment.

+3. Prader-Willi syndrome: This is a genetic disorder characterized by hypotonia, feeding difficulties, intellectual disability, and behavioral problems. Some individuals with Prader-Willi syndrome may also have hypogonadism, short stature, and obesity.

+4. CHARGE syndrome: This is a genetic disorder characterized by coloboma, heart defects, atresia choanae, retardation of growth and development, genital hypoplasia, and ear abnormalities. Some individuals with CHARGE syndrome may also have hearing impairment, balance problems, and swallowing difficulties.

+5. Cornelia de Lange syndrome: This is a genetic disorder characterized by intellectual disability, growth delay, hirsutism, and distinctive facial features, including synophrys, long eyelashes, and a thin upper lip. Some individuals with Cornelia de Lange syndrome may also have limb abnormalities, gastrointestinal problems, and hearing impairment.

+6. Noonan syndrome: This is a genetic disorder characterized by facial dysmorphism, congenital heart defects, and short stature. Some individuals with Noonan syndrome may also have intellectual disability, bleeding problems, and lymphatic abnormalities.

+7. Williams syndrome: This is a genetic disorder characterized by intellectual disability, distinctive facial features, and cardiovascular disease. Some individuals with Williams syndrome may also have growth delay, hypercalcemia, and hypersensitivity to sound.

+8. 22q11.2 deletion syndrome: This is a genetic disorder characterized by congenital heart defects, palatal abnormalities, immune dysfunction, and learning difficulties. Some individuals with 22q11.2 deletion syndrome may also have hypocalcemia, hearing impairment, and feeding difficulties.

+9. Angelman syndrome: This is a genetic disorder characterized by intellectual disability, ataxia, seizures, and a happy demeanor. Some individuals with Angelman syndrome may also have hyperactivity, sleep disturbances, and feeding difficulties.

+10. Fragile X syndrome: This is a genetic disorder caused by a mutation in the FMR1 gene, which is characterized by intellectual disability, behavioral problems, and distinctive facial features. Some individuals with Fragile X syndrome may also have autism spectrum disorder, anxiety, and seizures.

The patient's symptoms of cryptorchidism, hypospadias, and recurrent viral infections are not typically associated with the above-listed diseases. However, these symptoms may be indicative of other medical conditions, and further evaluation is necessary for accurate"
['Canavan disease']," +1. Strabismus: Also known as crossed eyes, this condition is characterized by misalignment of the eyes, which can lead to visual impairment. The patient has this symptom.

+2. Hyporeflexia: This is a condition characterized by decreased or absent reflexes. The patient has this symptom.

+3. Generalized hypotonia: This is a condition characterized by decreased muscle tone throughout the body. The patient has this symptom.

+4. Obesity: This is a condition characterized by excessive body fat. The patient has this symptom.

+5. Death in infancy: This is a symptom, not a disease, but it can be associated with many genetic and congenital disorders. The patient does not have this symptom.

+6. Fever: This is a symptom, not a disease, and can be caused by many different conditions. The patient has this symptom.

+7. Cerebral atrophy: This is a condition characterized by the degeneration of brain tissue. The patient has this symptom.

+8. Abnormal circulating aspartate family amino acid concentration: This is a symptom, not a disease, and can be associated with many metabolic disorders. The patient has this symptom.

+9. Down syndrome: A genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It is associated with intellectual disability, characteristic facial features, and poor muscle tone. The patient does not have intellectual disability or characteristic facial features, but has poor muscle tone.

+10. Prader-Willi syndrome: A genetic disorder caused by the loss of function of certain genes in chromosome 15. It is associated with obesity, hypotonia, and developmental delays. The patient has obesity and hypotonia, but not developmental delays.

+11. Phenylketonuria (PKU): A metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. It is associated with intellectual disability, seizures, and skin rashes. The patient does not have intellectual disability or seizures, but has abnormal circulating aspartate family amino acid concentration.

+12. Maple syrup urine disease: A metabolic disorder caused by a deficiency of the enzyme branched-chain ketoacid dehydrogenase. It is associated with sweet-smelling urine, intellectual disability, and seizures. The patient does not have sweet-smelling urine, intellectual disability or seizures, but has abnormal circulating aspartate family amino acid concentration.

+13. Leigh syndrome: A rare inherited neurometabolic disorder that affects the central nervous system. It is associated with progressive neurologic decline, including hypotonia, ataxia, and developmental delays. The patient has hypotonia, but not ataxia or developmental delays.

+14. Alexander disease: A rare inherited neurological disorder that affects the central nervous system. It is associated with progressive neurologic decline, including hypotonia, ataxia, and developmental delays. The patient has hypotonia, but not ataxia or developmental delays.

+15. Canavan disease: A rare inherited neurological disorder that affects the central nervous system. It is associated with progressive neurologic decline, including hypotonia, ataxia, and developmental delays. The patient has hypotonia, but not ataxia or developmental delays."
['Phenylketonuria']," Based on the symptoms you have provided, I will list some potential diseases that could match the patient's condition. Please note that this is not a definitive diagnosis, and further medical evaluation is necessary for accurate diagnosis.

1. Obesity: Obesity is a condition characterized by excessive body fat accumulation, which may impair health. The patient has obesity, which is a significant symptom. However, other symptoms like coarctation of the aorta, fever, pneumonia, and various forms of early death are not typically associated with obesity.

+2. Coarctation of the Aorta: This is a congenital heart defect where the aorta narrows, causing obstruction of blood flow. The patient has coarctation of the aorta, but other symptoms like obesity, fever, pneumonia, hyperphenylalaninemia, and various forms of early death are not typically associated with this condition.

+3. Phenylketonuria (PKU): PKU is a genetic disorder characterized by a deficiency of the enzyme phenylalanine hydroxylase, leading to an accumulation of phenylalanine and its metabolites. This can cause brain damage. The patient has hyperphenylalaninemia, which is a symptom of PKU. However, other symptoms like obesity, coarctation of the aorta, fever, pneumonia, and various forms of early death are not typically associated with PKU.

+4. Tyrosinemia type I (Hypertyrosinemia): This is a genetic disorder affecting the breakdown of the amino acid tyrosine, which can lead to liver and kidney damage, as well as neurological issues. The patient has hypertyrosinemia, which is a symptom of Tyrosinemia type I. However, other symptoms like obesity, coarctation of the aorta, fever, pneumonia, and various forms of early death are not typically associated with Tyrosinemia type I.

For the symptoms related to early death (death in infancy, neonatal death, death in childhood, death in adolescence, and death in early adulthood), these could be indicative of various genetic disorders, congenital conditions, or other severe health issues. It is crucial to consult a medical professional for further evaluation and testing to determine the exact cause."
['Classic homocystinuria']," +1. Homocystinuria: This disorder is characterized by an abnormality of prenatal development or birth, death in infancy, hyperhomocystinemia, and hypermethioninemia. It is a genetic disorder that affects the metabolism of the amino acid methionine.

+2. Maple Syrup Urine Disease: This disorder is characterized by hyperhomocystinemia, hypermethioninemia, and aminoaciduria. It is a genetic disorder that affects the breakdown of certain amino acids.

+3. Nonketotic Hyperglycinemia: This disorder is characterized by hyperhomocystinemia, hypermethioninemia, and aminoaciduria. It is a genetic disorder that affects the metabolism of the amino acid glycine.

+4. Phenylketonuria (PKU): This disorder is characterized by aminoaciduria. It is a genetic disorder that affects the metabolism of the amino acid phenylalanine.

+5. Tyrosinemia: This disorder is characterized by aminoaciduria. It is a genetic disorder that affects the metabolism of the amino acid tyrosine.

It is important to note that the symptoms provided do not necessarily indicate any of the above disorders, and further testing would be needed to confirm a diagnosis. Additionally, the patient's symptoms of ""Neonatal death"" and ""Death in childhood"" may indicate a more severe form of one of the above disorders, or it could be caused by a different, unrelated condition."
[]," +1. Ataxia-Telangiectasia: This is a genetic disorder that affects the brain and immune system. Symptoms include Ataxia, Generalized hypotonia, and often death in childhood. However, this disease does not typically cause abnormal circulating pyrimidine concentration or uraciluria.

+2. Friedreich's Ataxia: This is a genetic disorder that affects the nervous system and causes movement problems. Symptoms include Ataxia and Generalized hypotonia. However, this disease does not typically cause death in childhood, abnormal circulating pyrimidine concentration, or uraciluria.

+3. Maple Syrup Urine Disease: This is a genetic disorder that affects how the body breaks down certain amino acids. Symptoms can include abnormal circulating pyrimidine concentration and uraciluria. However, this disease does not typically cause Ataxia or Generalized hypotonia, and death in childhood is not a common outcome.

+4. Pyrimidine 5'-Nucleotidase Deficiency: This is a rare genetic disorder that affects the metabolism of pyrimidines. Symptoms can include abnormal circulating pyrimidine concentration and uraciluria. However, this disease does not typically cause Ataxia or Generalized hypotonia, and death in childhood is not a common outcome.

+5. Spinal Muscular Atrophy: This is a genetic disorder that affects the nerves that control voluntary muscle movement. Symptoms include Generalized hypotonia, but Ataxia is not a typical symptom. This disease does not typically cause abnormal circulating pyrimidine concentration or uraciluria, and death in childhood is a possible outcome depending on the type and severity of the disease.

It is important to note that these are potential diagnoses based on the given symptoms, and further testing and evaluation would be necessary to confirm any diagnosis. Additionally, it is possible that the patient's symptoms may be caused by a combination of factors or a yet-to-be-identified condition."
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder characterized by a deficiency of the enzyme phenylalanine hydroxylase, leading to an accumulation of phenylalanine in the body. Symptoms can include intellectual disability, behavioral problems, seizures, and skin rashes. However, Hypertyrosinemia and Death in early adulthood are not typical symptoms of PKU.

+2. Tyrosinemia type I: This is a genetic disorder caused by a deficiency of the enzyme fumarylacetoacetase, leading to an accumulation of tyrosine and its metabolites in the body. Symptoms can include liver disease, kidney problems, and rickets. Hyperphenylalaninemia is not a typical symptom of Tyrosinemia type I.

+3. Maple syrup urine disease (MSUD): This is a genetic disorder caused by a deficiency of the enzyme branched-chain keto acid dehydrogenase complex, leading to an accumulation of branched-chain amino acids in the body. Symptoms can include maple syrup odor in urine, poor feeding, vomiting, and developmental delay. Hypertyrosinemia and Death in early adulthood are not typical symptoms of MSUD.

+4. Homocystinuria: This is a genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase, leading to an accumulation of homocysteine in the body. Symptoms can include intellectual disability, developmental delay, lens dislocation, and osteoporosis. Hyperphenylalaninemia and Death in early adulthood are not typical symptoms of Homocystinuria.

+5. Phenylalanine hydroxylase deficiency: This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, leading to an accumulation of phenylalanine in the body. Symptoms can include intellectual disability, behavioral problems, seizures, and skin rashes. Hypertyrosinemia is not a typical symptom of Phenylalanine hydroxylase deficiency.

It is important to note that the symptoms provided do not necessarily indicate a specific disease, and further testing and evaluation are necessary to make an accurate diagnosis. Additionally, the patient's medical history, family history, and other factors should be taken into consideration when making a diagnosis."
[]," +1. Congenital Heart Disease: This condition is a problem with the structure of the heart that is present at birth. It can cause respiratory insufficiency and, in severe cases, can lead to neonatal death. However, this condition would not cause death in infancy, abnormal circulating pyrimidine concentration, or uraciluria.

+2. Pyrimidemia: This is a condition characterized by an abnormally high concentration of pyrimidines in the blood. This would explain the symptom of abnormal circulating pyrimidine concentration, but it would not cause death in infancy, respiratory insufficiency, neonatal death, or uraciluria.

+3. Maple Syrup Urine Disease: This is an inherited disorder that affects the body's ability to break down certain amino acids. It can cause uraciluria, but it would not cause death in infancy, respiratory insufficiency, neonatal death, or abnormal circulating pyrimidine concentration.

+4. Urea Cycle Disorder: This is a group of inherited disorders caused by a deficiency of one of the enzymes in the urea cycle. These disorders can cause respiratory insufficiency and, in severe cases, can lead to neonatal death. However, they would not cause death in infancy, abnormal circulating pyrimidine concentration, or uraciluria.

+5. Fanconi's Anemia: This is a genetic disorder that affects the bone marrow. It can cause death in infancy and respiratory insufficiency, but it would not cause neonatal death, abnormal circulating pyrimidine concentration, or uraciluria.

Please note that this is not an exhaustive list and the symptoms provided could potentially be associated with other medical conditions. It is important to consult with a healthcare professional for an accurate diagnosis."
['Tyrosinemia type 1']," +1. Anemia: The patient has anemia, which is a condition in which the number of red blood cells is lower than normal, resulting in less oxygen being carried to the body's tissues. However, the patient does not have all the symptoms typically associated with anemia, such as fatigue and weakness.

+2. Cirrhosis: The patient has ascites, which is a symptom of cirrhosis, a chronic liver disease. Additionally, the patient has hypoalbuminemia and hypoproteinemia, which are also common in cirrhosis. However, the patient does not have other symptoms typically associated with cirrhosis, such as jaundice and spider-like blood vessels on the skin.

+3. Hemolytic disease of the newborn: The patient has anemia and death in infancy, which are symptoms of hemolytic disease of the newborn, a condition in which a newborn's red blood cells are destroyed by the mother's immune system. However, the patient does not have other symptoms typically associated with this condition, such as jaundice and a large spleen.

+4. Hepatitis: The patient has anemia, hypoalbuminemia, and hypoproteinemia, which are symptoms of hepatitis, an inflammation of the liver. However, the patient does not have other symptoms typically associated with hepatitis, such as jaundice and abdominal pain.

+5. Hyperthyroidism: The patient has anemia, which is a symptom of hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. However, the patient does not have other symptoms typically associated with hyperthyroidism, such as weight loss, rapid heart rate, and heat intolerance.

+6. Inflammatory bowel disease: The patient has anemia, which is a symptom of inflammatory bowel disease, a group of conditions that cause inflammation in the digestive tract. However, the patient does not have other symptoms typically associated with inflammatory bowel disease, such as diarrhea, abdominal pain, and weight loss.

+7. Leukemia: The patient has thrombocytosis, which is a symptom of leukemia, a cancer of the body's blood-forming tissues. However, the patient does not have other symptoms typically associated with leukemia, such as fever, fatigue, and frequent infections.

+8. Porphyria: The patient has anemia and abnormal circulating porphyrin concentration, which are symptoms of porphyria, a group of rare disorders that affect the skin or nervous system. However, the patient does not have other symptoms typically associated with porphyria, such as skin rashes and neurological symptoms.

+9. Sepsis: The patient has anemia, which is a symptom of sepsis, a life-threatening condition that occurs when the body's response to an infection injures its own tissues and organs. However, the patient does not have other symptoms typically associated with sepsis, such as fever, rapid heart rate, and rapid breathing.

+10. Tyrosinemia: The patient has hypertyrosinemia and aminoaciduria, which are symptoms of tyrosinemia, a rare genetic disorder that affects the breakdown of the amino acid tyrosine. However, the patient does not have other symptoms typically associated with tyrosinemia, such as liver disease and neu"
['Canavan disease']," +1. SIDS (Sudden Infant Death Syndrome): No specific symptoms, but associated with sudden and unexplained death in infancy.

+2. Epilepsy: Characterized by recurrent, unprovoked seizures.

+3. Cerebral Palsy: A group of disorders that affect movement and posture, may include motor delays.

+4. Maple Syrup Urine Disease: A genetic disorder affecting the metabolism of certain amino acids, can result in abnormal circulating aspartate family amino acid concentration.

+5. Phenylketonuria (PKU): A genetic disorder affecting the metabolism of the amino acid phenylalanine, does not typically cause seizures or motor delays.

+6. Homocystinuria: A genetic disorder affecting the metabolism of the amino acid methionine, can result in abnormal circulating amino acid concentrations, but not typically seizures or motor delays.

+7. Nonketotic Hyperglycinemia: A genetic disorder affecting the metabolism of the amino acid glycine, can result in seizures and motor delays, but not typically abnormal circulating amino acid concentrations.

+8. Pyridoxine-Dependent Epilepsy: A rare genetic disorder affecting the metabolism of the vitamin pyridoxine, can cause seizures, but not typically motor delays or abnormal circulating amino acid concentrations.

+9. Mitochondrial Disorders: A group of disorders affecting the energy production within cells, can result in a wide range of symptoms including seizures, motor delays, and metabolic abnormalities.

It is important to note that this is not an exhaustive list and that further testing and evaluation is necessary to confirm a diagnosis."
['Isovaleric acidemia']," +1. Sepsis: The patient has reported ""Death in infancy"" and ""Fever,"" which are potential symptoms of sepsis. However, sepsis does not typically present with vomiting, diarrhea, or abdominal pain.

+2. Necrotizing enterocolitis: The patient has reported ""Death in infancy"" and ""Gastrointestinal inflammation,"" which are potential symptoms of necrotizing enterocolitis. However, this condition is most commonly seen in premature infants and is not typically associated with fever, vomiting, diarrhea, or abnormal circulating glycine or carnitine concentrations.

+3. Inflammatory bowel disease: The patient has reported ""Abdominal pain,"" ""Gastrointestinal inflammation,"" and ""Vomiting,"" which are potential symptoms of inflammatory bowel disease. However, this condition is not typically associated with death in infancy, neonatal death, or death in childhood.

+4. Viral gastroenteritis: The patient has reported ""Vomiting,"" ""Diarrhea,"" and ""Fever,"" which are potential symptoms of viral gastroenteritis. However, this condition is not typically associated with death in infancy, neonatal death, or death in childhood.

+5. Maple syrup urine disease: The patient has reported ""Abnormal circulating glycine concentration"" and ""Body odor,"" which are potential symptoms of maple syrup urine disease. However, this condition is not typically associated with death in infancy, neonatal death, or death in childhood.

+6. Carnitine deficiency: The patient has reported ""Abnormal circulating carnitine concentration,"" which is a potential symptom of carnitine deficiency. However, this condition is not typically associated with death in infancy, neonatal death, or death in childhood.

+7. Primary ciliary dyskinesia: The patient has reported ""Recurrent viral infections,"" which is a potential symptom of primary ciliary dyskinesia. However, this condition is not typically associated with death in infancy, neonatal death, or death in childhood.

It is important to note that this is just a list of potential diseases based on the symptoms provided and further testing and evaluation would be needed to make a definitive diagnosis. It is also possible that the patient's symptoms are due to a combination of different conditions or to a single underlying condition that has not been considered here."
['Phenylketonuria']," +1. Hypertension: The patient has hypertension.

+2. Intellectual disability: The patient has intellectual disability.

+3. Obesity: The patient has obesity.

+4. Tyrosinemia type I (Hypertyrosinemia): The patient has elevated tyrosine levels in the blood (Hypertyrosinemia).

+5. Phenylketonuria (Hyperphenylalaninemia): The patient has elevated phenylalanine levels in the blood (Hyperphenylalaninemia).

+6. Hepatorenal tyrosinemia: The patient has Hypertyrosinemia and may have elevated urinary carboxylic acid.

+7. Tyrosinemia type II: The patient has Hypertyrosinemia and may have skin lesions.

+8. Tyrosinemia type III: The patient has Hypertyrosinemia and may have intellectual disability and neurological symptoms.

+9. Phenylalanine hydroxylase deficiency: The patient has Hyperphenylalaninemia and may have intellectual disability.

+10. Phenylketonuria (PKU): The patient has Hyperphenylalaninemia and may have intellectual disability and neurological symptoms.

+11. Alkaptonuria: The patient has elevated urinary carboxylic acid.

+12. Homocystinuria: The patient has intellectual disability and may have elevated urinary carboxylic acid.

+13. Maple syrup urine disease: The patient may have intellectual disability and neurological symptoms.

+14. Isovaleric acidemia: The patient may have intellectual disability and neurological symptoms.

+15. Glutaric acidemia type I: The patient may have intellectual disability and neurological symptoms.

+16. Methylmalonic acidemia: The patient may have intellectual disability and neurological symptoms.

+17. Propionic acidemia: The patient may have intellectual disability and neurological symptoms.

+18. 3-Methylcrotonyl-CoA carboxylase deficiency: The patient may have intellectual disability and neurological symptoms.

+19. Beta-ketothiolase deficiency: The patient may have intellectual disability and neurological symptoms.

+20. Multiple carboxylase deficiency: The patient may have intellectual disability and neurological symptoms.

+21. Non-ketotic hyperglycinemia: The patient may have intellectual disability and neurological symptoms.

+22. Pyruvate dehydrogenase deficiency: The patient may have intellectual disability and neurological symptoms.

+23. Mitochondrial disorders: The patient may have intellectual disability and neurological symptoms.

+24. Leigh syndrome: The patient may have intellectual disability and neurological symptoms.

+25. Wilson's disease: The patient may have intellectual disability and neurological symptoms.

+26. Neurodegenerative disorders: The patient may have intellectual disability and neurological symptoms.

+27. Metachromatic leukodystrophy: The patient may have intellectual disability and neurological symptoms.

+28. Krabbe disease: The patient may have intellectual disability and neurological symptoms."
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Smith-Lemli-Opitz syndrome: This is a genetic disorder that affects the development of many parts of the body. It can cause abnormalities of prenatal development or birth, small for gestational age, and death in infancy. Hyperalaninemia is also a common symptom. However, this syndrome does not typically cause abnormal circulating carnitine concentration or severe hearing impairment.

+2. Zellweger syndrome: This is a rare genetic disorder that affects the development of the brain, liver, kidneys, and other organs. It can cause abnormalities of prenatal development or birth, small for gestational age, and death in infancy. Hyperalaninemia and neonatal death are also common symptoms. However, this syndrome does not typically cause abnormal circulating carnitine concentration or severe hearing impairment.

+3. Nonketotic hyperglycinemia: This is a genetic disorder that affects the way the body breaks down the amino acid glycine. It can cause abnormal circulating carnitine concentration, hyperalaninemia, and death in infancy or childhood. However, this disorder does not typically cause abnormalities of prenatal development or birth, small for gestational age, or severe hearing impairment.

+4. Carnitine transporter deficiency: This is a genetic disorder that affects the body's ability to transport carnitine into cells. It can cause abnormal circulating carnitine concentration and death in infancy or childhood. However, this disorder does not typically cause abnormalities of prenatal development or birth, small for gestational age, hyperalaninemia, or severe hearing impairment.

+5. Jervell and Lange-Nielsen syndrome: This is a genetic disorder that affects the heart and hearing. It can cause severe hearing impairment and death in infancy or childhood. However, this disorder does not typically cause abnormalities of prenatal development or birth, small for gestational age, hyperalaninemia, or abnormal circulating carnitine concentration.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing and evaluation would be necessary to determine the underlying cause of the patient's symptoms."
['Ornithine transcarbamylase deficiency']," +1. Hyperekplexia: The patient has lethargy and sleep abnormality, but does not have death in infancy. Hyperekplexia is a rare genetic disorder characterized by abnormal startle reflex and stiffness.

+2. Maple syrup urine disease: The patient has oroticaciduria and abnormal circulating ornithine concentration, but does not have lethargy, drowsiness, sleep abnormality, or death in infancy. Maple syrup urine disease is a genetic disorder in which the body cannot break down certain amino acids properly.

+3. Homocystinuria: The patient has oroticaciduria and abnormal circulating ornithine concentration, but does not have lethargy, drowsiness, sleep abnormality, or death in infancy. Homocystinuria is a genetic disorder in which the body cannot process certain amino acids properly.

+4. Ornithine transcarbamylase deficiency: The patient has oroticaciduria and abnormal circulating ornithine concentration, but does not have lethargy, drowsiness, sleep abnormality, or death in infancy. Ornithine transcarbamylase deficiency is a genetic disorder in which the body cannot process ammonia properly.

+5. Urea cycle disorders: The patient has oroticaciduria and abnormal circulating ornithine concentration, but does not have lethargy, drowsiness, sleep abnormality, or death in infancy. Urea cycle disorders are a group of genetic disorders in which the body cannot process ammonia properly.

+6. Citrullinemia: The patient has oroticaciduria and abnormal circulating ornithine concentration, but does not have lethargy, drowsiness, sleep abnormality, or death in infancy. Citrullinemia is a genetic disorder in which the body cannot process certain amino acids properly.

+7. Argininosuccinic aciduria: The patient has oroticaciduria and abnormal circulating ornithine concentration, but does not have lethargy, drowsiness, sleep abnormality, or death in infancy. Argininosuccinic aciduria is a genetic disorder in which the body cannot process certain amino acids properly.

+8. Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: The patient has oroticaciduria and abnormal circulating ornithine concentration, but does not have lethargy, drowsiness, sleep abnormality, or death in infancy. HHH syndrome is a genetic disorder in which the body cannot process certain amino acids properly.

+9. Isovaleric acidemia: The patient has oroticaciduria and abnormal circulating ornithine concentration, but does not have lethargy, drowsiness, sleep abnormality, or death in infancy. Isovaleric acidemia is a genetic disorder in which the body cannot process certain amino acids properly.

+10. Propionic acidemia: The patient has oroticaciduria and abnormal circulating ornithine concentration, but does not have lethargy, drowsiness, sleep abnormality, or death in infancy. Propionic acidemia is a genetic disorder in which the body cannot process certain amino acids properly.
"
['Glutaryl-CoA dehydrogenase deficiency']," +1. Ataxia: This is a neurological symptom characterized by lack of coordination and unsteady movements. The patient has this symptom.

+2. Dystonia: This is a movement disorder characterized by involuntary muscle contractions and spasms. The patient has this symptom.

+3. Abnormal cerebral morphology: This refers to any abnormalities in the structure or shape of the brain. The patient has this symptom.

+4. Glutaric aciduria: This is a rare genetic disorder that affects the body's ability to break down certain amino acids, leading to a buildup of toxic substances in the body. The patient does not have this symptom.

+5. Death in childhood: This is a possible outcome for some severe medical conditions, but it is not a symptom. The patient does not have this symptom.

+6. Decreased plasma free carnitine: This is a condition in which there is a deficiency of carnitine in the blood. Carnitine is a substance that helps the body convert fat into energy. The patient does not have this symptom.

+7. Abnormal myelination: This refers to any abnormalities in the myelin sheath, which is the protective covering around nerve fibers. The patient has this symptom.

Based on the patient's symptoms, the following potential diseases could be considered:

+8. Ataxia-telangiectasia: This is a rare genetic disorder that affects the brain and immune system. It is characterized by progressive ataxia, telangiectasias (dilated blood vessels), and a weakened immune system.

+9. Friedreich's ataxia: This is a genetic disorder that affects the nervous system and causes progressive ataxia, among other symptoms.

+10. Leigh syndrome: This is a rare inherited neurometabolic disorder that affects the central nervous system. It is characterized by progressive degeneration of the brain and spinal cord.

+11. Pelizaeus-Merzbacher disease: This is a rare X-linked recessive genetic disorder that affects the nervous system. It is characterized by abnormal myelination and progressive ataxia.

+12. Maple syrup urine disease: This is a rare genetic disorder that affects the body's ability to break down certain amino acids. It is characterized by a maple syrup-like odor in the urine, but the patient does not have this symptom.

It is important to note that this is not an exhaustive list and that further testing and evaluation would be necessary to make a definitive diagnosis."
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder characterized by an inability to break down an amino acid called phenylalanine, leading to its buildup in the body. Symptoms can include developmental delays, neurological problems, and behavioral issues. However, PKU does not typically cause death in infancy or neonatal death. Hyperphenylalaninemia is a hallmark symptom of PKU.

+2. Tyrosinemia type I: This is a rare genetic disorder that affects the breakdown of the amino acid tyrosine. Symptoms can include liver disease, kidney problems, and neurological issues. Hyperphenylalaninemia can also be present in this disorder. However, Tyrosinemia type I does not typically cause death in infancy or neonatal death.

+3. Maple Syrup Urine Disease (MSUD): This is a genetic disorder that affects the breakdown of certain amino acids. Symptoms can include sweet-smelling urine, neurological problems, and developmental delays. Hyperphenylalaninemia is not a symptom of MSUD. Death in infancy or neonatal death can occur if MSUD is not diagnosed and treated early.

+4. Homocystinuria: This is a genetic disorder that affects the breakdown of the amino acid methionine. Symptoms can include developmental delays, neurological problems, and eye issues. Hyperphenylalaninemia is not a symptom of homocystinuria. Death in infancy or neonatal death is not typically associated with this disorder.

+5. Phenylalanine Hydroxylase Deficiency: This is a genetic disorder that affects the breakdown of the amino acid phenylalanine. Symptoms can include developmental delays, neurological problems, and behavioral issues. Hyperphenylalaninemia is a hallmark symptom of this disorder. Death in infancy or neonatal death can occur if the disorder is not diagnosed and treated early.

It is important to note that while these disorders share some symptoms with the patient's symptoms, they do not all match exactly. A definitive diagnosis should be made by a healthcare professional based on a thorough evaluation of the patient's medical history, physical examination, and diagnostic testing."
['Systemic primary carnitine deficiency']," +1. Maple Syrup Urine Disease: The patient has encephalopathy, vomiting, and elevated circulating hepatic transaminase concentration. However, they do not have maple syrup-smelling urine, which is a characteristic symptom of this disease.

+2. Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS): The patient has encephalopathy, hypotonia, cardiomyopathy, and vomiting. However, they do not have seizures, headaches, or muscle weakness, which are common symptoms of MELAS.

+3. Neonatal Hemochromatosis: The patient has hepatomegaly, elevated circulating hepatic transaminase concentration, and death in childhood. However, they do not have jaundice, which is a common symptom of neonatal hemochromatosis.

+4. Carnitine Deficiency: The patient has hypotonia, encephalopathy, and decreased plasma free carnitine. However, they do not have muscle weakness or cardiomyopathy, which are common symptoms of carnitine deficiency.

+5. Porphyria: The patient has abnormal circulating porphyrin concentration. However, they do not have abdominal pain, neurological symptoms, or skin symptoms, which are common in porphyria.

+6. Hyperammonemia: The patient has vomiting, encephalopathy, and hypotonia. However, they do not have seizures or coma, which are common symptoms of hyperammonemia.

+7. Organic Acidemias: The patient has vomiting, encephalopathy, and elevated circulating hepatic transaminase concentration. However, they do not have characteristic odors, such as a ""sweaty feet"" smell, which are common in organic acidemias.

+8. Urea Cycle Disorders: The patient has vomiting, encephalopathy, and hypotonia. However, they do not have hyperammonemia, which is a characteristic symptom of urea cycle disorders.

+9. Fatty Acid Oxidation Disorders: The patient has hypotonia, encephalopathy, and elevated circulating hepatic transaminase concentration. However, they do not have hypoglycemia, which is a common symptom of fatty acid oxidation disorders.

+10. Pyruvate Dehydrogenase Deficiency: The patient has encephalopathy, hypotonia, and elevated circulating hepatic transaminase concentration. However, they do not have lactic acidosis, which is a common symptom of pyruvate dehydrogenase deficiency.

+11. Glutaric Acidemia Type I: The patient has vomiting, encephalopathy, and elevated circulating hepatic transaminase concentration. However, they do not have macrocephaly or movement disorders, which are common symptoms of glutaric acidemia type I.

+12. Citrullinemia: The patient has vomiting, encephalopathy, and elevated circulating hepatic transaminase concentration. However, they do not have hyperammonemia, which is a characteristic symptom of citrullinemia.

+13. Argininosuccinic Acid"
['PMM2-CDG']," Based on the symptoms you have provided, I can suggest a list of potential diseases that the patient may have. Please note that this is not a definitive diagnosis and further medical tests and evaluations are necessary to confirm the presence of any disease.

Here are the potential diseases:

+1. Joubert Syndrome: This is a genetic disorder that affects the development of the cerebellum, the part of the brain that controls balance and coordination. Symptoms include strabismus, nystagmus, ataxia, hypotonia, and developmental delays.

+2. Pontocerebellar Hypoplasia: This is a group of genetic disorders that affect the development of the cerebellum and the brainstem. Symptoms include ataxia, hypotonia, developmental delays, and encephalopathy.

+3. Cerebellar Agenesis: This is a rare genetic disorder that affects the development of the cerebellum. Symptoms include ataxia, hypotonia, and developmental delays.

+4. Ataxia Telangiectasia: This is a genetic disorder that affects the immune system and the cerebellum. Symptoms include ataxia, oculomotor apraxia (a type of nystagmus), immune deficiency, and increased risk of cancer.

+5. Friedreich's Ataxia: This is a genetic disorder that affects the nerves that control muscle movement. Symptoms include ataxia, hyporeflexia, and developmental delays.

+6. Leigh Syndrome: This is a rare genetic disorder that affects the nervous system. Symptoms include encephalopathy, hypotonia, and developmental delays.

+7. Maple Syrup Urine Disease: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include encephalopathy, hypotonia, and developmental delays.

+8. Mitochondrial Encephalomyopathy: This is a group of genetic disorders that affect the mitochondria, the energy-producing structures in cells. Symptoms include encephalopathy, hypotonia, and developmental delays.

+9. Neurodegeneration with Brain Iron Accumulation: This is a group of genetic disorders that affect the brain and cause iron accumulation. Symptoms include ataxia, hypotonia, and developmental delays.

+10. Pelizaeus-Merzbacher Disease: This is a genetic disorder that affects the development of the white matter in the brain. Symptoms include nystagmus, ataxia, hypotonia, and developmental delays.

The patient has strabismus, nystagmus, ataxia, hyporeflexia, motor delay, cerebellar atrophy, generalized hypotonia, encephalopathy, and growth delay in common with many of these diseases. However, death in infancy and cerebellar agenesis are specific symptoms that may indicate a more narrow range of potential diagnoses.

It is important to consult with a medical professional for a definitive diagnosis and appropriate treatment."
['Classic homocystinuria']," Based on the symptoms you have provided, here are some potential diseases:

+1. Myopia: This is a common eye condition where you have difficulty seeing distant objects clearly. The patient has this symptom.

+2. Peters Anomaly: This is a rare genetic disorder that affects the eye's anterior chamber and cornea. The patient does not have any symptoms related to this disorder.

+3. Marfan Syndrome: This is a genetic disorder that affects the body's connective tissue. The patient has ectopia lentis, which is a common symptom of Marfan syndrome.

+4. Down Syndrome: This is a genetic disorder caused when abnormal cell division results in an extra full or partial copy of chromosome 21. The patient has delayed speech and language development and intellectual disability, which are common symptoms of Down syndrome.

+5. Homocystinuria: This is a genetic disorder in which the body is unable to process the amino acid methionine properly. The patient has hyperhomocystinemia and intellectual disability, which are common symptoms of Homocystinuria.

+6. Maple Syrup Urine Disease: This is a genetic disorder in which the body is unable to break down certain amino acids. The patient has hypermethioninemia, aminoaciduria, and abnormal circulating alanine concentration, which are common symptoms of Maple Syrup Urine Disease.

+7. Wilson's Disease: This is a genetic disorder that causes copper to accumulate in the body's tissues. The patient does not have any symptoms related to this disorder.

+8. Duchenne Muscular Dystrophy: This is a genetic disorder that causes muscle degeneration and weakness. The patient does not have any symptoms related to this disorder.

+9. Huntington's Disease: This is a genetic disorder that affects the nerve cells in the brain. The patient does not have any symptoms related to this disorder.

+10. Neurofibromatosis Type 1: This is a genetic disorder that causes tumors to grow on nerves. The patient does not have any symptoms related to this disorder.

+11. Tuberous Sclerosis Complex: This is a genetic disorder that causes non-cancerous (benign) tumors to grow in many parts of the body. The patient does not have any symptoms related to this disorder.

+12. Noonan Syndrome: This is a genetic disorder that causes problems with development, especially in the heart, blood vessels, and digestive system. The patient does not have any symptoms related to this disorder.

+13. Williams Syndrome: This is a genetic disorder that affects many parts of the body. The patient does not have any symptoms related to this disorder.

+14. Alagille Syndrome: This is a genetic disorder that affects the liver, heart, and other parts of the body. The patient does not have any symptoms related to this disorder.

+15. Smith-Lemli-Opitz Syndrome: This is a genetic disorder that affects many parts of the body. The patient does not have any symptoms related to this disorder.

+16. Phenylketonuria: This is a genetic disorder that affects the way the body processes protein. The patient does not have any symptoms related to this disorder.

+17. Congenital Adrenal Hyperplasia: This is a group of genetic disorders that affect the adrenal glands. The patient does not have any symptoms related to this"
['Ornithine transcarbamylase deficiency']," Based on the symptoms you have provided, I will list some potential diseases that could match. Please note that this is not a definitive diagnosis and medical examination and testing are necessary to confirm.

+1. Metabolic disorders:
+2. Maple syrup urine disease: This disorder is characterized by seizures, ataxia, lethargy, hyperreflexia, and metabolic acidosis. However, it does not typically present with fever, diarrhea, or orotic aciduria.
+3. Propionic acidemia: This disorder can present with seizures, ataxia, lethargy, hyperreflexia, metabolic acidosis, and hyperammonemia. However, it does not typically present with fever, diarrhea, or orotic aciduria.
+4. Methylmalonic acidemia: This disorder can present with seizures, ataxia, lethargy, hyperreflexia, metabolic acidosis, and hyperammonemia. However, it does not typically present with fever, diarrhea, or orotic aciduria.

+5. Neurological disorders:
+6. Leigh's disease: This disorder can present with seizures, ataxia, lethargy, hyperreflexia, and metabolic acidosis. However, it does not typically present with fever, diarrhea, or orotic aciduria.
+7. Pelizaeus-Merzbacher disease: This disorder can present with ataxia, lethargy, and sleep abnormalities. However, it does not typically present with seizures, hyperreflexia, metabolic acidosis, fever, diarrhea, or orotic aciduria.

+8. Genetic disorders:
+9. Urea cycle disorders: This group of disorders can present with seizures, lethargy, hyperammonemia, and death in childhood or adolescence. However, it does not typically present with ataxia, hyperreflexia, metabolic acidosis, fever, diarrhea, or orotic aciduria.
+10. Mitochondrial disorders: This group of disorders can present with seizures, ataxia, lethargy, hyperreflexia, and metabolic acidosis. However, it does not typically present with fever, diarrhea, or orotic aciduria.

+11. Other potential causes:
+12. Infectious diseases: Certain infections can present with fever, seizures, lethargy, and drowsiness. However, they typically do not present with ataxia, hyperreflexia, metabolic acidosis, diarrhea, or orotic aciduria.
+13. Toxins or drugs: Certain toxins or drugs can cause seizures, ataxia, lethargy, and hyperreflexia. However, they typically do not present with metabolic acidosis, diarrhea, or orotic aciduria.

Please consult with a healthcare professional for further evaluation and testing."
['Smith-Lemli-Opitz syndrome']," Based on the symptoms you have provided, I will list some potential diseases that the patient may have. Please note that this is not a definitive diagnosis and further testing would be needed to confirm.

+1. Microcephaly with Pointed Chin and Short Chin: This could potentially indicate a genetic disorder such as Seckel syndrome, which is characterized by microcephaly, a bird-like face with a pointed chin and a small jaw, and severe growth retardation.

+2. Strabismus and Ptosis: This could indicate a neurological disorder such as a brain tumor or myasthenia gravis.

+3. Hyperactivity: This could indicate a number of conditions, including ADHD, bipolar disorder, or anxiety disorders.

+4. Syndactyly: This could indicate a genetic disorder such as Apert syndrome, which is characterized by the fusion of fingers and toes.

+5. Intellectual Disability and Generalized Hypotonia: This could indicate a number of genetic disorders, such as Down syndrome or Prader-Willi syndrome.

+6. Ataxia and Hyperreflexia: This could indicate a neurological disorder such as cerebral palsy or Friedreich's ataxia.

+7. Failure to Thrive and Feeding Difficulties: This could indicate a number of conditions, including gastrointestinal disorders or genetic disorders such as cystic fibrosis.

+8. Death in Infancy or Childhood: This could indicate a number of genetic disorders, such as Tay-Sachs disease or Hurler syndrome.

+9. Hypocholesterolemia and Elevated 8-dehydrocholesterol: This could indicate a genetic disorder such as Smith-Lemli-Opitz syndrome, which is characterized by mental and physical developmental delays, microcephaly, and a variety of other symptoms.

+10. Elevated circulating 7-dehydrocholesterol concentration: This could indicate a genetic disorder such as X-linked dominant chondrodysplasia punctata, which is characterized by short stature, cataracts, and other skeletal abnormalities.

+11. Fatigue: This could indicate a number of conditions, including anemia, depression, or chronic fatigue syndrome.

Please note that this is not an exhaustive list and further testing would be needed to confirm a diagnosis. It is important to consult with a healthcare professional for an accurate diagnosis."
['Glycogen storage disease due to glycogen debranching enzyme deficiency']," Based on the symptoms you have provided, here are some potential diseases:

+1. Pompe Disease: This is a genetic disorder caused by the buildup of a complex sugar called glycogen in the body's cells. The symptoms you have mentioned, such as generalized hypotonia, increased circulating lactate concentration, hepatomegaly, and neonatal death, are consistent with this disease. However, Pompe disease does not typically cause hypertriglyceridemia or abnormal circulating aspartate family amino acid or alanine concentrations.

+2. McArdle Disease: This is a genetic disorder that affects the body's ability to break down glycogen, a complex sugar that provides energy to the muscles. The symptoms you have mentioned, such as generalized hypotonia, increased circulating lactate concentration, and abnormal circulating creatine kinase concentration, are consistent with this disease. However, McArdle disease does not typically cause hypertriglyceridemia, neonatal death, or abnormal circulating aspartate family amino acid or alanine concentrations.

+3. Carnitine Palmitoyltransferase II Deficiency: This is a genetic disorder that affects the body's ability to break down fatty acids for energy. The symptoms you have mentioned, such as generalized hypotonia, increased circulating lactate concentration, and abnormal circulating creatine kinase concentration, are consistent with this disease. However, Carnitine Palmitoyltransferase II Deficiency does not typically cause hypertriglyceridemia, neonatal death, or abnormal circulating aspartate family amino acid or alanine concentrations.

+4. Mitochondrial Diseases: This is a group of genetic disorders that affect the body's ability to produce energy. The symptoms you have mentioned, such as generalized hypotonia, increased circulating lactate concentration, and abnormal circulating lactate dehydrogenase concentration, are consistent with this disease. However, Mitochondrial diseases do not typically cause hypertriglyceridemia, neonatal death, or abnormal circulating aspartate family amino acid or alanine concentrations.

+5. Maple Syrup Urine Disease: This is a genetic disorder that affects the body's ability to break down certain amino acids. The symptoms you have mentioned, such as abnormal circulating aspartate family amino acid concentration and abnormal circulating alanine concentration, are consistent with this disease. However, Maple Syrup Urine Disease does not typically cause generalized hypotonia, increased circulating lactate concentration, hypertriglyceridemia, hepatomegaly, neonatal death, or abnormal circulating creatine kinase concentration.

It is important to note that these are potential diseases based on the symptoms you have provided, and further testing would be needed to confirm a diagnosis. Additionally, it is possible that the patient's symptoms are caused by a combination of factors, or by a different disease entirely."
['Glutaryl-CoA dehydrogenase deficiency']," Based on the symptoms you have provided, here are some potential diseases:

+1. Microcephaly with glutaric aciduria type I: This is a rare inherited disorder that affects the metabolism of the amino acids lysine, hydroxylysine, and tryptophan. Symptoms include microcephaly, generalized hypotonia, cerebral cortical atrophy, and abnormal circulating acylcarnitine concentration. However, this condition does not typically cause neonatal or adolescent death.

+2. Non-ketotic hyperglycinemia: This is a genetic disorder that affects the metabolism of the amino acid glycine. Symptoms include microcephaly, generalized hypotonia, and seizures. However, this condition does not typically cause glutaric aciduria, neonatal death, or decreased plasma free carnitine.

+3. Zellweger syndrome: This is a rare genetic disorder that affects the development of the brain, liver, and kidneys. Symptoms include microcephaly, generalized hypotonia, and neonatal death. However, this condition does not typically cause glutaric aciduria, athetosis, or decreased plasma free carnitine.

+4. Aicardi-Goutires syndrome: This is a rare genetic disorder that affects the brain and immune system. Symptoms include microcephaly, generalized hypotonia, and cerebral cortical atrophy. However, this condition does not typically cause glutaric aciduria, athetosis, or decreased plasma free carnitine.

+5. Glutaric acidemia type II: This is a rare genetic disorder that affects the metabolism of certain amino acids. Symptoms include microcephaly, generalized hypotonia, and decreased plasma free carnitine. However, this condition does not typically cause glutaric aciduria, athetosis, or neonatal death.

+6. Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS): This is a rare genetic disorder that affects the mitochondria, which are the energy-producing structures in cells. Symptoms include microcephaly, generalized hypotonia, and cerebral cortical atrophy. However, this condition does not typically cause glutaric aciduria, athetosis, or decreased plasma free carnitine.

+7. Leigh syndrome: This is a rare genetic disorder that affects the brain and nervous system. Symptoms include microcephaly, generalized hypotonia, and cerebral cortical atrophy. However, this condition does not typically cause glutaric aciduria, athetosis, or decreased plasma free carnitine.

+8. Neonatal adrenoleukodystrophy: This is a rare genetic disorder that affects the adrenal glands and nervous system. Symptoms include microcephaly, generalized hypotonia, and neonatal death. However, this condition does not typically cause glutaric aciduria, athetosis, or decreased plasma free carnitine.

+9. Pyruvate dehydrogenase deficiency: This is a rare genetic disorder that affects the metabolism of carbohydrates. Symptoms include microcephaly, generalized hypotonia, and cerebral cortical atrophy. However, this condition does not typically cause glutar"
['Propionic acidemia']," Based on the symptoms you have provided, here are some potential diseases:

+1. Nonketotic Hyperglycinemia: This is a genetic disorder characterized by elevated levels of glycine in the body. It can cause symptoms such as seizures, weak muscle tone, and developmental delays. The patient's symptoms of hyperammonemia, hyperglycinemia, hyperglycinuria, and abnormal circulating glutamine concentration are consistent with this diagnosis. However, this disorder does not typically cause death in infancy or childhood, and it is not associated with hyperalaninemia or abnormal circulating carnitine concentration.

+2. Propionic Acidemia: This is a genetic disorder that affects the body's ability to break down certain amino acids. It can cause symptoms such as vomiting, lethargy, and developmental delays. The patient's symptoms of vomiting, hyperammonemia, and elevated urinary carboxylic acid are consistent with this diagnosis. However, this disorder is not typically associated with death in infancy or childhood, and it is not associated with hyperglycinemia, hyperglycinuria, or abnormal circulating glutamine concentration.

+3. Methylmalonic Acidemia: This is a genetic disorder that affects the body's ability to break down certain amino acids and lipids. It can cause symptoms such as vomiting, lethargy, and developmental delays. The patient's symptoms of vomiting, hyperammonemia, and elevated urinary carboxylic acid are consistent with this diagnosis. However, this disorder is not typically associated with death in infancy or childhood, and it is not associated with hyperglycinemia, hyperglycinuria, or abnormal circulating glutamine concentration.

+4. Isovaleric Acidemia: This is a genetic disorder that affects the body's ability to break down certain amino acids. It can cause symptoms such as vomiting, lethargy, and developmental delays. The patient's symptoms of vomiting and elevated urinary carboxylic acid are consistent with this diagnosis. However, this disorder is not typically associated with death in infancy or childhood, and it is not associated with hyperglycinemia, hyperglycinuria, or abnormal circulating glutamine concentration.

+5. Multiple Carboxylase Deficiency: This is a genetic disorder that affects the body's ability to break down certain amino acids and lipids. It can cause symptoms such as vomiting, lethargy, and developmental delays. The patient's symptoms of vomiting, hyperammonemia, and elevated urinary carboxylic acid are consistent with this diagnosis. However, this disorder is not typically associated with death in infancy or childhood, and it is not associated with hyperglycinemia, hyperglycinuria, or abnormal circulating glutamine concentration.

It is important to note that these are potential diagnoses based on the symptoms provided, and further testing would be needed to confirm any diagnosis. Additionally, it is possible that the patient's symptoms are caused by a combination of factors, or by a different condition entirely."
['Succinic semialdehyde dehydrogenase deficiency']," +1. Smith-Lemli-Opitz syndrome: This genetic disorder is characterized by intellectual disability, motor delay, abnormal facial shape, and other physical abnormalities. However, it does not typically include abnormal calvaria morphology, death in childhood, or abnormal circulating monocarboxylic acid concentration.

+2. Glutaric acidemia type I: This metabolic disorder is characterized by elevated urinary carboxylic acid and abnormal circulating monocarboxylic acid concentration. However, it does not typically include intellectual disability, motor delay, abnormal facial shape, or abnormal calvaria morphology.

+3. Methylmalonic acidemia: This metabolic disorder is characterized by elevated urinary carboxylic acid and abnormal circulating monocarboxylic acid concentration. However, it does not typically include intellectual disability, motor delay, abnormal facial shape, or abnormal calvaria morphology.

+4. Maple syrup urine disease: This metabolic disorder is characterized by elevated urinary carboxylic acid and abnormal circulating monocarboxylic acid concentration. However, it does not typically include intellectual disability, motor delay, abnormal facial shape, or abnormal calvaria morphology.

+5. Homocystinuria: This metabolic disorder is characterized by elevated urinary carboxylic acid and abnormal circulating monocarboxylic acid concentration. However, it does not typically include intellectual disability, motor delay, abnormal facial shape, or abnormal calvaria morphology.

+6. Phenylketonuria: This metabolic disorder is characterized by elevated urinary carboxylic acid and abnormal circulating monocarboxylic acid concentration. However, it does not typically include intellectual disability, motor delay, abnormal facial shape, or abnormal calvaria morphology.

+7. Menkes disease: This genetic disorder is characterized by intellectual disability, motor delay, and abnormal facial shape. However, it does not typically include abnormal calvaria morphology, death in childhood, or abnormal circulating monocarboxylic acid concentration.

+8. Aicardi-Goutires syndrome: This genetic disorder is characterized by intellectual disability and motor delay. However, it does not typically include abnormal facial shape, abnormal calvaria morphology, death in childhood, or abnormal circulating monocarboxylic acid concentration.

+9. Zellweger syndrome: This genetic disorder is characterized by intellectual disability, motor delay, abnormal facial shape, and abnormal calvaria morphology. However, it does not typically include death in childhood or abnormal circulating monocarboxylic acid concentration.

+10. Neurodegeneration with brain iron accumulation: This group of genetic disorders is characterized by intellectual disability and motor delay. However, it does not typically include abnormal facial shape, abnormal calvaria morphology, death in childhood, or abnormal circulating monocarboxylic acid concentration.

It is important to note that this list is not exhaustive and that further testing and evaluation would be necessary to confirm a diagnosis. Additionally, it is possible that the patient's symptoms may be due to a combination of different conditions or to a yet-to-be-identified disorder."
['Classic galactosemia']," +1. Galactosemia: The patient has delayed speech and language development, intellectual disability, and abnormality of galactoside metabolism. However, the patient does not have cataracts, a common symptom in galactosemia.

+2. Maple Syrup Urine Disease: The patient has abnormal circulating aspartate family amino acid concentration and abnormal circulating alanine concentration. However, the patient does not have the characteristic sweet odor of urine, which is why this disease is named Maple Syrup Urine Disease.

+3. Urea Cycle Disorders: The patient has intellectual disability and hyperammonemia, which is a common symptom in urea cycle disorders. However, the patient does not have seizures or coma, which are also common symptoms.

+4. Phenylketonuria (PKU): The patient has intellectual disability, which can be a symptom of PKU. However, the patient does not have eczema, a common symptom in PKU.

+5. Homocystinuria: The patient has intellectual disability, which can be a symptom of homocystinuria. However, the patient does not have Marfanoid habitus, a common symptom in homocystinuria.

+6. Organic Acidemias: The patient has intellectual disability, which can be a symptom of organic acidemias. However, the patient does not have vomiting, a common symptom in organic acidemias.

+7. Congenital Disorders of Glycosylation: The patient has intellectual disability, which can be a symptom of congenital disorders of glycosylation. However, the patient does not have hypotonia, a common symptom in congenital disorders of glycosylation.

+8. Mitochondrial Disorders: The patient has intellectual disability, which can be a symptom of mitochondrial disorders. However, the patient does not have muscle weakness, a common symptom in mitochondrial disorders.

+9. Lysosomal Storage Disorders: The patient has intellectual disability, which can be a symptom of lysosomal storage disorders. However, the patient does not have coarse facial features, a common symptom in lysosomal storage disorders.

+10. Peroxisomal Disorders: The patient has intellectual disability, which can be a symptom of peroxisomal disorders. However, the patient does not have sensorineural hearing loss, a common symptom in peroxisomal disorders.

+11. Congenital Hypothyroidism: The patient has intellectual disability, which can be a symptom of congenital hypothyroidism. However, the patient does not have a large tongue, a common symptom in congenital hypothyroidism.

+12. Smith-Lemli-Opitz Syndrome: The patient has intellectual disability, which can be a symptom of Smith-Lemli-Opitz syndrome. However, the patient does not have 2-3 syndactyly, a common symptom in Smith-Lemli-Opitz syndrome.

+13. Aicardi-Goutires Syndrome: The patient has intellectual disability, which can be a symptom of Aicardi-Goutires syndrome. However, the patient does not have chilblains, a common symptom in Aicardi-Goutires syndrome.

+14. Rett Syndrome: The patient has intellectual disability, which can"
['Neonatal intrahepatic cholestasis due to citrin deficiency']," +1. Congenital Disorders of Glycosylation (CDG): This group of disorders is characterized by abnormalities in prenatal development or birth. However, CDG typically does not present with hyperammonemia, aminoaciduria, or neonatal or childhood death.

+2. Non-ketotic Hyperglycinemia (NKH): NKH is caused by a deficiency in the glycine cleavage system, leading to elevated glycine levels in body fluids. Symptoms include abnormal prenatal development or birth, death in infancy, and elevated plasma citrulline. However, NKH does not typically present with hyperammonemia or aminoaciduria.

+3. Maple Syrup Urine Disease (MSUD): MSUD is an organic acidemia caused by a deficiency in branched-chain alpha-keto acid dehydrogenase complex. Symptoms include abnormal prenatal development or birth, death in infancy, and elevated plasma citrulline. However, MSUD does not typically present with hyperammonemia or aminoaciduria.

+4. Urea Cycle Disorders (UCDs): UCDs are a group of disorders caused by a deficiency in one of the enzymes involved in the urea cycle, leading to hyperammonemia. Symptoms include neonatal death, death in childhood, and elevated plasma citrulline. However, UCDs do not typically present with abnormal prenatal development or birth or aminoaciduria.

+5. Citrullinemia: Citrullinemia is caused by a deficiency in the enzyme argininosuccinate synthetase, leading to elevated plasma citrulline. Symptoms include neonatal death, death in childhood, and hyperammonemia. However, citrullinemia does not typically present with abnormal prenatal development or birth or aminoaciduria.

+6. Argininosuccinic Aciduria: Argininosuccinic aciduria is caused by a deficiency in the enzyme argininosuccinate lyase, leading to elevated plasma citrulline and aminoaciduria. However, this disorder does not typically present with abnormal prenatal development or birth, hyperammonemia, or neonatal or childhood death.

Based on the patient's symptoms, the most likely diagnosis is a urea cycle disorder (UCD), specifically citrullinemia or argininosuccinic aciduria. Further testing, such as plasma ammonia levels, urine organic acid analysis, and enzyme assays, would be necessary to confirm the diagnosis and determine the specific type of UCD."
['Phenylketonuria']," Based on the symptoms you have provided, here are some potential diseases:

+1. Tyrosinemia type I: This is a genetic disorder characterized by an inability to metabolize the amino acid tyrosine, leading to its accumulation in the body. Symptoms can include death in infancy, fever, hypertyrosinemia, death in childhood, and hyperphenylalaninemia.

+2. Porphyria: This is a group of disorders caused by abnormalities in the production of heme, a component of hemoglobin. Symptoms can include abnormal circulating porphyrin concentration and neurological symptoms such as seizures and psychosis.

+3. Hemochromatosis: This is a genetic disorder characterized by the body's absorption of too much iron from food, leading to iron overload. Symptoms can include decreased circulating ferritin concentration and an increased risk of liver disease, heart problems, and other complications.

+4. Organic acidemias: This is a group of genetic disorders caused by defects in the metabolism of certain organic acids. Symptoms can include elevated urinary carboxylic acid, developmental delays, and recurrent viral infections.

Please note that this is not an exhaustive list and the symptoms provided may be associated with other medical conditions. It is important to consult with a healthcare professional for an accurate diagnosis."
['Maple syrup urine disease']," +1. Maple syrup urine disease: This is a genetic disorder that affects the body's ability to break down certain amino acids (leucine, isoleucine, and valine). Symptoms include lethargy, generalized hypotonia, tremor, drowsiness, sleep abnormality, elevated urinary carboxylic acid, and body odor. However, this disease does not typically cause death in infancy or neonatal death.

+2. Phenylketonuria (PKU): This is a genetic disorder that affects the body's ability to break down the amino acid phenylalanine. Symptoms include lethargy, generalized hypotonia, tremor, drowsiness, sleep abnormality, and elevated urinary carboxylic acid. However, PKU does not typically cause death in infancy, opisthotonus, or abnormal circulating leucine concentration.

+3. Nonketotic hyperglycinemia: This is a genetic disorder that affects the body's ability to break down the amino acid glycine. Symptoms include lethargy, generalized hypotonia, tremor, drowsiness, opisthotonus, and elevated urinary carboxylic acid. However, this disease does not typically cause death in infancy, neonatal death, or abnormal circulating leucine concentration.

+4. Isovaleric acidemia: This is a genetic disorder that affects the body's ability to break down the amino acid leucine. Symptoms include lethargy, generalized hypotonia, tremor, drowsiness, sleep abnormality, elevated urinary carboxylic acid, and body odor. However, isovaleric acidemia does not typically cause death in infancy or neonatal death.

+5. Glutaric acidemia type I: This is a genetic disorder that affects the body's ability to break down certain amino acids (lysine, hydroxylysine, and tryptophan). Symptoms include lethargy, generalized hypotonia, tremor, drowsiness, sleep abnormality, elevated urinary carboxylic acid, and body odor. However, glutaric acidemia type I does not typically cause death in infancy or neonatal death.

+6. Multiple acyl-CoA dehydrogenase deficiency (MADD): This is a genetic disorder that affects the body's ability to break down various fatty acids and amino acids. Symptoms include lethargy, generalized hypotonia, tremor, drowsiness, sleep abnormality, elevated urinary carboxylic acid, and body odor. However, MADD does not typically cause death in infancy or neonatal death.

It is important to note that these are potential diagnoses based on the symptoms provided, and further testing would be needed to confirm any diagnosis. Additionally, some of these diseases can present with a wide range of severity, so not all individuals with these conditions will experience all of the symptoms listed."
['Phenylketonuria']," +1. Congenital Disorder of Glycosylation (CDG) type Ia: The patient has generalized hypotonia, premature birth, and neonatal death in common. However, this disorder does not typically present with anemia, hypertyrosinemia, or hyperphenylalaninemia.

+2. Pearson Syndrome: The patient has generalized hypotonia, anemia, and neonatal death in common. However, this disorder does not typically present with hypertyrosinemia, hyperphenylalaninemia, or decreased circulating ferritin concentration.

+3. Zellweger Syndrome: The patient has generalized hypotonia, premature birth, and neonatal death in common. However, this disorder does not typically present with anemia, hypertyrosinemia, or hyperphenylalaninemia.

+4. Maple Syrup Urine Disease (MSUD): The patient has generalized hypotonia and hyperphenylalaninemia in common. However, this disorder does not typically present with anemia, hypertyrosinemia, neonatal death, or decreased circulating ferritin concentration.

+5. Homocystinuria: The patient has generalized hypotonia and hyperphenylalaninemia in common. However, this disorder does not typically present with anemia, hypertyrosinemia, neonatal death, or decreased circulating ferritin concentration.

+6. Ehlers-Danlos Syndrome (EDS): The patient has generalized hypotonia in common. However, this disorder does not typically present with anemia, hypertyrosinemia, hyperphenylalaninemia, neonatal death, or decreased circulating ferritin concentration.

+7. Marfan Syndrome: The patient has generalized hypotonia in common. However, this disorder does not typically present with anemia, hypertyrosinemia, hyperphenylalaninemia, neonatal death, or decreased circulating ferritin concentration.

+8. Osteogenesis Imperfecta (OI): The patient has generalized hypotonia in common. However, this disorder does not typically present with anemia, hypertyrosinemia, hyperphenylalaninemia, neonatal death, or decreased circulating ferritin concentration.

+9. Neonatal Alloimmune Thrombocytopenia (NAIT): The patient has anemia in common. However, this disorder does not typically present with generalized hypotonia, hypertyrosinemia, hyperphenylalaninemia, neonatal death, or decreased circulating ferritin concentration.

+10. Congenital Hemolytic Anemia: The patient has anemia in common. However, this disorder does not typically present with generalized hypotonia, hypertyrosinemia, hyperphenylalaninemia, neonatal death, or decreased circulating ferritin concentration.

+11. Vitamin B12 Deficiency: The patient has anemia in common. However, this disorder does not typically present with generalized hypotonia, hypertyrosinemia, hyperphenylalaninemia, neonatal death, or decreased circulating ferritin concentration.

+12. Vitamin"
['Smith-Lemli-Opitz syndrome']," Based on the symptoms you have provided, I will list some potential diseases that the patient may have. Please note that this is not a definitive diagnosis and further testing would be needed to confirm.

+1. Smith-Lemli-Opitz syndrome: This is a genetic disorder that affects the body's ability to make cholesterol. Symptoms can include hypertelorism, anteverted nares, intellectual disability, motor delay, and abnormal foot morphology. However, this syndrome does not typically cause self-mutilation, seizures, or hearing impairment.

+2. CHARGE syndrome: This is a genetic disorder that affects multiple systems in the body. Symptoms can include hypertelorism, anteverted nares, intellectual disability, motor delay, hearing impairment, and heart defects. However, this syndrome does not typically cause self-mutilation, seizures, or cholesterol abnormalities.

+3. Cornelia de Lange syndrome: This is a genetic disorder that affects development of the face, limbs, and organs. Symptoms can include hypertelorism, intellectual disability, motor delay, and hearing impairment. However, this syndrome does not typically cause self-mutilation, seizures, or cholesterol abnormalities.

+4. Williams syndrome: This is a genetic disorder that affects many parts of the body. Symptoms can include hypertelorism, anteverted nares, intellectual disability, motor delay, and heart defects. However, this syndrome does not typically cause self-mutilation, seizures, or cholesterol abnormalities.

+5. Down syndrome: This is a genetic disorder caused when abnormal cell division results in an extra full or partial copy of chromosome 21. Symptoms can include intellectual disability, delayed speech and language development, and motor delay. However, this syndrome does not typically cause hypertelorism, anteverted nares, self-mutilation, seizures, or cholesterol abnormalities.

+6. Fragile X syndrome: This is a genetic disorder that causes intellectual disability, behavioral and learning challenges, and various physical characteristics. Symptoms can include intellectual disability, delayed speech and language development, and hyperactivity. However, this syndrome does not typically cause hypertelorism, anteverted nares, self-mutilation, seizures, or cholesterol abnormalities.

+7. Phenylketonuria (PKU): This is a genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms can include intellectual disability, delayed speech and language development, and motor delay. However, this syndrome does not typically cause hypertelorism, anteverted nares, self-mutilation, seizures, or cholesterol abnormalities.

+8. Tuberous sclerosis complex: This is a genetic disorder that causes non-cancerous (benign) tumors to grow in many parts of the body. Symptoms can include intellectual disability, seizures, and behavioral problems. However, this syndrome does not typically cause hypertelorism, anteverted nares, self-mutilation, or cholesterol abnormalities.

Please consult with a healthcare professional for further evaluation and diagnosis."
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Microcephaly: The patient has microcephaly, which is a condition where the head is smaller than expected when compared to children of the same age and sex. This can be a sign of various disorders, including genetic abnormalities and infections during pregnancy.

+2. Intellectual disability: The patient has intellectual disability, which is characterized by significant limitations in intellectual functioning and adaptive behavior. This can be caused by various genetic and environmental factors.

+3. Motor delay: The patient has motor delay, which is a condition where a child does not reach motor milestones at the expected time. This can be a sign of various neurological disorders.

+4. Generalized hypotonia: The patient has generalized hypotonia, which is a condition of low muscle tone. This can be a sign of various neurological disorders, including genetic disorders and metabolic disorders.

+5. Failure to thrive: The patient has failure to thrive, which is a condition where a child does not gain weight and grow as expected. This can be caused by various medical conditions, including gastrointestinal disorders and genetic disorders.

+6. Small for gestational age: The patient was small for gestational age at birth, which means that they were born smaller than expected for the number of weeks of pregnancy. This can be a sign of various conditions, including genetic disorders and problems with the placenta.

+7. Anemia: The patient has anemia, which is a condition where the body does not have enough red blood cells or hemoglobin. This can be caused by various medical conditions, including iron deficiency, vitamin deficiency, and chronic diseases.

+8. Acute kidney injury: The patient has acute kidney injury, which is a sudden episode of kidney failure or damage. This can be caused by various medical conditions, including infections, trauma, and exposure to toxins.

+9. Metabolic acidosis: The patient has metabolic acidosis, which is a condition where the body has too much acid. This can be caused by various medical conditions, including diabetes, kidney disease, and severe infections.

+10. Hypoglycemia: The patient has hypoglycemia, which is a condition where the blood sugar level is too low. This can be caused by various medical conditions, including diabetes, liver disease, and certain medications.

+11. Dehydration: The patient has dehydration, which is a condition where the body does not have enough water. This can be caused by various medical conditions, including vomiting, diarrhea, and excessive sweating.

+12. Fever: The patient has a fever, which is a body temperature that is higher than normal. This can be caused by various medical conditions, including infections and autoimmune disorders.

+13. Hyperammonemia: The patient has hyperammonemia, which is a condition where the level of ammonia in the blood is too high. This can be caused by various medical conditions, including liver disease and certain genetic disorders.

+14. Hypothermia: The patient has hypothermia, which is a condition where the body temperature is lower than normal. This can be caused by various medical conditions, including exposure to cold weather and certain medications.

+15. Pneumonia: The patient has pneumonia, which is an infection of the lungs. This can be caused by various bacteria, viruses, and fungi.

+16. Hyperuricemia: The patient has hyperuricemia"
[]," +1. Ataxia-Telangiectasia: This is a rare, progressive, neurodegenerative disorder. It is characterized by ataxia, telangiectasias, immune deficiency, and a predisposition to cancer. However, this disease does not typically present with lethargy, generalized hypotonia, or death in infancy.

+2. Maple Syrup Urine Disease: This is an inherited metabolic disorder. It is characterized by an inability to break down certain amino acids, leading to their build-up in the body. Symptoms can include lethargy, hypotonia, and sleep abnormalities. However, this disease does not typically present with ataxia, death in infancy, or uraciluria.

+3. Phenylketonuria (PKU): This is an inherited disorder that affects the body's ability to metabolize an amino acid called phenylalanine. Symptoms can include lethargy, hypotonia, and sleep abnormalities. However, this disease does not typically present with ataxia, death in infancy, or uraciluria.

+4. Homocystinuria: This is an inherited disorder of methionine metabolism. Symptoms can include lethargy, hypotonia, and developmental delay. However, this disease does not typically present with ataxia, death in infancy, or uraciluria.

+5. Non-ketotic hyperglycinemia: This is a disorder of glycine metabolism. Symptoms can include lethargy, hypotonia, and seizures. However, this disease does not typically present with ataxia, death in infancy, or uraciluria.

+6. Dihydropyrimidine dehydrogenase deficiency: This is a disorder of pyrimidine metabolism. Symptoms can include neurological problems, seizures, and an increased risk of certain cancers. This disease can present with abnormal circulating pyrimidine concentration and uraciluria. However, it does not typically present with ataxia, lethargy, or generalized hypotonia.

+7. Ornithine transcarbamylase deficiency: This is a urea cycle disorder. Symptoms can include lethargy, hypotonia, and seizures. However, this disease does not typically present with ataxia, death in infancy, or uraciluria.

+8. Argininosuccinic aciduria: This is a urea cycle disorder. Symptoms can include lethargy, hypotonia, and seizures. However, this disease does not typically present with ataxia, death in infancy, or uraciluria.

+9. Citrullinemia: This is a urea cycle disorder. Symptoms can include lethargy, hypotonia, and seizures. However, this disease does not typically present with ataxia, death in infancy, or uraciluria.

+10. Glutaric acidemia type I: This is an inherited disorder of lysine, hydroxylysine, and tryptophan metabolism. Symptoms can include neurological problems, seizures, and an increased risk of certain infections. However, this disease does not typically present with ataxia, death in infancy, or uraciluria.

Please note that this is not an"
['Isovaleric acidemia']," +1. Ornithine Transcarbamylase Deficiency: This is a urea cycle disorder that can lead to abnormal prenatal development or birth, hyperammonemia, neonatal death, and death in infancy or childhood. It can also cause abnormal circulating glycine and carnitine concentrations.

+2. Propionic Acidemia: This is a disorder of organic acid metabolism that can result in abnormal prenatal development or birth, hyperammonemia, neonatal death, and death in infancy or childhood. It can also cause abnormal circulating glycine and carnitine concentrations.

+3. Methylmalonic Acidemia: This is another disorder of organic acid metabolism that can lead to abnormal prenatal development or birth, hyperammonemia, neonatal death, and death in infancy or childhood. It can also cause abnormal circulating glycine and carnitine concentrations.

+4. Isovaleric Acidemia: This is a disorder of leucine metabolism that can result in abnormal prenatal development or birth, hyperammonemia, neonatal death, and death in infancy or childhood. It can also cause abnormal circulating glycine and carnitine concentrations.

+5. Maple Syrup Urine Disease: This is a disorder of branched-chain amino acid metabolism that can lead to abnormal prenatal development or birth, hyperammonemia, and death in infancy or childhood. It can also cause abnormal circulating glycine concentrations.

+6. Citrullinemia: This is a urea cycle disorder that can result in abnormal prenatal development or birth, hyperammonemia, neonatal death, and death in infancy or childhood. It can also cause abnormal circulating glycine concentrations.

+7. Argininosuccinic Aciduria: This is another urea cycle disorder that can lead to abnormal prenatal development or birth, hyperammonemia, neonatal death, and death in infancy or childhood. It can also cause abnormal circulating glycine concentrations.

+8. Glutaric Acidemia Type I: This is a disorder of lysine, hydroxylysine, and tryptophan metabolism that can result in abnormal prenatal development or birth, hyperammonemia, neonatal death, and death in infancy or childhood. It can also cause abnormal circulating carnitine concentrations.

+9. Multiple Carboxylase Deficiency: This is a disorder of biotin metabolism that can lead to abnormal prenatal development or birth, hyperammonemia, neonatal death, and death in infancy or childhood. It can also cause abnormal circulating glycine and carnitine concentrations.

+10. 3-Methylcrotonyl-CoA Carboxylase Deficiency: This is a disorder of leucine metabolism that can result in abnormal prenatal development or birth, hyperammonemia, neonatal death, and death in infancy or childhood. It can also cause abnormal circulating carnitine concentrations.

It is important to note that these are just potential diagnoses based on the symptoms provided, and further testing would be needed to confirm any diagnosis."
['Biotinidase deficiency']," +1. Pyruvate Dehydrogenase Deficiency: This is a genetic disorder that affects the body's ability to convert food into energy. Symptoms can include seizures, generalized hypotonia, and developmental delays. However, death in infancy and elevated urinary carboxylic acid are not typical symptoms of this disease.

+2. Maple Syrup Urine Disease: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include seizures, maple syrup-like odor in urine, and developmental delays. Generalized hypotonia and death in infancy can also occur in severe cases.

+3. Methylmalonic Acidemia: This is a genetic disorder that affects the body's ability to metabolize certain proteins and fats. Symptoms can include seizures, vomiting, and developmental delays. Elevated urinary carboxylic acid and generalized hypotonia can also occur. Death in infancy is possible in severe cases.

+4. Isovaleric Acidemia: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include seizures, a sweaty or musty odor, and developmental delays. Elevated urinary carboxylic acid and generalized hypotonia can also occur. Death in infancy is possible in severe cases.

+5. Glutaric Acidemia Type I: This is a genetic disorder that affects the body's ability to metabolize certain amino acids. Symptoms can include seizures, macrocephaly, and developmental delays. Elevated urinary carboxylic acid and generalized hypotonia can also occur. Death in infancy is possible in severe cases.

+6. Propionic Acidemia: This is a genetic disorder that affects the body's ability to metabolize certain proteins and fats. Symptoms can include seizures, vomiting, and developmental delays. Elevated urinary carboxylic acid and generalized hypotonia can also occur. Death in infancy is possible in severe cases.

It is important to note that these are potential diagnoses based on the given symptoms, and further testing would be needed to confirm any diagnosis."
['Medium chain acyl-CoA dehydrogenase deficiency']," Based on the symptoms you have provided, here are some potential diseases:

+1. 3-Methylcrotonyl-CoA Carboxylase Deficiency: This is a genetic disorder that affects the body's ability to break down certain proteins. Symptoms can include delayed speech and language development, abnormalities in prenatal development or birth, and decreased plasma free carnitine. However, this disorder would not typically cause neonatal death, death in infancy, or death in childhood.

+2. 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency: This is a rare genetic disorder that affects the body's ability to break down certain fats. Symptoms can include delayed speech and language development, abnormalities in prenatal development or birth, and decreased 3-hydroxyacyl-CoA dehydrogenase level. However, this disorder would not typically cause neonatal death, death in infancy, or death in childhood.

+3. Carnitine Palmitoyltransferase II Deficiency: This is a genetic disorder that affects the body's ability to transport fatty acids into the mitochondria, where they can be broken down for energy. Symptoms can include delayed speech and language development, decreased plasma free carnitine, and abnormalities in prenatal development or birth. However, this disorder would not typically cause neonatal death, death in infancy, or death in childhood.

+4. Glutaric Acidemia Type II: This is a rare genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include delayed speech and language development, abnormalities in prenatal development or birth, and decreased 3-hydroxyacyl-CoA dehydrogenase level. However, this disorder can cause neonatal death, death in infancy, or death in childhood in severe cases.

+5. Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency: This is a genetic disorder that affects the body's ability to break down certain fats. Symptoms can include delayed speech and language development, decreased 3-hydroxyacyl-CoA dehydrogenase level, and abnormalities in prenatal development or birth. However, this disorder would not typically cause neonatal death, death in infancy, or death in childhood.

It is important to note that these are just potential diagnoses based on the symptoms you have provided. Further testing and evaluation would be necessary to confirm any diagnosis."
['Maple syrup urine disease']," Based on the symptoms you have provided, here are some potential diseases that the patient may have:

+1. Nonketotic hyperglycinemia: This is a genetic disorder that affects the body's ability to break down the amino acid glycine. Symptoms include seizures, spasticity, hypotonia, and developmental delay.

+2. Phenylketonuria (PKU): This is a genetic disorder that affects the body's ability to break down the amino acid phenylalanine. Symptoms include seizures, developmental delay, and feeding difficulties.

+3. Maple syrup urine disease: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include seizures, developmental delay, and a sweet odor to the urine.

+4. Glutaric acidemia type I: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include seizures, developmental delay, and metabolic acidosis.

+5. Methylmalonic acidemia: This is a genetic disorder that affects the body's ability to break down certain proteins and fats. Symptoms include seizures, developmental delay, and metabolic acidosis.

+6. Isovaleric acidemia: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include seizures, developmental delay, and a sweaty or cheesy odor.

+7. Propionic acidemia: This is a genetic disorder that affects the body's ability to break down certain proteins and fats. Symptoms include seizures, developmental delay, and metabolic acidosis.

+8. Citrullinemia: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include seizures, developmental delay, and hyperammonemia.

+9. Argininosuccinic aciduria: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include seizures, developmental delay, and hyperammonemia.

For the symptoms provided, the patient does not have:

- Neonatal death
- Opisthotonus
- Spastic tetraplegia
- Dyspnea
- Apnea

Please note that this is not an exhaustive list and further testing would be needed to confirm a diagnosis."
['Propionic acidemia']," +1. Schizophrenia: The patient is experiencing psychosis, which is a common symptom of this disorder. However, schizophrenia does not typically cause physical symptoms such as osteoporosis, anemia, or kyphoscoliosis.

+2. Intellectual disability: The patient has an intellectual disability, which is a defining feature of this disorder. However, intellectual disability does not typically cause physical symptoms such as osteoporosis, anemia, or kyphoscoliosis.

+3. Porphyria: The patient has an abnormal circulating porphyrin concentration, which is a characteristic feature of this disorder. However, porphyria does not typically cause intellectual disability or severe short stature.

+4. Carnitine deficiency: The patient has an abnormal circulating carnitine concentration, which is a characteristic feature of this disorder. However, carnitine deficiency does not typically cause psychosis, intellectual disability, or physical symptoms such as osteoporosis or anemia.

+5. Hyperammonemia: The patient has hyperammonemia, which is a characteristic feature of this disorder. However, hyperammonemia does not typically cause physical symptoms such as osteoporosis, anemia, or kyphoscoliosis.

+6. Urea cycle disorder: The patient has increased blood urea nitrogen and elevated circulating creatinine concentration, which are characteristic features of this disorder. However, urea cycle disorders do not typically cause psychosis, intellectual disability, or physical symptoms such as osteoporosis or anemia.

+7. Organic acidemia: The patient has elevated urinary carboxylic acid, which is a characteristic feature of this disorder. However, organic acidemias do not typically cause psychosis, intellectual disability, or physical symptoms such as osteoporosis or anemia.

+8. Maple syrup urine disease: The patient has elevated urinary carboxylic acid, which is a characteristic feature of this disorder. However, maple syrup urine disease does not typically cause psychosis, intellectual disability, or physical symptoms such as osteoporosis or anemia.

+9. Homocystinuria: The patient has severe short stature, which is a characteristic feature of this disorder. However, homocystinuria does not typically cause psychosis, intellectual disability, or physical symptoms such as osteoporosis or anemia.

+10. Wilson's disease: The patient does not have any symptoms that are characteristic of this disorder.

+11. Menkes disease: The patient has severe short stature, which is a characteristic feature of this disorder. However, Menkes disease does not typically cause psychosis, intellectual disability, or physical symptoms such as osteoporosis or anemia.

+12. Hunter syndrome: The patient does not have any symptoms that are characteristic of this disorder.

+13. Hurler syndrome: The patient does not have any symptoms that are characteristic of this disorder.

+14. Sanfilippo syndrome: The patient does not have any symptoms that are characteristic of this disorder.

+15. Niemann-Pick disease: The patient does not have any symptoms that are characteristic of this disorder.

+16. Gaucher disease: The patient does not have any symptoms that are characteristic of this disorder.

+17. Fabry disease: The patient does not have any symptoms that are characteristic of this disorder.

+18. Krabbe"
['L-2-hydroxyglutaric aciduria']," +1. Leigh's Disease: This is a rare inherited neurometabolic disorder that affects the central nervous system. Symptoms may include intellectual disability, seizures, ataxia, and tremors. However, Leigh's disease usually presents earlier in life and does not specifically include L-2-hydroxyglutaric aciduria.

+2. Pyruvate Dehydrogenase Deficiency: This is a genetic disorder that affects the body's ability to convert food into energy. Symptoms can include intellectual disability, seizures, and ataxia. However, tremors and L-2-hydroxyglutaric aciduria are not typically associated with this condition.

+3. Canavan Disease: This is a rare inherited disorder that affects the breakdown and protection of nerve fibers in the brain. Symptoms include intellectual disability and seizures, but ataxia, tremors, and L-2-hydroxyglutaric aciduria are not typically associated with this condition.

+4. Glutaric Acidemia Type I: This is an inherited disorder in which the body is unable to process certain amino acids properly. Symptoms can include intellectual disability, seizures, and ataxia. However, tremors and L-2-hydroxyglutaric aciduria are not typically associated with this condition.

+5. Methylmalonic Acidemia: This is an inherited disorder in which the body is unable to process certain proteins and fats properly. Symptoms can include intellectual disability, seizures, and ataxia. However, tremors and L-2-hydroxyglutaric aciduria are not typically associated with this condition.

+6. Propionic Acidemia: This is an inherited disorder in which the body is unable to process certain proteins and fats properly. Symptoms can include intellectual disability, seizures, and ataxia. However, tremors and L-2-hydroxyglutaric aciduria are not typically associated with this condition.

+7. L-2-Hydroxyglutaric Aciduria: This is a rare inherited metabolic disorder that affects the body's ability to break down certain amino acids. Symptoms can include intellectual disability, seizures, ataxia, and tremors. This condition is specifically associated with L-2-hydroxyglutaric aciduria.

Please note that this is not an exhaustive list and the patient should consult with a healthcare professional for an accurate diagnosis."
['Canavan disease']," +1. Maple Syrup Urine Disease: This is a genetic disorder that affects the way the body breaks down certain amino acids (proteins). Symptoms include motor delay, abnormal circulating aspartate family amino acid concentration, but not typically associated with death in infancy unless left untreated.

+2. Nonketotic Hyperglycinemia: This is a genetic disorder that affects the way the body processes an amino acid called glycine. Symptoms include motor delay, abnormal circulating aspartate family amino acid concentration, and in severe cases, can lead to death in infancy.

+3. Phenylketonuria (PKU): This is a genetic disorder that affects the way the body processes an amino acid called phenylalanine. Symptoms include motor delay, but typically not associated with abnormal circulating aspartate family amino acid concentration or death in infancy.

+4. Homocystinuria: This is a genetic disorder that affects the way the body processes an amino acid called methionine. Symptoms include motor delay, but typically not associated with abnormal circulating aspartate family amino acid concentration or death in infancy.

+5. Methylmalonic Acidemia: This is a genetic disorder that affects the way the body processes certain proteins and fats. Symptoms include motor delay, but typically not associated with abnormal circulating aspartate family amino acid concentration or death in infancy.

It is important to note that these are potential diagnoses and further testing would be needed to confirm. The patient should be referred to a specialist for further evaluation."
['Citrullinemia type I']," +1. Urea Cycle Disorders (UCDs): This group of genetic disorders affects the body's ability to break down ammonia, leading to hyperammonemia. However, UCDs do not typically cause increased total bilirubin or death in infancy.

+2. Citrullinemia Type I: This is a urea cycle disorder caused by a deficiency of the enzyme argininosuccinate synthetase. Symptoms include hyperammonemia, elevated plasma citrulline, and may lead to neonatal death. However, increased total bilirubin is not a typical symptom.

+3. Citrullinemia Type II: Also known as N-acetylglutamate synthetase (NAGS) deficiency, this disorder affects the urea cycle and can cause hyperammonemia, elevated plasma citrulline, and may lead to neonatal death. Increased total bilirubin is not a typical symptom.

+4. Crigler-Najjar Syndrome: A genetic disorder affecting bilirubin metabolism, leading to increased total bilirubin. Death in infancy and neonatal death can occur in the severe form of the disease (Crigler-Najjar Syndrome Type I). Hyperammonemia and elevated plasma citrulline are not typical symptoms.

+5. Gilbert's Syndrome: A common genetic disorder affecting bilirubin metabolism, leading to increased total bilirubin. Death in infancy, hyperammonemia, and elevated plasma citrulline are not typical symptoms.

+6. Neonatal Hemochromatosis: A rare disorder causing neonatal death and hyperammonemia, but increased total bilirubin is not a typical symptom. Elevated plasma citrulline is not a typical symptom either.

Please note that this list is not exhaustive, and further diagnostic tests are necessary to determine the exact cause of the patient's symptoms."
['3-hydroxy-3-methylglutaric aciduria']," Based on the symptoms you have provided, here are some potential diseases:

+1. Maple Syrup Urine Disease: This is a genetic disorder in which the body cannot break down certain amino acids. Symptoms include lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, and dicarboxylic aciduria.

+2. Propionic Acidemia: This is a genetic disorder in which the body cannot break down certain proteins and fats. Symptoms include lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, dicarboxylic aciduria, and 3-methylglutaric aciduria.

+3. Methylmalonic Acidemia: This is a genetic disorder in which the body cannot break down certain proteins and fats. Symptoms include lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, dicarboxylic aciduria, and 3-methylglutaric aciduria.

+4. Isovaleric Acidemia: This is a genetic disorder in which the body cannot break down certain amino acids. Symptoms include lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, and dicarboxylic aciduria.

+5. Glutaric Acidemia Type I: This is a genetic disorder in which the body cannot break down certain amino acids. Symptoms include lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, and dicarboxylic aciduria.

+6. Citrullinemia: This is a genetic disorder in which the body cannot break down certain proteins. Symptoms include lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, and vomiting.

+7. Urea Cycle Disorders: This is a group of genetic disorders in which the body cannot properly process ammonia. Symptoms include lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, and drowsiness.

+8. Organic Acidemias: This is a group of genetic disorders in which the body cannot properly break down certain amino acids. Symptoms include lethargy, metabolic acidosis, hypoglycemia, hyperammonemia, vomiting, dicarboxylic aciduria, and 3-methylglutaric aciduria.

+9. Fatty Acid Oxidation Disorders: This is a group of genetic disorders in which the body cannot properly break down fats for energy. Symptoms include lethargy, metabolic acidosis, hypoglycemia, vomiting, and dicarboxylic aciduria.

The symptoms that the patient does not have in common with these proposed diseases are diarrhea, hepatomegaly, sleep abnormality, death in infancy, death in childhood, recurrent viral infections, and elevated urinary carboxylic acid. However, it is important to note that some of these symptoms may be present in some of these diseases but were not mentioned in the provided list. Therefore, further testing and evaluation are"
['Cystinuria']," +1. Sudden Unexpected Death in Epilepsy (SUDEP): The patient has a history of seizure, which is a common symptom of SUDEP. However, SUDEP usually occurs in individuals with a history of epilepsy and is not typically associated with death in infancy or splenomegaly. Respiratory insufficiency can be a consequence of a severe seizure, but it is not a primary symptom of SUDEP.

+2. Congenital Disorders of Glycosylation (CDG): CDG is a group of genetic disorders that can affect various organs in the body, including the brain and spleen. While CDG can cause seizures and splenomegaly, it is not typically associated with death in infancy or respiratory insufficiency.

+3. Niemann-Pick Disease: Niemann-Pick disease is a group of inherited metabolic disorders that affect fat metabolism in the body. The disease can cause splenomegaly and respiratory insufficiency, but it is not typically associated with seizures or death in infancy.

+4. Gaucher Disease: Gaucher disease is a genetic disorder that affects the body's ability to break down a type of fat called glucocerebroside. The disease can cause splenomegaly and respiratory insufficiency, but it is not typically associated with seizures or death in infancy.

+5. Tay-Sachs Disease: Tay-Sachs disease is a rare genetic disorder that affects the nervous system. The disease can cause seizures and death in infancy, but it is not typically associated with splenomegaly or respiratory insufficiency.

+6. Metachromatic Leukodystrophy (MLD): MLD is a genetic disorder that affects the nervous system and can cause seizures, respiratory insufficiency, and splenomegaly. However, MLD is not typically associated with death in infancy.

It is important to note that this list is not exhaustive, and further diagnostic testing is necessary to determine the underlying cause of the patient's symptoms."
['Vitamin B12-unresponsive methylmalonic acidemia']," Based on the symptoms you have provided, I will list some potential diseases that could match. Please note that this is not a definitive diagnosis and further testing would be needed to confirm.

1. +Maple Syrup Urine Disease: This is an inherited metabolic disorder characterized by an inability to break down certain amino acids. Symptoms can include intellectual disability, motor delay, generalized hypotonia, vomiting, and abnormal circulating isoleucine and valine concentrations.
2. +Urea Cycle Disorders: This is a group of inherited metabolic disorders that affect the body's ability to remove ammonia from the blood. Symptoms can include intellectual disability, motor delay, generalized hypotonia, hyperammonemia, vomiting, and increased blood urea nitrogen.
3. +Non-ketotic Hyperglycinemia: This is an inherited metabolic disorder that affects the body's ability to break down the amino acid glycine. Symptoms can include intellectual disability, motor delay, generalized hypotonia, seizures, and hyperglycinemia.
4. +Organic Acidemias: This is a group of inherited metabolic disorders that affect the body's ability to break down certain amino acids. Symptoms can include intellectual disability, motor delay, generalized hypotonia, vomiting, methylmalonic aciduria, and abnormal circulating amino acid concentrations.
5. +Phenylketonuria (PKU): This is an inherited metabolic disorder that affects the body's ability to break down the amino acid phenylalanine. Symptoms can include intellectual disability, motor delay, generalized hypotonia, and abnormal circulating amino acid concentrations.
6. +Congenital Disorders of Glycosylation (CDG): This is a group of inherited metabolic disorders that affect the body's ability to produce or modify proteins. Symptoms can include intellectual disability, motor delay, generalized hypotonia, and recurrent viral infections.
7. +Mitochondrial Disorders: This is a group of inherited metabolic disorders that affect the body's ability to produce energy. Symptoms can include intellectual disability, motor delay, generalized hypotonia, feeding difficulties, and decreased serum creatinine.

The following symptoms are not commonly associated with the above diseases:

* Death in infancy
* Death in childhood
* Hypoproteinemia
* Hyperthreoninemia
* Neonatal death
* Abnormal circulating carnitine concentration
* Increased blood urea nitrogen

Please consult with a healthcare professional for further evaluation and testing."
['Phenylketonuria']," +1. Tyrosinemia type I: This is a genetic disorder that affects the breakdown of the amino acid tyrosine. Symptoms can include death in infancy or childhood, hypertyrosinemia, hyperphenylalaninemia, elevated urinary carboxylic acid, and recurrent viral infections.

+2. Phenylketonuria (PKU): This is a genetic disorder that affects the breakdown of the amino acid phenylalanine. Symptoms can include hypertyrosinemia, hyperphenylalaninemia, and developmental delays. However, PKU does not typically cause death in infancy or childhood or recurrent viral infections.

+3. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the breakdown of certain amino acids. Symptoms can include elevated urinary carboxylic acid, but typically do not include hypertyrosinemia, hyperphenylalaninemia, or recurrent viral infections.

+4. Organic acidemias: This is a group of genetic disorders that affect the breakdown of certain amino acids. Symptoms can include elevated urinary carboxylic acid, but typically do not include hypertyrosinemia, hyperphenylalaninemia, or recurrent viral infections.

+5. Inborn errors of immunity: This is a group of genetic disorders that affect the immune system. Symptoms can include recurrent viral infections, but typically do not include hypertyrosinemia, hyperphenylalaninemia, or elevated urinary carboxylic acid.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing would be needed to confirm any of these possibilities. Additionally, some of these conditions may have overlapping symptoms, and it is possible that the patient's symptoms may be caused by a combination of different conditions. A healthcare professional would be able to provide a more accurate diagnosis based on a thorough evaluation of the patient's medical history, physical examination, and laboratory test results."
['Phenylketonuria']," +1. Down syndrome: This condition is characterized by abnormal prenatal development and intellectual disability. It is not associated with strabismus, obesity, or any of the metabolic conditions listed.

+2. Phenylketonuria (PKU): This is a metabolic disorder that results in an inability to break down the amino acid phenylalanine, leading to its accumulation in the body. Symptoms can include intellectual disability, if left untreated. It is not associated with strabismus, obesity, or prenatal developmental abnormalities.

+3. Turner syndrome: This is a genetic disorder that affects females and is characterized by abnormal prenatal development. It is not associated with strabismus, intellectual disability, or any of the metabolic conditions listed.

+4. Prader-Willi syndrome: This is a genetic disorder that affects both sexes and is characterized by intellectual disability and obesity. It is not associated with strabismus, prenatal developmental abnormalities, or any of the metabolic conditions listed.

+5. Neonatal diabetes mellitus: This is a rare form of diabetes that occurs in the first six months of life. It is not associated with strabismus, intellectual disability, or prenatal developmental abnormalities.

+6. Congenital hypothyroidism: This is a condition in which the thyroid gland does not produce enough thyroid hormone. It can cause intellectual disability if left untreated, but is not associated with strabismus, obesity, or prenatal developmental abnormalities.

+7. Fetal alcohol syndrome: This condition is caused by alcohol exposure during pregnancy and is characterized by abnormal prenatal development and intellectual disability. It is not associated with strabismus, obesity, or any of the metabolic conditions listed.

+8. Tay-Sachs disease: This is a rare, inherited disorder that progressively destroys nerve cells in the brain and spinal cord. It is not associated with strabismus, intellectual disability, or prenatal developmental abnormalities.

+9. Hurler syndrome: This is a rare, inherited disorder of metabolism that is characterized by the accumulation of mucopolysaccharides in the body's cells and tissues. It is not associated with strabismus, intellectual disability, or prenatal developmental abnormalities.

+10. Sanfilippo syndrome: This is a group of rare, inherited metabolic disorders that affect the body's ability to break down long chains of sugar molecules called glycosaminoglycans. It is not associated with strabismus, intellectual disability, or prenatal developmental abnormalities.

I hope this information is helpful. It is important to note that this is not an exhaustive list of potential diagnoses, and further evaluation and testing would be necessary to determine the cause of the patient's symptoms."
['Ornithine transcarbamylase deficiency']," +1. Metabolic Disorders: This category includes several potential diseases that could match the patient's symptoms. Hyperammonemia and oroticaciduria are indicative of metabolic disorders. However, the symptom ""Death in infancy"" is not typically associated with metabolic disorders, unless it's a severe form of the disease.

+2. Hemorrhagic Disorders: Abnormal bleeding and an abnormality of the coagulation cascade suggest a hemorrhagic disorder. This category includes diseases such as Hemophilia and Von Willebrand Disease. However, vomiting and hyperammonemia are not typical symptoms of these disorders.

+3. Liver Diseases: Hyperammonemia can be a symptom of liver diseases, as the liver plays a key role in ammonia metabolism. However, the other symptoms do not typically align with liver diseases.

+4. Inborn Errors of Metabolism: This is a broad category that includes several diseases that could match the patient's symptoms. Oroticaciduria and hyperammonemia are indicative of inborn errors of metabolism. However, the symptom ""Death in infancy"" is not typically associated with these disorders, unless it's a severe form of the disease.

Please note that this is a hypothetical diagnosis and actual medical advice should be sought from a healthcare professional. The patient's symptoms should be further investigated to determine the exact cause."
['L-2-hydroxyglutaric aciduria']," Based on the symptoms you have provided, I can suggest several potential diseases. Please note that this is not a definitive diagnosis, and further testing would be needed to confirm.

+1. L-2-Hydroxyglutaric Aciduria: This is a rare genetic disorder characterized by the buildup of L-2-hydroxyglutaric acid in the body. Symptoms include intellectual disability, generalized hypotonia, hyperreflexia, and elevated levels of L-2-hydroxyglutaric acid in the urine. However, hyperammonemia and abnormal cerebral morphology are not typically associated with this disorder.

+2. Canavan Disease: This is a rare genetic disorder that affects the breakdown of N-acetyl-L-aspartic acid (NAA) in the brain. Symptoms include intellectual disability, generalized hypotonia, hyperreflexia, and abnormal cerebral morphology. However, hyperammonemia and L-2-hydroxyglutaric acidemia are not typically associated with this disorder.

+3. Alexander Disease: This is a rare genetic disorder that affects the nervous system and is caused by mutations in the GFAP gene. Symptoms include intellectual disability, generalized hypotonia, hyperreflexia, and abnormal cerebral morphology. However, hyperammonemia and L-2-hydroxyglutaric acidemia are not typically associated with this disorder.

+4. Maple Syrup Urine Disease: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include intellectual disability, generalized hypotonia, hyperreflexia, and hyperammonemia. However, abnormal cerebral morphology and L-2-hydroxyglutaric acidemia are not typically associated with this disorder.

+5. Non-Ketotic Hyperglycinemia: This is a genetic disorder that affects the body's ability to break down the amino acid glycine. Symptoms include intellectual disability, generalized hypotonia, hyperreflexia, and hyperammonemia. However, abnormal cerebral morphology and L-2-hydroxyglutaric acidemia are not typically associated with this disorder.

+6. Phenylketonuria (PKU): This is a genetic disorder that affects the body's ability to break down the amino acid phenylalanine. Symptoms include intellectual disability, generalized hypotonia, and hyperreflexia. However, hyperammonemia, abnormal cerebral morphology, and L-2-hydroxyglutaric acidemia are not typically associated with this disorder.

+7. Glutaric Acidemia Type I: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include intellectual disability, generalized hypotonia, hyperreflexia, and hyperammonemia. However, abnormal cerebral morphology and L-2-hydroxyglutaric acidemia are not typically associated with this disorder.

+8. Methylmalonic Acidemia: This is a genetic disorder that affects the body's ability to break down certain proteins and fats. Symptoms include intellectual disability, generalized hypotonia, hyperreflexia, and hyperammonemia. However, abnormal cerebral morphology and L-2-hydroxyglutaric"
['PMM2-CDG']," Based on the symptoms you have provided, here are some potential diseases that the patient may have:

+1. Pontocerebellar hypoplasia: This is a group of genetic disorders that affect the development of the cerebellum and brainstem. Symptoms may include intellectual disability, ataxia, cerebellar atrophy, and death in infancy. However, thromboembolism and stroke-like episodes are not typically associated with this condition.

+2. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): This is a rare genetic disorder that affects the blood vessels in the brain. Symptoms may include intellectual disability, ataxia, cerebellar atrophy, and stroke-like episodes. However, cerebellar agenesis is not typically associated with this condition.

+3. Moyamoya disease: This is a rare, progressive cerebrovascular disorder caused by blocked arteries at the base of the brain in an area called the basal ganglia. Symptoms may include intellectual disability, ataxia, cerebellar atrophy, and stroke-like episodes. However, thromboembolism and cerebellar agenesis are not typically associated with this condition.

+4. Joubert syndrome: This is a genetic disorder that affects the development of the cerebellum and other parts of the brain. Symptoms may include intellectual disability, ataxia, cerebellar atrophy, and cerebellar agenesis. However, thromboembolism and stroke-like episodes are not typically associated with this condition.

+5. Cohen syndrome: This is a rare genetic disorder that affects many parts of the body, including the brain. Symptoms may include intellectual disability, ataxia, and cerebellar atrophy. However, thromboembolism, stroke-like episodes, and cerebellar agenesis are not typically associated with this condition.

It is important to note that these are just potential diagnoses based on the symptoms you have provided. The patient should undergo further testing and evaluation by a healthcare professional to determine the exact cause of their symptoms."
['Phenylketonuria']," +1. Tyrosinemia type I: This is a genetic disorder that affects the breakdown of the amino acid tyrosine. Symptoms can include death in infancy, premature birth, hypertyrosinemia, neonatal death, and hyperphenylalaninemia.

+2. Phenylketonuria (PKU): This is a genetic disorder that affects the breakdown of the amino acid phenylalanine. Symptoms can include hypertyrosinemia, hyperphenylalaninemia, and can lead to death in infancy if left untreated. However, PKU does not typically cause premature birth or neonatal death.

+3. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the breakdown of certain amino acids (leucine, isoleucine, and valine). Symptoms can include hypertyrosinemia, hyperphenylalaninemia, and can lead to death in infancy if left untreated. However, MSUD does not typically cause premature birth or neonatal death.

+4. Homocystinuria: This is a genetic disorder that affects the breakdown of the amino acid methionine. Symptoms can include hypertyrosinemia, hyperphenylalaninemia, and can lead to death in infancy if left untreated. However, homocystinuria does not typically cause premature birth or neonatal death.

+5. Isovaleric acidemia: This is a genetic disorder that affects the breakdown of the amino acid leucine. Symptoms can include hypertyrosinemia, hyperphenylalaninemia, and can lead to death in infancy if left untreated. However, isovaleric acidemia does not typically cause premature birth or neonatal death.

It is important to note that these are only potential diagnoses based on the symptoms provided and further testing would be needed to confirm any diagnosis. Additionally, some of these disorders may have overlapping symptoms and it is possible that the patient may have more than one disorder."
['Propionic acidemia']," Based on the symptoms you have provided, I will list some potential diseases that the patient may have. Please note that this is not a definitive diagnosis and medical tests are necessary to confirm the presence of any disease.

+1. Nonketotic hyperglycinemia: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, generalized hypotonia, hyperammonemia, and hyperglycinemia.

+2. Maple syrup urine disease: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, generalized hypotonia, hyperammonemia, increased circulating lactate concentration, and hyperglycinemia.

+3. Urea cycle disorders: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, generalized hypotonia, hyperammonemia, and increased blood urea nitrogen.

+4. Organic acidemias: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, generalized hypotonia, increased circulating lactate concentration, hyperglycinemia, hyperammonemia, and vomiting.

+5. Mitochondrial disorders: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, generalized hypotonia, increased circulating lactate concentration, and hyperglycinemia.

+6. Pelizaeus-Merzbacher disease: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, and generalized hypotonia.

+7. Rett syndrome: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, and sleep abnormality.

+8. Phenylketonuria: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, and hyperalaninemia.

+9. Homocystinuria: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, and hyperglycinemia.

+10. Glutaric acidemia type I: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, generalized hypotonia, and increased circulating lactate concentration.

+11. Propionic acidemia: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, generalized hypotonia, increased circulating lactate concentration, hyperammonemia, and vomiting.

+12. Isovaleric acidemia: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, generalized hypotonia, increased circulating lactate concentration, hyperammonemia, and vomiting.

+13. Multiple acyl-CoA dehydrogenase deficiency: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, generalized hypotonia, increased circulating lactate concentration, and hyperglycinemia.

+14. Carnitine transporter deficiency: The patient has delayed speech and language development, intellectual disability, seizure, lethargy, motor delay, generalized hypotonia, and abnormal circulating carnitine concentration.

+"
['Wilson disease']," +1. Diabetes Insipidus: The patient's symptom of polydipsia (excessive thirst) is a common symptom of this disease. However, this disease does not typically present with elevated circulating hepatic transaminase concentration, decreased circulating ceruloplasmin concentration, death in adolescence, or decreased circulating copper concentration.

+2. Wilson's Disease: The patient's symptoms of elevated circulating hepatic transaminase concentration, decreased circulating ceruloplasmin concentration, and decreased circulating copper concentration are common in this disease. However, this disease does not typically present with polydipsia, and death in adolescence is not a common outcome.

+3. Hepatitis: The patient's symptom of elevated circulating hepatic transaminase concentration is a common symptom of this disease. However, this disease does not typically present with polydipsia, decreased circulating ceruloplasmin concentration, decreased circulating copper concentration, or death in adolescence.

+4. Cirrhosis: The patient's symptom of elevated circulating hepatic transaminase concentration is a common symptom of this disease. However, this disease does not typically present with polydipsia, decreased circulating ceruloplasmin concentration, decreased circulating copper concentration, or death in adolescence.

+5. Hemochromatosis: The patient's symptoms of decreased circulating ceruloplasmin concentration and decreased circulating copper concentration are common in this disease. However, this disease does not typically present with polydipsia, elevated circulating hepatic transaminase concentration, or death in adolescence.

It is important to note that these are potential diagnoses based on the symptoms provided and further testing and evaluation would be necessary to confirm any diagnosis."
['Ornithine transcarbamylase deficiency']," +1. Sudden Unexpected Death in Epilepsy (SUDEP): The patient has experienced seizure and neonatal death, which are common symptoms of SUDEP. However, not all patients with SUDEP have hypotonia, hyperglutaminemia, or oroticaciduria.

+2. Ohtahara Syndrome: The patient has experienced seizure, lethargy, hypotonia, and neonatal death, which are common symptoms of Ohtahara Syndrome. However, not all patients with Ohtahara Syndrome have vomiting, drowsiness, sleep abnormality, hyperglutaminemia, or oroticaciduria.

+3. Nonketotic Hyperglycinemia (NKH): The patient has experienced seizure, lethargy, hypotonia, and death in infancy, which are common symptoms of NKH. Additionally, some patients with NKH may have hyperglutaminemia and oroticaciduria. However, not all patients with NKH have vomiting, drowsiness, or sleep abnormality.

+4. Maple Syrup Urine Disease (MSUD): The patient has experienced seizure, lethargy, hypotonia, and oroticaciduria, which are common symptoms of MSUD. However, not all patients with MSUD have vomiting, drowsiness, sleep abnormality, hyperglutaminemia, or neonatal death.

+5. Pyridoxine-Dependent Epilepsy (PDE): The patient has experienced seizure, which is a common symptom of PDE. However, not all patients with PDE have lethargy, hypotonia, death in infancy, vomiting, drowsiness, sleep abnormality, hyperglutaminemia, or oroticaciduria.

+6. Glutaric Acidemia Type I (GA-I): The patient has experienced seizure, hypotonia, and death in infancy, which are common symptoms of GA-I. However, not all patients with GA-I have lethargy, vomiting, drowsiness, sleep abnormality, hyperglutaminemia, or oroticaciduria.

+7. Isovaleric Acidemia (IVA): The patient has experienced seizure, lethargy, hypotonia, and vomiting, which are common symptoms of IVA. However, not all patients with IVA have drowsiness, sleep abnormality, hyperglutaminemia, or oroticaciduria.

+8. Methylmalonic Acidemia (MMA): The patient has experienced seizure, lethargy, hypotonia, and vomiting, which are common symptoms of MMA. However, not all patients with MMA have drowsiness, sleep abnormality, hyperglutaminemia, or oroticaciduria.

+9. Propionic Acidemia (PA): The patient has experienced seizure, lethargy, hypotonia, and vomiting, which are common symptoms of PA. However, not all patients with PA have drowsiness, sleep abnormality, hyperglutaminemia, or oroticaciduria.

It is important to note that this list is not exhaustive and that further testing and evaluation is necessary to make a definitive diagnosis."
['Classic galactosemia']," +1. Microcephaly: This is a condition where the baby's head is much smaller than expected. The baby's brain may not have developed properly or grew slowly during pregnancy.

+2. Delayed speech and language development: This is a common problem in children where they may not be meeting the typical milestones for speech and language development.

+3. Abnormality of prenatal development or birth: This is a broad category that can include any number of conditions that affect the baby's development before or during birth.

+4. Intellectual disability: This is a condition characterized by significant limitations in intellectual functioning and adaptive behavior, which covers many everyday social and practical skills.

+5. Motor delay: This is a condition where the child may be slow to develop motor skills such as sitting, standing, and walking.

+6. Generalized hypotonia: This is a condition characterized by low muscle tone, which can lead to problems with movement and posture.

+7. Obesity: This is a condition characterized by excessive body fat, which can lead to a range of health problems.

+8. Death in infancy: This is a tragic outcome that can be caused by a wide range of factors, including genetic disorders, infections, and accidents.

+9. Anemia: This is a condition characterized by a low red blood cell count, which can lead to fatigue, weakness, and shortness of breath.

+10. Elevated circulating alkaline phosphatase concentration: This is a condition where there are high levels of alkaline phosphatase in the blood, which can be a sign of liver or bone disease.

+11. Neonatal death: This is a tragic outcome that can be caused by a wide range of factors, including genetic disorders, infections, and complications during birth.

+12. Death in childhood: This is a tragic outcome that can be caused by a wide range of factors, including genetic disorders, infections, and accidents.

+13. Abnormality of galactoside metabolism: This is a condition where the body has difficulty breaking down the sugar galactose, which can lead to a range of health problems.

+14. Abnormal circulating porphyrin concentration: This is a condition where there are high levels of porphyrins in the blood, which can be a sign of a range of disorders affecting the liver, bone marrow, or nervous system.

+15. Feeding difficulties: This is a common problem in infants and young children, and can be caused by a wide range of factors, including gastrointestinal disorders and developmental delays.

+16. Hypergalactosemia: This is a condition where the body has difficulty breaking down the sugar galactose, which can lead to a range of health problems.

+17. Decreased circulating ferritin concentration: This is a condition where there are low levels of ferritin in the blood, which can be a sign of iron deficiency anemia.

+18. Decreased serum iron: This is a condition where there are low levels of iron in the blood, which can be a sign of iron deficiency anemia.

It's important to note that these are just potential diagnoses based on the symptoms provided, and further testing and evaluation would be needed to confirm any diagnosis. Additionally, some of these conditions can overlap or be related, so it's possible that a patient could have multiple diagnoses."
['Biotinidase deficiency']," +1. Morbid Obesity: The patient has obesity, which is a chronic condition characterized by excessive body fat accumulation to the extent that it has a negative effect on health.

+2. Charcot Foot: The patient has abnormal foot morphology, which could indicate a condition such as Charcot foot, a type of foot deformity that can occur in people with diabetes or other conditions that cause nerve damage.

+3. Urea Cycle Disorders: The patient has hyperammonemia, which is a condition characterized by high levels of ammonia in the blood. This can be a symptom of a urea cycle disorder, a group of inherited metabolic disorders that affect the body's ability to remove ammonia from the blood.

+4. Mitochondrial Disorders: The patient has hyperammonemia and death in childhood, which could indicate a mitochondrial disorder. Mitochondrial disorders are a group of genetic disorders that affect the energy production within cells, and can cause a wide range of symptoms, including developmental delays, muscle weakness, and seizures.

It's important to note that these are only potential diagnoses based on the symptoms provided, and further testing and evaluation would be needed to confirm any diagnosis. Additionally, it's possible that the patient's symptoms may be caused by multiple conditions, or by something other than the conditions listed here."
['Canavan disease']," +1. Phenylketonuria (PKU): This is a genetic disorder in which the body cannot break down an amino acid called phenylalanine. If left untreated, it can lead to brain damage, intellectual disability, and other serious health problems. However, PKU does not typically cause hyperactivity or feeding difficulties.

+2. Maple Syrup Urine Disease (MSUD): This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include sweet-smelling urine, feeding difficulties, and neurological problems. However, MSUD does not typically cause hyperactivity or abnormal myelination.

+3. Homocystinuria: This is a genetic disorder that affects the body's ability to process the amino acid methionine. Symptoms can include developmental delays, intellectual disability, and abnormal myelination. However, homocystinuria does not typically cause hyperactivity or feeding difficulties.

+4. Nonketotic Hyperglycinemia (NKH): This is a genetic disorder that affects the body's ability to break down the amino acid glycine. Symptoms can include seizures, developmental delays, and feeding difficulties. However, NKH does not typically cause hyperactivity or abnormal circulating aspartate family amino acid concentration.

+5. Isovaleric Acidemia (IVA): This is a genetic disorder that affects the body's ability to break down the amino acid leucine. Symptoms can include vomiting, seizures, and a distinctive odor on the breath and urine. However, IVA does not typically cause hyperactivity or abnormal myelination.

+6. Glutaric Acidemia Type I (GA-I): This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include vomiting, seizures, and a distinctive odor on the breath and urine. However, GA-I does not typically cause hyperactivity or feeding difficulties.

+7. Methylmalonic Acidemia (MMA): This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include vomiting, seizures, and a distinctive odor on the breath and urine. However, MMA does not typically cause hyperactivity or abnormal myelination.

+8. Propionic Acidemia (PA): This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include vomiting, seizures, and a distinctive odor on the breath and urine. However, PA does not typically cause hyperactivity or feeding difficulties.

Based on the symptoms provided, it is possible that the patient may have a genetic disorder that affects the body's ability to break down certain amino acids. However, further testing would be needed to confirm a diagnosis. It is important to note that the symptoms listed (hyperactivity, feeding difficulties, abnormal circulating aspartate family amino acid concentration, and abnormal myelination) are non-specific and can be caused by a variety of medical conditions. Therefore, a thorough diagnostic workup would be necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria']," +1 Phenylketonuria (PKU): This is a genetic disorder that affects the metabolism of an amino acid called phenylalanine. Symptoms include abnormality of prenatal development or birth, hyperphenylalaninemia, and if left untreated, can lead to death in infancy or neonatal death.

+2 Congenital Central Hypoventilation Syndrome (CCHS): This is a rare genetic disorder that affects the autonomic nervous system, leading to problems with breathing regulation. Symptoms include abnormality of prenatal development or birth and can lead to death in infancy or neonatal death. However, hyperphenylalaninemia is not a symptom of this disease.

+3 Nonketotic Hyperglycinemia (NKH): This is a genetic disorder that affects the metabolism of the amino acid glycine. Symptoms include abnormality of prenatal development or birth, and hyperphenylalaninemia. However, death in infancy or neonatal death is not always a symptom of this disease.

+4 Maple Syrup Urine Disease (MSUD): This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include abnormality of prenatal development or birth, and hyperphenylalaninemia. However, death in infancy or neonatal death is not always a symptom of this disease.

+5 Tyrosinemia Type I: This is a genetic disorder that affects the metabolism of the amino acid tyrosine. Symptoms include abnormality of prenatal development or birth, hyperphenylalaninemia, and can lead to death in infancy or neonatal death if left untreated.

+6 Homocystinuria: This is a genetic disorder that affects the metabolism of the amino acid methionine. Symptoms include hyperphenylalaninemia, but not abnormality of prenatal development or birth, death in infancy or neonatal death.

+7 Phenylalanine Hydroxylase Deficiency: This is a genetic disorder that affects the metabolism of the amino acid phenylalanine. Symptoms include abnormality of prenatal development or birth, hyperphenylalaninemia, and can lead to death in infancy or neonatal death if left untreated.

+8 Histidinemia: This is a genetic disorder that affects the metabolism of the amino acid histidine. Symptoms include hyperphenylalaninemia, but not abnormality of prenatal development or birth, death in infancy or neonatal death.

+9 Glutaric Acidemia Type I: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include abnormality of prenatal development or birth, but not hyperphenylalaninemia, and can lead to death in infancy or neonatal death if left untreated.

+10 Isovaleric Acidemia: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include abnormality of prenatal development or birth, but not hyperphenylalaninemia, and can lead to death in infancy or neonatal death if left untreated.

It is important to note that this list is not exhaustive and"
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder that affects the metabolism of an amino acid called phenylalanine. Symptoms can include delayed speech and language development, abnormal prenatal development or birth, and hyperphenylalaninemia. However, PKU would not typically cause neonatal death, death in infancy, death in childhood, or death in early adulthood.

+2. Edwards syndrome (Trisomy 18): This is a chromosomal disorder that can cause a wide range of symptoms, including abnormal prenatal development or birth, and death in infancy. However, Edwards syndrome would not typically cause delayed speech and language development, hypertyrosinemia, neonatal death, death in childhood, or death in early adulthood.

+3. Tay-Sachs disease: This is a genetic disorder that affects the metabolism of a fatty substance called ganglioside GM2. Symptoms can include delayed speech and language development and abnormal prenatal development or birth. However, Tay-Sachs disease would not typically cause hypertyrosinemia, neonatal death, death in infancy, death in childhood, or death in early adulthood.

+4. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms can include hyperphenylalaninemia and hypertyrosinemia. However, MSUD would not typically cause delayed speech and language development, abnormal prenatal development or birth, neonatal death, death in infancy, death in childhood, or death in early adulthood.

+5. Neonatal adrenoleukodystrophy (NALD): This is a genetic disorder that affects the metabolism of very long chain fatty acids. Symptoms can include neonatal death and abnormal prenatal development or birth. However, NALD would not typically cause delayed speech and language development, hyperphenylalaninemia, hypertyrosinemia, death in infancy, death in childhood, or death in early adulthood.

+6. Zellweger syndrome: This is a genetic disorder that affects the metabolism of lipids. Symptoms can include abnormal prenatal development or birth, neonatal death, and death in infancy. However, Zellweger syndrome would not typically cause delayed speech and language development, hyperphenylalaninemia, hypertyrosinemia, death in childhood, or death in early adulthood.

+7. Infantile neuronal ceroid lipofuscinosis (INCL): This is a genetic disorder that affects the metabolism of lipids. Symptoms can include delayed speech and language development and death in childhood. However, INCL would not typically cause abnormal prenatal development or birth, hyperphenylalaninemia, hypertyrosinemia, neonatal death, death in infancy, or death in early adulthood.

+8. Mucopolysaccharidosis (MPS): This is a group of genetic disorders that affect the metabolism of mucopolysaccharides. Symptoms can include delayed speech and language development, abnormal prenatal development or birth, and death in childhood. However, MPS would not typically cause hyperphenylalaninemia, hypertyrosinemia, neonatal death, or death in early adulth"
[]," +1. Nephritis: This is a kidney disease that can cause inflammation and damage to the kidneys. The patient has this symptom.

+2. Hypotonia: This is a condition characterized by reduced muscle tone. The patient has this symptom.

+3. Sudden Infant Death Syndrome (SIDS): This is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. The patient has the symptom ""Death in infancy,"" which could be indicative of SIDS.

+4. Ventricular Septal Defect (VSD): This is a congenital heart defect in which there is a hole in the wall between the two lower chambers of the heart. The patient has this symptom.

+5. Cardiomyopathy: This is a disease of the heart muscle that makes it harder for the heart to pump blood to the rest of the body. The patient has this symptom.

+6. Pulmonic Stenosis: This is a heart condition in which the pulmonary valve, located between the right ventricle and the pulmonary artery, is narrowed or stenotic. The patient has this symptom.

It is important to note that this is just a list of potential diseases based on the symptoms provided. The patient should consult with a healthcare professional for an accurate diagnosis."
['Phenylketonuria']," +1. Irritability: This is a common symptom in many medical conditions, and it can be caused by a variety of factors such as stress, lack of sleep, or underlying medical conditions. It is not a specific disease.

+2. Spasticity: This is a condition in which there is increased muscle tone and stiffness, making it difficult to move muscles and joints normally. It is often seen in conditions affecting the brain or spinal cord, such as cerebral palsy, multiple sclerosis, or spinal cord injury.

+3. Hyperreflexia: This is a condition in which there is an exaggerated response to a stimulus, often seen as an overactive reflex. It can be caused by damage to the nerves that control the reflexes, such as in spinal cord injury or multiple sclerosis.

+4. Death in infancy: This is not a specific medical condition, but rather a symptom that can be seen in a variety of serious illnesses, such as congenital heart defects, genetic disorders, or infections.

+5. Hypertyrosinemia: This is a rare genetic disorder in which the body is unable to properly metabolize the amino acid tyrosine. This can lead to a buildup of tyrosine in the body, which can cause symptoms such as developmental delays, seizures, and liver damage.

+6. Neonatal death: This is the death of a baby within the first 28 days of life. It can be caused by a variety of factors, such as prematurity, birth defects, or infections.

+7. Death in childhood: This is the death of a child between the ages of 1 and 18. It can be caused by a variety of factors, such as accidents, illnesses, or genetic disorders.

+8. Recurrent viral infections: This is a condition in which a person experiences frequent viral infections, such as the common cold or flu. It can be caused by a weakened immune system due to an underlying medical condition, such as HIV/AIDS, or by certain medications.

+9. Hyperphenylalaninemia: This is a condition in which there is an elevated level of the amino acid phenylalanine in the blood. It can be caused by a variety of factors, such as a genetic disorder or certain medications.

+10. Death in adolescence: This is the death of a person between the ages of 13 and 19. It can be caused by a variety of factors, such as accidents, illnesses, or genetic disorders."
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Smith-Lemli-Opitz syndrome: A genetic disorder affecting the metabolism of cholesterol, which can result in abnormal prenatal development or birth, and in some cases, death in infancy or neonatal death. However, this syndrome does not typically cause abnormal circulating carnitine concentration.

+2. Maple syrup urine disease: A genetic disorder affecting the metabolism of certain amino acids, which can result in abnormal prenatal development or birth, and in some cases, death in infancy or neonatal death. This disease does not typically cause abnormal circulating carnitine concentration.

+3. Carnitine transporter deficiency: A genetic disorder affecting the transport of carnitine in the body, which can result in abnormal circulating carnitine concentration. However, this disorder does not typically cause abnormal prenatal development or birth, or death in infancy or neonatal death.

+4. Carnitine palmitoyltransferase II deficiency: A genetic disorder affecting the metabolism of fatty acids, which can result in abnormal circulating carnitine concentration. However, this disorder does not typically cause abnormal prenatal development or birth, or death in infancy or neonatal death.

+5. 3-methylcrotonyl-CoA carboxylase deficiency: A genetic disorder affecting the metabolism of certain amino acids, which can result in abnormal prenatal development or birth, and in some cases, death in infancy or neonatal death. However, this disorder does not typically cause abnormal circulating carnitine concentration.

It is important to note that these are potential diagnoses based on the given symptoms, and further testing and evaluation would be necessary to confirm any diagnosis."
['Phenylketonuria']," Based on the symptoms you have provided, here are some potential diseases:

+1 Phenylketonuria (PKU): PKU is a genetic disorder characterized by an inability to break down the amino acid phenylalanine, leading to its accumulation in the body. Symptoms can include delayed speech and language development, abnormal prenatal development or birth, generalized hypotonia, and hyperphenylalaninemia. However, PKU would not typically cause neonatal or childhood death.

+2 Non-ketotic hyperglycinemia (NKH): NKH is a genetic disorder that affects the body's ability to break down the amino acid glycine. Symptoms can include delayed speech and language development, abnormal prenatal development or birth, generalized hypotonia, and hyperglycinemia. However, NKH would not typically cause hyperphenylalaninemia.

+3 Maple syrup urine disease (MSUD): MSUD is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include delayed speech and language development, abnormal prenatal development or birth, generalized hypotonia, and hyperphenylalaninemia. However, MSUD would not typically cause hyperglycinemia.

+4 Down syndrome: Down syndrome is a genetic disorder caused by the presence of an extra copy of chromosome 21. Symptoms can include delayed speech and language development, abnormal prenatal development or birth, and generalized hypotonia. However, Down syndrome would not typically cause hyperphenylalaninemia or hyperglycinemia.

+5 Prader-Willi syndrome: Prader-Willi syndrome is a genetic disorder that affects the body's production of certain hormones. Symptoms can include delayed speech and language development, abnormal prenatal development or birth, and generalized hypotonia. However, Prader-Willi syndrome would not typically cause hyperphenylalaninemia or hyperglycinemia.

+6 Zellweger syndrome: Zellweger syndrome is a rare genetic disorder that affects the body's ability to produce peroxisomes, which are necessary for the breakdown of certain substances in the body. Symptoms can include abnormal prenatal development or birth, generalized hypotonia, and neonatal or childhood death. However, Zellweger syndrome would not typically cause delayed speech and language development or hyperphenylalaninemia.

+7 Tyrosinemia type I: Tyrosinemia type I is a genetic disorder that affects the body's ability to break down the amino acid tyrosine. Symptoms can include delayed speech and language development, abnormal prenatal development or birth, generalized hypotonia, hyperphenylalaninemia, and neonatal or childhood death. However, Tyrosinemia type I would not typically cause hyperglycinemia.

It is important to note that these are only potential diagnoses based on the symptoms provided, and further testing would be necessary to confirm any diagnosis. Additionally, some of these conditions can be managed with appropriate medical care and interventions."
['Glutaryl-CoA dehydrogenase deficiency']," Based on the symptoms you have provided, here are some potential diseases:

+1. Glutaric acidemia type 1: This is a genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. The symptoms include seizures, encephalopathy, death in infancy or childhood, opisthotonus, glutaric aciduria, elevated circulating glutaric acid concentration, decreased plasma free carnitine, and elevated urinary carboxylic acid.

+2. Pyridoxine-dependent epilepsy: This is a rare genetic disorder that affects the brain's ability to process certain amino acids. The symptoms include seizures, encephalopathy, and death in infancy or childhood. However, this disorder does not typically cause opisthotonus, glutaric aciduria, or elevated circulating glutaric acid concentration.

+3. Maple syrup urine disease: This is a genetic disorder that affects the body's ability to break down certain amino acids. The symptoms include seizures, encephalopathy, and death in infancy or childhood. However, this disorder does not typically cause opisthotonus, glutaric aciduria, or elevated circulating glutaric acid concentration.

+4. Nonketotic hyperglycinemia: This is a genetic disorder that affects the body's ability to process the amino acid glycine. The symptoms include seizures, encephalopathy, and death in infancy or childhood. However, this disorder does not typically cause opisthotonus, glutaric aciduria, or elevated circulating glutaric acid concentration.

+5. Methylmalonic acidemia: This is a genetic disorder that affects the body's ability to process certain amino acids and fats. The symptoms include seizures, encephalopathy, and death in infancy or childhood. However, this disorder does not typically cause opisthotonus, glutaric aciduria, or elevated circulating glutaric acid concentration.

+6. Propionic acidemia: This is a genetic disorder that affects the body's ability to process certain amino acids and fats. The symptoms include seizures, encephalopathy, and death in infancy or childhood. However, this disorder does not typically cause opisthotonus, glutaric aciduria, or elevated circulating glutaric acid concentration.

It is important to note that these are just potential diagnoses based on the symptoms you have provided. Further testing and evaluation would be necessary to confirm any diagnosis."
[]," +1. Leigh's Disease: The patient has Intellectual disability, Seizure, and Hypotonia. However, the patient does not show symptoms of Ataxia or Optic atrophy which are common in Leigh's Disease.

+2. Pelizaeus-Merzbacher Disease: The patient has Nystagmus, Hypotonia, and Motor delay. However, the patient does not show symptoms of Ataxia or Dysarthria which are common in Pelizaeus-Merzbacher Disease.

+3. Phenylketonuria: The patient has Intellectual disability, Seizure, and Fair hair. However, the patient does not show symptoms of Eczema or Musty odor which are common in Phenylketonuria.

+4. Maple Syrup Urine Disease: The patient has Metabolic acidosis, Seizure, and Hypotonia. However, the patient does not show symptoms of Maple syrup odor in urine or Sweet odor in cerumen which are common in Maple Syrup Urine Disease.

+5. Non-ketotic Hyperglycinemia: The patient has Intellectual disability, Seizure, and Hypotonia. However, the patient does not show symptoms of Myoclonic jerks or Apnea which are common in Non-ketotic Hyperglycinemia.

+6. Mitochondrial Depletion Syndrome: The patient has Hypotonia, Seizure, and Motor delay. However, the patient does not show symptoms of Cardiomyopathy or Ragged-red fibers on muscle biopsy which are common in Mitochondrial Depletion Syndrome.

+7. Glutaric Acidemia Type I: The patient has Metabolic acidosis, Seizure, and Hypotonia. However, the patient does not show symptoms of Macrocephaly or Generalized dystonia which are common in Glutaric Acidemia Type I.

+8. Citrullinemia: The patient has Metabolic acidosis, Seizure, and Hypotonia. However, the patient does not show symptoms of Failure to thrive or Ammonia in the blood which are common in Citrullinemia.

+9. Homocystinuria: The patient has Intellectual disability, Seizure, and Fair hair. However, the patient does not show symptoms of Marfanoid habitus or Ectopia lentis which are common in Homocystinuria.

+10. Menkes Disease: The patient has Intellectual disability, Seizure, and White hair. However, the patient does not show symptoms of Kinky hair or Scoliosis which are common in Menkes Disease.

+11. Pyruvate Dehydrogenase Deficiency: The patient has Metabolic acidosis, Seizure, and Hypotonia. However, the patient does not show symptoms of Lactic acidosis or Ataxia which are common in Pyruvate Dehydrogenase Deficiency.

+12. Wilson's Disease: The patient has Seizure and Hypotonia. However, the patient does not show symptoms of Kayser-Fleischer rings or Liver disease which are common in Wilson's Disease.

+13. Neuroblastoma: The patient has Seizure and Hypotonia. However, the patient does not"
['PMM2-CDG']," +1. Congenital Disorder of Glycosylation (CDG) II: The patient has intellectual disability, motor delay, cerebellar atrophy, generalized hypotonia, and can have death in infancy or childhood. However, this disorder does not typically present with strabismus, ataxia, cirrhosis, hepatic fibrosis, thromboembolism, reduced antithrombin III activity, cerebellar agenesis, or lipodystrophy.

+2. Joubert Syndrome: The patient has motor delay, cerebellar atrophy, and cerebellar agenesis. However, this disorder does not typically present with strabismus, intellectual disability, ataxia, cirrhosis, hepatic fibrosis, thromboembolism, reduced antithrombin III activity, death in infancy or adolescence, or lipodystrophy.

+3. Ataxia-Telangiectasia: The patient has ataxia, intellectual disability, and cerebellar atrophy. However, this disorder does not typically present with strabismus, motor delay, cirrhosis, hepatic fibrosis, thromboembolism, reduced antithrombin III activity, death in infancy or adolescence, or lipodystrophy.

+4. Pearson Syndrome: The patient has motor delay, cerebellar atrophy, and can have death in infancy or childhood. However, this disorder typically presents with bone marrow failure, pancreatic insufficiency, and may have associated features such as exocrine pancreas dysfunction, but does not typically present with strabismus, intellectual disability, ataxia, cirrhosis, hepatic fibrosis, thromboembolism, reduced antithrombin III activity, cerebellar agenesis, or lipodystrophy.

+5. Alpers-Huttenlocher Syndrome: The patient has intellectual disability, motor delay, and cerebellar atrophy. However, this disorder typically presents with intractable seizures, liver disease, and can have death in infancy or childhood. It does not typically present with strabismus, ataxia, cirrhosis, hepatic fibrosis, thromboembolism, reduced antithrombin III activity, cerebellar agenesis, or lipodystrophy.

+6. Mitochondrial DNA Depletion Syndrome (MDS): The patient has motor delay, cerebellar atrophy, and can have death in infancy or childhood. However, this disorder typically presents with muscle weakness, hypotonia, and may have associated features such as lactic acidosis, but does not typically present with strabismus, intellectual disability, ataxia, cirrhosis, hepatic fibrosis, thromboembolism, reduced antithrombin III activity, cerebellar agenesis, or lipodystrophy.

+7. Leigh Syndrome: The patient has motor delay, cerebellar atrophy, and can have death in infancy or childhood. However, this disorder typically presents with muscle weakness, hypotonia, and may have associated features such as lactic acidosis, but does not typically present with strabismus, intellectual disability, ataxia, cirrhosis, hepatic fibrosis, thromboembolism, reduced antithrombin III activity, cerebellar agenesis, or lipodystrophy.

+8. Wilson Disease: The patient has cirrhosis and"
['Canavan disease']," +1. Epilepsy: The patient's seizure and hyperreflexia align with this neurological disorder, but irritability, generalized hypotonia, opisthotonus, abnormal circulating aspartate family amino acid concentration, and feeding difficulties are not typical symptoms.

+2. Cerebral Palsy: The patient's generalized hypotonia, hyperreflexia, and opisthotonus are consistent with cerebral palsy, but irritability, seizure, abnormal circulating aspartate family amino acid concentration, and feeding difficulties are not common symptoms.

+3. Nonketotic Hyperglycinemia: The patient's seizure, irritability, and abnormal circulating aspartate family amino acid concentration are consistent with this metabolic disorder, but generalized hypotonia, hyperreflexia, opisthotonus, and feeding difficulties are not common symptoms.

+4. Phenylketonuria (PKU): The patient's irritability and abnormal circulating aspartate family amino acid concentration are consistent with this metabolic disorder, but generalized hypotonia, hyperreflexia, seizure, opisthotonus, and feeding difficulties are not common symptoms.

+5. Maple Syrup Urine Disease: The patient's irritability and abnormal circulating aspartate family amino acid concentration are consistent with this metabolic disorder, but generalized hypotonia, hyperreflexia, seizure, opisthotonus, and feeding difficulties are not common symptoms.

+6. Mitochondrial Disorders: The patient's seizure, irritability, generalized hypotonia, and feeding difficulties are consistent with mitochondrial disorders, but hyperreflexia, opisthotonus, and abnormal circulating aspartate family amino acid concentration are not common symptoms.

+7. Leigh Syndrome: The patient's seizure, irritability, generalized hypotonia, and feeding difficulties are consistent with this mitochondrial disorder, but hyperreflexia, opisthotonus, and abnormal circulating aspartate family amino acid concentration are not common symptoms.

+8. Pelizaeus-Merzbacher Disease: The patient's irritability, generalized hypotonia, and hyperreflexia are consistent with this genetic disorder, but seizure, opisthotonus, abnormal circulating aspartate family amino acid concentration, and feeding difficulties are not common symptoms.

+9. Rett Syndrome: The patient's irritability, generalized hypotonia, and hyperreflexia are consistent with this genetic disorder, but seizure, opisthotonus, abnormal circulating aspartate family amino acid concentration, and feeding difficulties are not common symptoms.

+10. Infantile Neuroaxonal Dystrophy (INAD): The patient's seizure, irritability, generalized hypotonia, and feeding difficulties are consistent with this neurodegenerative disorder, but hyperreflexia, opisthotonus, and abnormal circulating aspartate family amino acid concentration are not common symptoms.

Please note that this list is not exhaustive, and further diagnostic testing is necessary to determine the exact cause of the patient's symptoms."
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, this condition does not typically cause gastrointestinal inflammation.

+2. Tyrosinemia type I: This is a rare genetic disorder that affects the breakdown of the amino acid tyrosine. Symptoms include abnormality of prenatal development or birth, neonatal death, hypertyrosinemia, and gastrointestinal inflammation. However, this condition does not typically cause hyperphenylalaninemia.

+3. Hirschsprung's disease: This is a birth defect that affects the nerves in the muscles of the colon. Symptoms include abnormality of prenatal development or birth, neonatal death, and gastrointestinal inflammation. However, this condition does not typically cause hyperphenylalaninemia or hypertyrosinemia.

+4. Maple syrup urine disease: This is a genetic disorder that affects the breakdown of certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, this condition does not typically cause hypertyrosinemia or gastrointestinal inflammation.

+5. Niemann-Pick disease type A: This is a rare genetic disorder that affects the metabolism of lipids in the body. Symptoms include abnormality of prenatal development or birth, neonatal death, and gastrointestinal inflammation. However, this condition does not typically cause hyperphenylalaninemia or hypertyrosinemia.

+6. Cystic fibrosis: This is a genetic disorder that affects the lungs and digestive system. Symptoms include gastrointestinal inflammation, but not typically abnormality of prenatal development or birth, neonatal death, hyperphenylalaninemia, or hypertyrosinemia.

+7. Galactosemia: This is a genetic disorder that affects the body's ability to metabolize the sugar galactose. Symptoms include abnormality of prenatal development or birth, neonatal death, and gastrointestinal inflammation. However, this condition does not typically cause hyperphenylalaninemia or hypertyrosinemia.

+8. Phenylalanine hydroxylase deficiency: This is a genetic disorder that affects the body's ability to break down the amino acid phenylalanine. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, this condition does not typically cause hypertyrosinemia or gastrointestinal inflammation.

+9. Homocystinuria: This is a genetic disorder that affects the body's ability to metabolize the amino acid methionine. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, this condition does not typically cause hypertyrosinemia or gastrointestinal inflammation.

+10. Biotinidase deficiency: This is a"
['Maple syrup urine disease']," +1. Ataxia-telangiectasia: The patient has ataxia and can also have alopecia, reduced tendon reflexes, and may die in childhood. However, this genetic disorder does not typically present with coma, metabolic acidosis, cerebral edema, abnormal cerebral white matter morphology, or hyperleucinemia.

+2. Leigh syndrome: The patient's symptoms of ataxia, reduced tendon reflexes, and death in childhood are consistent with Leigh syndrome, a mitochondrial disorder. However, Leigh syndrome does not typically present with coma, metabolic acidosis, cerebral edema, abnormal cerebral white matter morphology, alopecia, recurrent viral infections, or hyperleucinemia.

+3. Canavan disease: The patient's symptoms of ataxia, abnormal cerebral white matter morphology, and death in childhood are consistent with Canavan disease, a genetic disorder that affects the white matter of the brain. However, Canavan disease does not typically present with coma, metabolic acidosis, cerebral edema, reduced tendon reflexes, alopecia, recurrent viral infections, or hyperleucinemia.

+4. Wernicke-Korsakoff syndrome: The patient's symptom of ataxia is consistent with Wernicke-Korsakoff syndrome, a neurological disorder caused by thiamine (vitamin B1) deficiency. However, this syndrome does not typically present with coma, metabolic acidosis, cerebral edema, abnormal cerebral white matter morphology, alopecia, recurrent viral infections, or hyperleucinemia.

+5. Miller Fisher syndrome: The patient's symptom of ataxia is consistent with Miller Fisher syndrome, a variant of Guillain-Barr syndrome. However, this syndrome does not typically present with coma, metabolic acidosis, cerebral edema, abnormal cerebral white matter morphology, alopecia, recurrent viral infections, or hyperleucinemia.

+6. Meningitis: The patient's symptom of reduced tendon reflexes is consistent with meningitis, an inflammation of the membranes surrounding the brain and spinal cord. However, meningitis does not typically present with ataxia, coma, metabolic acidosis, cerebral edema, abnormal cerebral white matter morphology, alopecia, or hyperleucinemia. Recurrent viral infections could be a symptom of meningitis, depending on the cause.

+7. Encephalitis: The patient's symptom of reduced tendon reflexes is consistent with encephalitis, an inflammation of the brain. However, encephalitis does not typically present with ataxia, coma, metabolic acidosis, cerebral edema, abnormal cerebral white matter morphology, alopecia, or hyperleucinemia. Recurrent viral infections could be a symptom of encephalitis, depending on the cause.

+8. Guillain-Barr syndrome: The patient's symptom of reduced tendon reflexes is consistent with Guillain-Barr syndrome, an autoimmune disorder that affects the nerves. However, Guillain-Barr syndrome does not"
['Acute intermittent porphyria']," +1. Hemolytic anemia: This condition is characterized by the destruction of red blood cells, which can lead to anemia, fatigue, and abdominal pain. However, elevated urinary delta-aminolevulinic acid and death in childhood are not typical symptoms of this disease.

+2. Lead poisoning: This condition can cause abdominal pain, but it does not typically cause elevated urinary delta-aminolevulinic acid or death in childhood. Lead poisoning can occur from exposure to lead in the environment, such as from old paint or contaminated water.

+3. Sickle cell anemia: This is a genetic disorder that can cause anemia, fatigue, and abdominal pain. However, elevated urinary delta-aminolevulinic acid and death in childhood are not typical symptoms of this disease.

+4. Porphyria: This is a group of genetic disorders that can cause elevated urinary delta-aminolevulinic acid. However, it does not typically cause abdominal pain or death in childhood.

+5. Wilson's disease: This is a genetic disorder that can cause death in childhood, but it does not typically cause abdominal pain or elevated urinary delta-aminolevulinic acid.

It is important to note that this list is not exhaustive and that the symptoms provided could be caused by a number of different medical conditions. It is important to consult with a healthcare professional for an accurate diagnosis."
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Epilepsy: The patient has seizures, which is a common symptom of epilepsy. However, epilepsy does not typically cause death in infancy, metabolic acidosis, or neonatal death. Methylmalonic aciduria is not a symptom of epilepsy.

+2. Sudden Infant Death Syndrome (SIDS): The patient has death in infancy, but SIDS does not typically cause seizures, metabolic acidosis, neonatal death, or methylmalonic aciduria.

+3. Methylmalonic Acidemia: The patient has methylmalonic aciduria, which is a hallmark symptom of this disorder. Methylmalonic acidemia can also cause metabolic acidosis and neonatal death. However, it does not typically cause seizures or death in infancy.

+4. Organic Acidemias: The patient has methylmalonic aciduria, which is a type of organic acidemia. Organic acidemias can also cause metabolic acidosis and neonatal death. Seizures and death in infancy are not typical symptoms of organic acidemias, but they can occur in some cases.

+5. Maple Syrup Urine Disease: The patient does not have any symptoms that are typical of maple syrup urine disease.

+6. Homocystinuria: The patient does not have any symptoms that are typical of homocystinuria.

+7. Phenylketonuria (PKU): The patient does not have any symptoms that are typical of PKU.

+8. Urea Cycle Disorders: The patient does not have any symptoms that are typical of urea cycle disorders.

+9. Fatty Acid Oxidation Disorders: The patient does not have any symptoms that are typical of fatty acid oxidation disorders.

+10. Pyruvate Dehydrogenase Deficiency: The patient does not have any symptoms that are typical of pyruvate dehydrogenase deficiency.

Based on the patient's symptoms, the most likely diagnosis is Methylmalonic Acidemia or another type of organic acidemia. It is important to conduct further testing to confirm the diagnosis and determine the best course of treatment."
['Alkaptonuria']," +1. Epilepsy: The patient is experiencing seizures, which is a common symptom of this condition. However, not all types of epilepsy are associated with lethargy, generalized hypotonia, growth delay, drowsiness, sleep abnormalities, or death in childhood.

+2. Mitochondrial disorders: The patient's symptoms of lethargy, generalized hypotonia, growth delay, drowsiness, and sleep abnormalities may indicate a mitochondrial disorder. However, not all mitochondrial disorders are associated with seizures or dark urine.

+3. Leigh syndrome: This is a specific mitochondrial disorder that can cause seizures, lethargy, generalized hypotonia, growth delay, drowsiness, and sleep abnormalities. However, death in childhood and dark urine are not typical symptoms of Leigh syndrome.

+4. Pelizaeus-Merzbacher disease: This genetic disorder affects the nervous system and can cause seizures, lethargy, generalized hypotonia, and growth delay. However, it is not typically associated with drowsiness, sleep abnormalities, death in childhood, or dark urine.

+5. Neuroblastoma: This is a type of cancer that can cause seizures, lethargy, and generalized hypotonia. However, it is not typically associated with growth delay, drowsiness, sleep abnormalities, death in childhood, or dark urine.

+6. Phenylketonuria (PKU): This genetic disorder affects the body's ability to break down an amino acid called phenylalanine, which can cause seizures, lethargy, and growth delay. However, it is not typically associated with generalized hypotonia, drowsiness, sleep abnormalities, death in childhood, or dark urine.

+7. Maple syrup urine disease: This genetic disorder affects the body's ability to break down certain amino acids, which can cause seizures, lethargy, and generalized hypotonia. It can also cause dark urine, but it is not typically associated with growth delay, drowsiness, sleep abnormalities, or death in childhood.

+8. Urea cycle disorders: These genetic disorders affect the body's ability to remove ammonia from the blood, which can cause seizures, lethargy, and generalized hypotonia. They can also cause death in childhood, but they are not typically associated with growth delay, drowsiness, sleep abnormalities, or dark urine.

+9. Nonketotic hyperglycinemia: This genetic disorder affects the body's ability to break down the amino acid glycine, which can cause seizures, lethargy, and generalized hypotonia. It can also cause drowsiness and sleep abnormalities, but it is not typically associated with growth delay, death in childhood, or dark urine.

+10. Pyridoxine-dependent epilepsy: This rare genetic disorder affects the body's ability to use vitamin B6, which can cause seizures, lethargy, and generalized hypotonia. It can also cause drowsiness and sleep abnormalities, but it is not typically associated with growth delay, death in childhood, or dark urine.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing and evaluation would be necessary to determine the underlying cause of the patient's symptoms."
['Maple syrup urine disease']," +1. Maple Syrup Urine Disease (MSUD): This is a genetic disorder that affects the body's ability to break down certain amino acids (leucine, isoleucine, and valine). Symptoms include seizures, abnormal circulating concentrations of these amino acids, and in severe cases, death in infancy or neonatal death. Aminoaciduria (the presence of amino acids in the urine) is also a common symptom.

+2. Phenylketonuria (PKU): This is another genetic disorder that affects the body's ability to break down an amino acid called phenylalanine. Symptoms can include seizures and abnormal circulating concentrations of phenylalanine. However, PKU does not typically cause aminoaciduria, neonatal death, or death in infancy.

+3. Homocystinuria: This is a genetic disorder that affects the body's ability to process the amino acid methionine. Symptoms can include seizures and abnormal circulating concentrations of certain amino acids. However, homocystinuria does not typically cause aminoaciduria, neonatal death, or death in infancy.

+4. Nonketotic Hyperglycinemia: This is a genetic disorder that affects the body's ability to break down the amino acid glycine. Symptoms can include seizures and abnormal circulating concentrations of glycine. However, this condition does not typically cause aminoaciduria, neonatal death, or death in infancy.

+5. Isovaleric Acidemia: This is a genetic disorder that affects the body's ability to break down the amino acid leucine. Symptoms can include seizures and abnormal circulating concentrations of certain amino acids. However, isovaleric acidemia does not typically cause aminoaciduria, neonatal death, or death in infancy.

Please note that these are potential diagnoses based on the symptoms provided and further testing would be needed to confirm any diagnosis. It is also important to note that these conditions are rare, and it is possible that the patient's symptoms may be caused by a different condition."
['Very long chain acyl-CoA dehydrogenase deficiency']," Based on the symptoms you have provided, here are some potential diseases that the patient may have:

+1. Medium-chain acyl-CoA dehydrogenase deficiency (MCAD): This is a genetic disorder that affects the body's ability to break down certain fats for energy. Symptoms include hypoglycemia, lethargy, and vomiting, which can lead to seizures, coma, and even death in infancy or childhood. However, cardiomegaly, hepatomegaly, tachypnea, dicarboxylic aciduria, and abnormal circulating carnitine concentration are not typically associated with MCAD.

+2. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD): This is another genetic disorder that affects fatty acid oxidation. Symptoms include hypoglycemia, hepatomegaly, muscle weakness, and cardiomyopathy. In severe cases, it can lead to death in infancy or childhood. However, recurrent viral infections and dicarboxylic aciduria are not typically associated with LCHAD.

+3. Very long-chain acyl-CoA dehydrogenase deficiency (VLCAD): This is a genetic disorder that affects fatty acid oxidation. Symptoms include hypoglycemia, cardiomyopathy, hepatomegaly, and muscle weakness. In severe cases, it can lead to death in infancy or childhood. However, recurrent viral infections and dicarboxylic aciduria are not typically associated with VLCAD.

+4. Carnitine palmitoyltransferase II deficiency (CPT II): This is a genetic disorder that affects fatty acid oxidation. Symptoms include hypoglycemia, muscle weakness, and cardiomyopathy. In severe cases, it can lead to death in infancy or childhood. However, recurrent viral infections and dicarboxylic aciduria are not typically associated with CPT II.

+5. Glutaric acidemia type II: This is a genetic disorder that affects fatty acid and amino acid metabolism. Symptoms include hypoglycemia, cardiomyopathy, hepatomegaly, and recurrent viral infections. In severe cases, it can lead to death in infancy or childhood. Dicarboxylic aciduria is a characteristic feature of this disorder.

+6. Multiple acyl-CoA dehydrogenase deficiency (MADD): This is a genetic disorder that affects fatty acid, amino acid, and choline metabolism. Symptoms include hypoglycemia, cardiomyopathy, hepatomegaly, recurrent viral infections, and dicarboxylic aciduria. In severe cases, it can lead to death in infancy or childhood.

+7. Isovaleric acidemia: This is a genetic disorder that affects the breakdown of the amino acid leucine. Symptoms include hypoglycemia, cardiomyopathy, hepatomegaly, and recurrent viral infections. Dicarboxylic aciduria is not typically associated with isovaleric acidemia.

It is important to note that these are only potential diagnoses based on the symptoms provided. Further testing and evaluation would be necessary to confirm any diagnosis."
['3-hydroxy-3-methylglutaric aciduria']," Based on the symptoms you have provided, here are some potential diseases:

+1. Epilepsy: The patient has seizures, which is a common symptom of epilepsy. However, the patient does not have any other symptoms that are typically associated with epilepsy, such as confusion or memory loss after a seizure.

+2. Mitochondrial disorders: The patient has lethargy, hypoglycemia, and metabolic acidosis, which are all symptoms that can be associated with mitochondrial disorders. However, the patient does not have any other symptoms that are typically associated with mitochondrial disorders, such as muscle weakness or developmental delays.

+3. Glutaric aciduria type I: The patient has seizures, lethargy, metabolic acidosis, hypoglycemia, and elevated urinary carboxylic acid, which are all symptoms that can be associated with glutaric aciduria type I. This is a genetic disorder that affects the body's ability to break down certain amino acids.

+4. 3-Methylglutaconic aciduria: The patient has seizures, lethargy, metabolic acidosis, hypoglycemia, and elevated urinary carboxylic acid, which are all symptoms that can be associated with 3-methylglutaconic aciduria. This is a genetic disorder that affects the body's ability to break down certain amino acids.

+5. Organic acidemias: The patient has seizures, lethargy, metabolic acidosis, hypoglycemia, and elevated urinary carboxylic acid, which are all symptoms that can be associated with organic acidemias. These are genetic disorders that affect the body's ability to break down certain amino acids and other organic compounds.

+6. Maple syrup urine disease: The patient has seizures, lethargy, metabolic acidosis, hypoglycemia, and elevated urinary carboxylic acid, which are all symptoms that can be associated with maple syrup urine disease. This is a genetic disorder that affects the body's ability to break down certain amino acids.

+7. Pyridoxine-dependent epilepsy: The patient has seizures, which is a common symptom of pyridoxine-dependent epilepsy. This is a genetic disorder that affects the body's ability to use pyridoxine (vitamin B6).

+8. Nonketotic hyperglycinemia: The patient has seizures, lethargy, hypoglycemia, and abnormal circulating glycine concentration, which are all symptoms that can be associated with nonketotic hyperglycinemia. This is a genetic disorder that affects the body's ability to break down the amino acid glycine.

+9. Urea cycle disorders: The patient has seizures, lethargy, and metabolic acidosis, which are all symptoms that can be associated with urea cycle disorders. These are genetic disorders that affect the body's ability to remove ammonia from the blood.

+10. Methylmalonic acidemia: The patient has seizures, lethargy, metabolic acidosis, hypoglycemia, and elevated urinary carboxylic acid, which are all symptoms that can be associated with methylmalonic acidemia. This is a genetic disorder that affects"
['MODY']," +1. Hypoglycemia: This condition is characterized by abnormally low levels of glucose in the blood. The patient has reported hypoglycemia, which aligns with this potential diagnosis. However, the patient has also reported glycosuria, which is the presence of glucose in the urine, typically a sign of high blood sugar rather than low. Abnormal circulating porphyrin concentration is not typically associated with hypoglycemia.

+2. Diabetes Mellitus: This is a group of metabolic disorders characterized by high blood sugar levels over a prolonged period. The patient's reported symptom of glycosuria aligns with this potential diagnosis. However, hypoglycemia is not typically associated with diabetes mellitus. Abnormal circulating porphyrin concentration is not a common symptom of diabetes mellitus.

+3. Porphyria: This is a group of rare genetic disorders that affect the production of heme, a component of hemoglobin in red blood cells. Symptoms can include abdominal pain, neurological symptoms, and skin symptoms. Abnormal circulating porphyrin concentration is a key characteristic of porphyria, which aligns with this potential diagnosis. However, hypoglycemia and glycosuria are not typically associated with porphyria.

In conclusion, based on the patient's reported symptoms of hypoglycemia, glycosuria, and abnormal circulating porphyrin concentration, the potential diagnoses include hypoglycemia, diabetes mellitus, and porphyria. However, it is important to note that these symptoms can be associated with other medical conditions as well. Therefore, further diagnostic tests and evaluations are necessary to confirm the diagnosis."
['Phenylketonuria']," +1 Phenylketonuria (PKU): This is a genetic disorder that affects the metabolism of an amino acid called phenylalanine. Symptoms include abnormality of prenatal development or birth, hyperphenylalaninemia, and if left untreated, can lead to death in infancy or neonatal death.

+2 Congenital Central Hypoventilation Syndrome (CCHS): This is a rare genetic disorder that affects the autonomic nervous system, leading to problems with breathing regulation. Symptoms include abnormality of prenatal development or birth and can lead to death in infancy or neonatal death. However, hyperphenylalaninemia is not a symptom of this disease.

+3 Nonketotic Hyperglycinemia (NKH): This is a genetic disorder that affects the metabolism of the amino acid glycine. Symptoms include abnormality of prenatal development or birth, and hyperphenylalaninemia. However, death in infancy or neonatal death is not always a symptom of this disease.

+4 Maple Syrup Urine Disease (MSUD): This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include abnormality of prenatal development or birth, and hyperphenylalaninemia. However, death in infancy or neonatal death is not always a symptom of this disease.

+5 Tyrosinemia Type I: This is a genetic disorder that affects the metabolism of the amino acid tyrosine. Symptoms include abnormality of prenatal development or birth, hyperphenylalaninemia, and can lead to death in infancy or neonatal death if left untreated.

+6 Homocystinuria: This is a genetic disorder that affects the metabolism of the amino acid methionine. Symptoms include hyperphenylalaninemia, but not abnormality of prenatal development or birth, death in infancy or neonatal death.

+7 Phenylalanine Hydroxylase Deficiency: This is a genetic disorder that affects the metabolism of the amino acid phenylalanine. Symptoms include abnormality of prenatal development or birth, hyperphenylalaninemia, and can lead to death in infancy or neonatal death if left untreated.

+8 Histidinemia: This is a genetic disorder that affects the metabolism of the amino acid histidine. Symptoms include hyperphenylalaninemia, but not abnormality of prenatal development or birth, death in infancy or neonatal death.

+9 Glutaric Acidemia Type I: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include abnormality of prenatal development or birth, but not hyperphenylalaninemia, and can lead to death in infancy or neonatal death if left untreated.

+10 Isovaleric Acidemia: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include abnormality of prenatal development or birth, but not hyperphenylalaninemia, and can lead to death in infancy or neonatal death if left untreated.

It is important to note that this list is not exhaustive and"
['Glutaryl-CoA dehydrogenase deficiency']," +1. Hydrocephalus: The patient has this symptom. Hydrocephalus is a condition in which there is an abnormal accumulation of cerebrospinal fluid (CSF) in the brain, leading to increased pressure and potential brain damage.

+2. Macrocephaly: The patient has this symptom. Macrocephaly is a condition in which the head is larger than normal, often due to an increase in the volume of the brain or CSF.

+3. Hyperhidrosis: The patient does not have this symptom. Hyperhidrosis is a condition characterized by excessive sweating.

+4. Seizure: The patient has this symptom. A seizure is a sudden, uncontrolled electrical disturbance in the brain that can cause changes in behavior, movements, feelings, or levels of consciousness.

+5. Lethargy: The patient has this symptom. Lethargy is a state of drowsiness or sluggishness, often accompanied by a lack of energy and motivation.

+6. Dystonia: The patient has this symptom. Dystonia is a movement disorder characterized by involuntary muscle contractions and sustained or intermittent twisting postures.

+7. Hyperreflexia: The patient has this symptom. Hyperreflexia is an increased or exaggerated response to a stimulus that normally elicits a reflex.

+8. Death in infancy: The patient does not have this symptom.

+9. Anemia: The patient does not have this symptom. Anemia is a condition in which the blood has a lower than normal number of red blood cells or a lower than normal amount of hemoglobin.

+10. Fever: The patient does not have this symptom. A fever is an elevation of the body's temperature above the normal range, often as a response to an infection or other illness.

+11. Vomiting: The patient has this symptom. Vomiting is the forceful expulsion of stomach contents through the mouth.

+12. Cerebral atrophy: The patient has this symptom. Cerebral atrophy is a condition in which there is a decrease in the size of the brain, often due to the loss of neurons or other brain cells.

+13. Opisthotonus: The patient has this symptom. Opisthotonus is a posture in which the head and heels are bent backward and the body is arched forward.

+14. Drowsiness: The patient has this symptom. Drowsiness is a state of sleepiness or decreased alertness.

+15. Sleep abnormality: The patient has this symptom. Sleep abnormalities are any deviations from normal sleep patterns, such as insomnia, sleep apnea, or narcolepsy.

+16. Fasciculations: The patient does not have this symptom. Fasciculations are involuntary muscle twitches or contractions.

+17. Upper airway obstruction: The patient does not have this symptom. Upper airway obstruction is a blockage of the airway that can make it difficult to breathe.

+18. Increased CSF protein concentration: The patient does not have this symptom. Increased CSF protein concentration is an elevation of the level of protein in the cerebrospinal fluid.

+19. Glutaric aciduria: The patient does not have this symptom. Glutaric acidur"
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, PKU does not typically cause death in infancy or childhood.

+2. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, MSUD does not typically cause death in infancy or childhood.

+3. Homocystinuria: This is a genetic disorder that affects the body's ability to process the amino acid methionine. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, homocystinuria does not typically cause death in infancy or childhood.

+4. Tyrosinemia type I: This is a genetic disorder that affects the body's ability to break down the amino acid tyrosine. Symptoms include abnormality of prenatal development or birth, neonatal death, hyperphenylalaninemia, and hypertyrosinemia. However, tyrosinemia type I does not typically cause death in childhood.

+5. Isovaleric acidemia: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, isovaleric acidemia does not typically cause hypertyrosinemia or death in infancy or childhood.

It is important to note that these are just potential diagnoses based on the symptoms provided. Further testing and evaluation would be necessary to confirm any diagnosis."
['Phenylketonuria']," Based on the symptoms you have provided, here are some potential diseases:

+1. Tyrosinemia type I: Hypertyrosinemia is a characteristic symptom of Tyrosinemia type I, which is a genetic disorder caused by a deficiency of the enzyme fumarylacetoacetase. Other symptoms can include liver disease, failure to thrive, and rickets. However, Hyperphenylalaninemia is not a symptom of Tyrosinemia type I.

+2. Phenylketonuria (PKU): Hyperphenylalaninemia is a characteristic symptom of PKU, which is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Other symptoms can include intellectual disability, behavioral problems, and seizures. However, Tyrosinemia and Preeclampsia are not symptoms of PKU.

+3. Preeclampsia: Preeclampsia is a pregnancy complication characterized by high blood pressure and damage to organs such as the liver and kidneys. Other symptoms can include proteinuria (protein in the urine), swelling, and headaches. However, Hypertyrosinemia and Hyperphenylalaninemia are not symptoms of Preeclampsia.

+4. Sudden Infant Death Syndrome (SIDS): Death in early adulthood is not a symptom of SIDS, which is the unexplained death of a seemingly healthy baby under one year of age. However, Hypertyrosinemia and Hyperphenylalaninemia are not symptoms of SIDS either.

Please note that this is not an exhaustive list of potential diseases, and further diagnostic testing would be needed to confirm a diagnosis. It is important to consult with a healthcare professional for accurate information."
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder that affects the metabolism of an amino acid called phenylalanine. Symptoms include abnormality of prenatal development or birth, neonatal death, hyperphenylalaninemia, and elevated urinary carboxylic acid. However, PKU does not typically cause death in early adulthood.

+2. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, hyperphenylalaninemia, and elevated urinary carboxylic acid. However, MSUD does not typically cause hypertyrosinemia or death in early adulthood.

+3. Homocystinuria: This is a genetic disorder that affects the metabolism of an amino acid called methionine. Symptoms include abnormality of prenatal development or birth, neonatal death, hyperphenylalaninemia, and elevated urinary carboxylic acid. However, homocystinuria does not typically cause hypertyrosinemia or death in early adulthood.

+4. Tyrosinemia type I: This is a genetic disorder that affects the metabolism of the amino acid tyrosine. Symptoms include abnormality of prenatal development or birth, neonatal death, hypertyrosinemia, and elevated urinary carboxylic acid. However, tyrosinemia type I does not typically cause hyperphenylalaninemia or death in early adulthood.

+5. Isovaleric acidemia: This is a genetic disorder that affects the metabolism of an amino acid called leucine. Symptoms include abnormality of prenatal development or birth, neonatal death, and elevated urinary carboxylic acid. However, isovaleric acidemia does not typically cause hyperphenylalaninemia, hypertyrosinemia, or death in early adulthood.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing and evaluation would be necessary to confirm a diagnosis. Additionally, some of these disorders can present with a wide range of severity, and not all individuals with these disorders will experience all of the symptoms listed."
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, PKU does not typically cause death in infancy or childhood.

+2. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, MSUD does not typically cause death in infancy or childhood.

+3. Homocystinuria: This is a genetic disorder that affects the body's ability to process the amino acid methionine. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, homocystinuria does not typically cause death in infancy or childhood.

+4. Tyrosinemia type I: This is a genetic disorder that affects the body's ability to break down the amino acid tyrosine. Symptoms include abnormality of prenatal development or birth, neonatal death, hyperphenylalaninemia, and hypertyrosinemia. However, tyrosinemia type I does not typically cause death in childhood.

+5. Isovaleric acidemia: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, isovaleric acidemia does not typically cause hypertyrosinemia or death in infancy or childhood.

It is important to note that these are just potential diagnoses based on the symptoms provided. Further testing and evaluation would be necessary to confirm any diagnosis."
['Hereditary orotic aciduria']," +1. Possible Disease: Various types of Rashes
Description: The patient's symptom of ""Skin rash"" is present, but the other symptoms do not align with any specific rash-related disease.

+2. Possible Disease: Various types of Metabolic Disorders
Description: The patient's symptoms of ""Hyperglycinuria"", ""Cystinuria"", ""Oroticaciduria"", and ""Ornithinuria"" indicate a possible metabolic disorder.

+3. Possible Disease: Various types of Infections
Description: The patient's symptoms of ""Fever"", ""Vomiting"", ""Pneumonia"", and ""Hepatomegaly"" suggest a possible infection.

+4. Possible Disease: Various types of Neurological Disorders
Description: The patient's symptoms of ""Lethargy"", ""Generalized hypotonia"", ""Drowsiness"", and ""Sleep abnormality"" suggest a possible neurological disorder.

+5. Possible Disease: Various types of Liver Disorders
Description: The patient's symptoms of ""Hepatomegaly"" and ""Hyperglycinuria"" suggest a possible liver disorder.

+6. Possible Disease: Various types of Spleen Disorders
Description: The patient's symptom of ""Splenomegaly"" suggests a possible spleen disorder.

+7. Possible Disease: Lysinuric Protein Intolerance
Description: The patient's symptoms of ""Hyperglycinuria"", ""Feeding difficulties"", and ""Cystinuria"" are consistent with this metabolic disorder.

+8. Possible Disease: Maple Syrup Urine Disease
Description: The patient's symptoms of ""Hyperglycinuria"", ""Feeding difficulties"", and ""Erythematous plaque"" are consistent with this metabolic disorder.

+9. Possible Disease: Homocystinuria
Description: The patient's symptoms of ""Erythematous plaque"", ""Hepatomegaly"", and ""Hyperglycinuria"" are consistent with this metabolic disorder.

+10. Possible Disease: Wolman Disease
Description: The patient's symptoms of ""Hepatomegaly"", ""Splenomegaly"", and ""Hyperglycinuria"" are consistent with this metabolic disorder.

+11. Possible Disease: Niemann-Pick Disease
Description: The patient's symptoms of ""Hepatomegaly"", ""Splenomegaly"", and ""Generalized hypotonia"" are consistent with this metabolic disorder.

+12. Possible Disease: Gaucher Disease
Description: The patient's symptoms of ""Hepatomegaly"", ""Splenomegaly"", and ""Anemia"" are consistent with this metabolic disorder.

+13. Possible Disease: Fabry Disease
Description: The patient's symptoms of ""Hepatomegaly"", ""Splenomegaly"", and ""Angiokeratomas"" are consistent with this metabolic disorder.

+14. Possible Disease: Mucopolysaccharidosis
Description: The patient's symptoms of ""Hepatomegaly"", ""Splenomegaly"", and ""Coarse facial features"" are consistent with this metabolic disorder.

+"
['Holocarboxylase synthetase deficiency'], +1
['Ornithine transcarbamylase deficiency']," +1. Hepatic Encephalopathy: The patient's symptoms of apathy, lethargy, vomiting, drowsiness, and death in adolescence could indicate this liver-related disorder. However, this condition does not typically cause ataxia or sleep abnormalities.

+2. Reye's Syndrome: The patient's symptoms of apathy, lethargy, vomiting, drowsiness, and death in adolescence could suggest this rare but serious condition, which can affect the liver and brain. However, this condition does not typically cause ataxia or sleep abnormalities.

+3. Orotic Aciduria: The patient's symptoms of oroticaciduria, hyperammonemia, and drowsiness could indicate this rare genetic disorder that affects the body's ability to process certain amino acids. However, this condition does not typically cause apathy, ataxia, lethargy, or vomiting.

+4. Maple Syrup Urine Disease: The patient's symptoms of hyperammonemia, vomiting, and drowsiness could suggest this rare metabolic disorder that affects the body's ability to break down certain amino acids. However, this condition does not typically cause apathy, ataxia, lethargy, sleep abnormalities, or oroticaciduria.

+5. Urea Cycle Disorders: The patient's symptoms of hyperammonemia, vomiting, drowsiness, and death in adolescence could indicate a urea cycle disorder, which affects the body's ability to remove ammonia from the bloodstream. However, this condition does not typically cause apathy, ataxia, or sleep abnormalities.

+6. Wilson's Disease: The patient's symptoms of apathy, lethargy, vomiting, drowsiness, and death in adolescence could suggest this rare genetic disorder that affects copper metabolism. However, this condition does not typically cause ataxia or sleep abnormalities.

+7. Leigh's Disease: The patient's symptoms of apathy, lethargy, ataxia, vomiting, drowsiness, and sleep abnormalities could indicate this rare genetic disorder that affects the body's energy production. However, this condition does not typically cause hyperammonemia or oroticaciduria.

+8. Pelizaeus-Merzbacher Disease: The patient's symptoms of ataxia, lethargy, and death in adolescence could suggest this rare genetic disorder that affects the myelin sheath of nerve cells in the brain. However, this condition does not typically cause apathy, vomiting, drowsiness, sleep abnormalities, hyperammonemia, or oroticaciduria.

+9. Mitochondrial Disorders: The patient's symptoms of apathy, lethargy, ataxia, vomiting, drowsiness, and sleep abnormalities could indicate a mitochondrial disorder, which affects the body's energy production. However, this condition does not typically cause hyperammonemia or oroticaciduria.

+10. Neurodegenerative Disorders: The patient's symptoms of apathy, lethargy, ataxia, vomiting, drowsiness, and sleep abnormalities could suggest a neurodegenerative disorder, which affects the brain and nervous system. However, this category is broad and does not typically cause hyperammonem"
[]," +1. Vomiting: This is a symptom that can be associated with a wide range of medical conditions, from simple stomach flu to more serious conditions such as brain tumors or meningitis. More information is needed to determine the cause of this symptom in this patient.

+2. Ethylmalonic aciduria: This is a rare genetic disorder that affects the body's ability to break down certain types of fats. Symptoms can include vomiting, developmental delays, and an abnormal smell to the urine. However, this disorder is typically diagnosed in infancy or early childhood, and it is not associated with abnormal circulating carnitine concentration or decreased 3-hydroxyacyl-CoA dehydrogenase level.

+3. Death in childhood: This is not a medical condition, but rather a possible outcome of many different medical conditions. More information is needed to determine the cause of death in this patient's case.

+4. Abnormal circulating carnitine concentration: This can be a symptom of a number of different medical conditions, including certain types of metabolic disorders. However, it is not typically associated with vomiting, death in childhood or adolescence, or decreased 3-hydroxyacyl-CoA dehydrogenase level.

+5. Death in adolescence: This is not a medical condition, but rather a possible outcome of many different medical conditions. More information is needed to determine the cause of death in this patient's case.

+6. Decreased 3-hydroxyacyl-CoA dehydrogenase level: This can be a symptom of certain types of metabolic disorders, such as long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. However, it is not typically associated with vomiting, death in childhood or adolescence, or abnormal circulating carnitine concentration.

It is important to note that this is not a definitive diagnosis, and more information and testing would be needed to determine the underlying cause of the patient's symptoms."
['Smith-Lemli-Opitz syndrome']," Based on the symptoms you have provided, I will list some potential diseases that the patient may have. Please note that this is not a definitive diagnosis and further testing would be needed to confirm.

+1. Smith-Lemli-Opitz syndrome: This is a genetic disorder that affects the metabolism of cholesterol. Symptoms include low-set ears, wide nasal bridge, anteverted nares, ptosis, syndactyly, intellectual disability, motor delay, generalized hypotonia, feeding difficulties, and elevated 8-dehydrocholesterol and 7-dehydrocholesterol concentrations. However, this condition does not typically cause neonatal death or hypocholesterolemia.

+2. Zellweger syndrome: This is a rare genetic disorder that affects the development of the brain, liver, and kidneys. Symptoms include low-set ears, wide nasal bridge, anteverted nares, ptosis, intellectual disability, motor delay, generalized hypotonia, feeding difficulties, and neonatal death. However, this condition does not typically cause syndactyly or elevated 8-dehydrocholesterol and 7-dehydrocholesterol concentrations.

+3. CHARGE syndrome: This is a genetic disorder that affects multiple organ systems. Symptoms include low-set ears, wide nasal bridge, anteverted nares, ptosis, intellectual disability, motor delay, generalized hypotonia, feeding difficulties, and sometimes syndactyly. However, this condition does not typically cause elevated 8-dehydrocholesterol and 7-dehydrocholesterol concentrations or neonatal death.

+4. Down syndrome: This is a genetic disorder caused by an extra copy of chromosome 21. Symptoms include intellectual disability, motor delay, generalized hypotonia, and sometimes low-set ears and wide nasal bridge. However, this condition does not typically cause syndactyly, ptosis, feeding difficulties, or elevated 8-dehydrocholesterol and 7-dehydrocholesterol concentrations.

+5. Fetal alcohol syndrome: This is a condition that can occur in a fetus if the mother drinks alcohol during pregnancy. Symptoms include low-set ears, wide nasal bridge, intellectual disability, motor delay, generalized hypotonia, and feeding difficulties. However, this condition does not typically cause syndactyly, ptosis, or elevated 8-dehydrocholesterol and 7-dehydrocholesterol concentrations.

Please consult with a healthcare professional for further evaluation and diagnosis."
['L-2-hydroxyglutaric aciduria']," Based on the symptoms you have provided, here are some potential diseases:

+1. Leigh Syndrome: This is a rare inherited neurometabolic disorder that affects the central nervous system. Symptoms include intellectual disability, ataxia, tremor, and cerebral atrophy. However, Leigh Syndrome is typically not associated with abnormal basal ganglia morphology, L-2-hydroxyglutaric aciduria, or death in infancy or childhood.

+2. Pelizaeus-Merzbacher Disease: This is a rare X-linked recessive genetic disorder that affects the nervous system. Symptoms include intellectual disability, ataxia, tremor, and abnormalities in the white matter of the brain, which can appear as cerebral atrophy. However, Pelizaeus-Merzbacher Disease is not typically associated with L-2-hydroxyglutaric aciduria or death in infancy or childhood.

+3. Joubert Syndrome: This is a genetic disorder that affects the development of the brain. Symptoms include intellectual disability, ataxia, tremor, and cerebral atrophy. However, Joubert Syndrome is not typically associated with L-2-hydroxyglutaric aciduria or death in infancy or childhood.

+4. Alexander Disease: This is a progressive neurological disorder that affects the nervous system. Symptoms include intellectual disability, ataxia, tremor, and cerebral atrophy. However, Alexander Disease is not typically associated with L-2-hydroxyglutaric aciduria or death in infancy or childhood.

+5. Canavan Disease: This is a rare genetic disorder that affects the nervous system. Symptoms include intellectual disability, ataxia, tremor, and cerebral atrophy. However, Canavan Disease is not typically associated with L-2-hydroxyglutaric aciduria or death in infancy or childhood.

+6. L-2-Hydroxyglutaric Aciduria: This is a rare genetic disorder that affects the metabolism of the amino acid L-serine. Symptoms include intellectual disability, ataxia, tremor, and L-2-hydroxyglutaric aciduria. However, L-2-Hydroxyglutaric Aciduria is not typically associated with death in infancy or childhood or abnormal basal ganglia morphology.

It is important to note that these are potential diagnoses based on the symptoms you have provided, and further testing would be needed to confirm any diagnosis. Additionally, it is possible that the patient's symptoms are caused by a combination of factors or a yet-to-be-identified condition."
['3-hydroxy-3-methylglutaric aciduria']," Based on the symptoms you have provided, here are some potential diseases:

+1. Pyruvate Dehydrogenase Deficiency: This is a genetic disorder that affects the body's ability to convert food into energy. Symptoms can include seizures, hypotonia, and metabolic acidosis. However, this condition does not typically cause irritability, opisthotonus, dicarboxylic aciduria, 3-methylglutaconic aciduria, or an elevated urinary carboxylic acid.

+2. Glutaric Acidemia Type I: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include seizures, hypotonia, and metabolic acidosis. However, this condition does not typically cause irritability, opisthotonus, dicarboxylic aciduria, 3-methylglutaconic aciduria, or an elevated urinary carboxylic acid.

+3. Isovaleric Acidemia: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include seizures, hypotonia, and metabolic acidosis. However, this condition does not typically cause irritability, opisthotonus, dicarboxylic aciduria, 3-methylglutaconic aciduria, or an elevated urinary carboxylic acid.

+4. Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): This is a genetic disorder that affects the body's ability to break down certain fats and proteins. Symptoms can include seizures, hypotonia, and metabolic acidosis. However, this condition does not typically cause irritability, opisthotonus, dicarboxylic aciduria, 3-methylglutaconic aciduria, or an elevated urinary carboxylic acid.

+5. Nonketotic Hyperglycinemia: This is a genetic disorder that affects the body's ability to break down the amino acid glycine. Symptoms can include seizures, hypotonia, and metabolic acidosis. However, this condition does not typically cause irritability, opisthotonus, dicarboxylic aciduria, 3-methylglutaconic aciduria, or an elevated urinary carboxylic acid.

+6. Maple Syrup Urine Disease: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include seizures, hypotonia, and metabolic acidosis. However, this condition does not typically cause irritability, opisthotonus, dicarboxylic aciduria, 3-methylglutaconic aciduria, or an elevated urinary carboxylic acid.

+7. Methylmalonic Acidemia: This is a genetic disorder that affects the body's ability to break down certain proteins and fats. Symptoms can include seizures, hypotonia, and metabolic acidosis. However, this condition does not typically cause irritability, opisthotonus, dicarboxylic aciduria, 3-methylglutaconic aciduria, or an elevated urinary carboxylic acid.

+8. Propionic Acidemia: This is a genetic disorder"
['L-2-hydroxyglutaric aciduria']," Based on the symptoms you have provided, I will list some potential diseases that could match. Please note that this is not a definitive diagnosis and medical consultation is necessary for accurate diagnosis.

1. + Staphylococcal scalded skin syndrome (SSSS): Obsolete eczematoid dermatitis and skin rash. SSSS is a bacterial skin infection common in infants and young children, characterized by widespread rash and blistering.
2. + Scarlet fever: Skin rash and fever. Scarlet fever is a bacterial illness caused by group A streptococcus, characterized by a bright red rash on the body and high fever.
3. + Meningococcemia: Skin rash, fever, and seizure. Meningococcemia is a bacterial blood infection caused by Neisseria meningitidis, characterized by a petechial or purpuric rash, fever, and sometimes seizures.
4. + Sudden infant death syndrome (SIDS): Death in infancy. SIDS is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old.
5. + Kawasaki disease: Skin rash, fever, and elevated circulating C-reactive protein concentration. Kawasaki disease is a childhood illness characterized by inflammation of blood vessels throughout the body, including skin rash and high fever.
6. + L-2-hydroxyglutaric aciduria: L-2-hydroxyglutaric aciduria and decreased serum iron. L-2-hydroxyglutaric aciduria is a rare genetic disorder characterized by the accumulation of L-2-hydroxyglutaric acid in the body, which can lead to decreased serum iron levels.

Again, this is not a definitive diagnosis and medical consultation is necessary for accurate diagnosis."
['X-linked hypophosphatemia']," +1. Hypophosphatemic Rickets: The patient has hypophosphatemia and abnormal limb bone morphology, which are common symptoms of this genetic disorder. However, this disease does not typically cause nephritis or death in infancy or childhood.

+2. Hypopituitarism: The patient has abnormal circulating hormone concentration, which is a common symptom of this disorder of the pituitary gland. However, this disease does not typically cause nephritis, hypophosphatemia, or abnormal limb bone morphology.

+3. Renal Fanconi Syndrome: The patient has hypophosphatemia, which is a common symptom of this kidney disorder. However, this disease does not typically cause nephritis, death in infancy or childhood, or abnormal limb bone morphology.

+4. Hyperparathyroidism: The patient has elevated circulating alkaline phosphatase concentration, which is a common symptom of this disorder of the parathyroid glands. However, this disease does not typically cause nephritis, hypophosphatemia, or abnormal limb bone morphology.

+5. Infantile Renal Failure: The patient has death in infancy, which is a common symptom of this kidney disorder. However, this disease does not typically cause nephritis, hypophosphatemia, or abnormal limb bone morphology.

+6. Childhood Nephrotic Syndrome: The patient has nephritis and death in childhood, which are common symptoms of this kidney disorder. However, this disease does not typically cause hypophosphatemia or abnormal limb bone morphology.

+7. Osteogenesis Imperfecta: The patient has abnormal limb bone morphology, which is a common symptom of this genetic disorder of the bones. However, this disease does not typically cause nephritis, hypophosphatemia, or abnormal circulating hormone concentration.

It is important to note that this list is not exhaustive and further diagnostic testing is necessary to determine the underlying cause of the patient's symptoms."
['Propionic acidemia']," +1. Autism Spectrum Disorder: Delayed speech and language development is a common symptom, but skin rashes, abnormal circulating amino acid and carnitine concentrations, and elevated urinary carboxylic acid are not typically associated with this disorder.

+2. Eczema: Obsolete eczematoid dermatitis and skin rash are common symptoms, but the other listed symptoms are not typically associated with eczema.

+3. Leukemia: Leukopenia and death in infancy or childhood are possible symptoms, but skin rashes, hyperammonemia, hyperglycinemia, hyperglycinuria, and elevated circulating alkaline phosphatase concentration are not typically associated with leukemia.

+4. Maple Syrup Urine Disease: Elevated urinary carboxylic acid, abnormal circulating alanine concentration, and abnormal circulating aspartate family amino acid concentration are common symptoms, but delayed speech and language development, obsolete eczematoid dermatitis, skin rash, and leukopenia are not typically associated with this disease.

+5. Nonketotic Hyperglycinemia: Delayed speech and language development, hyperglycinemia, hyperglycinuria, and elevated circulating alanine concentration are common symptoms, but obsolete eczematoid dermatitis, skin rash, leukopenia, hyperammonemia, and elevated urinary carboxylic acid are not typically associated with this disease.

+6. Hypophosphatasia: Elevated circulating alkaline phosphatase concentration is a common symptom, but delayed speech and language development, obsolete eczematoid dermatitis, skin rash, leukopenia, hyperammonemia, hyperglycinemia, hyperglycinuria, and elevated urinary carboxylic acid are not typically associated with this disease.

+7. Carnitine Deficiency: Abnormal circulating carnitine concentration is a common symptom, but delayed speech and language development, obsolete eczematoid dermatitis, skin rash, leukopenia, hyperammonemia, hyperglycinemia, hyperglycinuria, elevated circulating alkaline phosphatase concentration, and elevated urinary carboxylic acid are not typically associated with this disease.

+8. Serine Deficiency: Abnormal circulating serine concentration is a common symptom, but delayed speech and language development, obsolete eczematoid dermatitis, skin rash, leukopenia, hyperammonemia, hyperglycinemia, hyperglycinuria, elevated circulating alkaline phosphatase concentration, and elevated urinary carboxylic acid are not typically associated with this disease.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing and evaluation would be necessary to confirm any diagnosis. Additionally, some of these symptoms may be present in multiple conditions, and the presence of one or more symptoms does not necessarily indicate the presence of a specific disease."
"['Methylmalonic acidemia with homocystinuria, type cblC']"," Based on the symptoms you have provided, I can suggest several potential diseases. Please note that this is not a definitive diagnosis, and further testing would be needed to confirm:

+1. Non-ketotic hyperglycinemia: This is a genetic disorder characterized by delayed speech and language development, generalized hypotonia, and death in infancy. It is caused by an accumulation of glycine in the body due to a deficiency of the enzyme that breaks it down.

Symptoms: ['Delayed speech and language development' (+), 'Generalized hypotonia' (+), 'Death in infancy' (+), 'Hyperhomocystinemia' (-), 'Abnormal cerebral white matter morphology' (+), 'Neonatal death' (+), 'Death in childhood' (+), 'Gastrointestinal inflammation' (-), 'Decreased plasma free carnitine' (-), 'Methylmalonic aciduria' (-)]

+2. Maple syrup urine disease: This is a genetic disorder characterized by an inability to break down certain amino acids, leading to their accumulation in the body. Symptoms can include delayed speech and language development, generalized hypotonia, and death in infancy or childhood.

Symptoms: ['Delayed speech and language development' (+), 'Generalized hypotonia' (+), 'Death in infancy' (+), 'Hyperhomocystinemia' (-), 'Abnormal cerebral white matter morphology' (+), 'Neonatal death' (+), 'Death in childhood' (+), 'Gastrointestinal inflammation' (-), 'Decreased plasma free carnitine' (-), 'Methylmalonic aciduria' (-)]

+3. Methylmalonic acidemia: This is a genetic disorder characterized by an inability to break down certain proteins, leading to the accumulation of methylmalonic acid in the body. Symptoms can include delayed speech and language development, generalized hypotonia, and death in infancy or childhood.

Symptoms: ['Delayed speech and language development' (+), 'Generalized hypotonia' (+), 'Death in infancy' (+), 'Hyperhomocystinemia' (-), 'Abnormal cerebral white matter morphology' (+), 'Neonatal death' (+), 'Death in childhood' (+), 'Gastrointestinal inflammation' (+), 'Decreased plasma free carnitine' (+), 'Methylmalonic aciduria' (+)]

+4. Carnitine transporter deficiency: This is a genetic disorder characterized by an inability to transport carnitine into cells, leading to decreased plasma free carnitine levels. Symptoms can include delayed speech and language development, generalized hypotonia, and death in infancy or childhood.

Symptoms: ['Delayed speech and language development' (+), 'Generalized hypotonia' (+), 'Death in infancy' (+), 'Hyperhomocystinemia' (-), 'Abnormal cerebral white matter morphology' (+), 'Neonatal death' (+), 'Death in childhood' (+), 'Gastrointestinal inflammation' (-), 'Decreased plasma free carnitine' (+), 'Methylmalonic aciduria' (-)]

+5. Homocystinuria: This is a genetic disorder characterized by an inability to break down the amino acid methionine, leading to the accumulation of homocysteine in the body"
['Biotinidase deficiency']," +1.	Trimethylaminuria: This is a genetic disorder that affects the body's ability to break down trimethylamine, a compound that has a strong odor. The symptoms that the patient has in common with this disease are elevated urinary carboxylic acid. However, this disease does not cause death in infancy or neonatal death.

+2.	Isovaleric acidemia: This is an inherited disorder that affects the body's ability to break down certain proteins. The symptoms that the patient has in common with this disease are elevated urinary carboxylic acid. However, this disease does not cause death in infancy or neonatal death.

+3.	Maple syrup urine disease: This is an inherited disorder that affects the body's ability to break down certain amino acids. The symptoms that the patient has in common with this disease are elevated urinary carboxylic acid. However, this disease does not cause death in infancy or neonatal death.

+4.	Propionic acidemia: This is an inherited disorder that affects the body's ability to break down certain proteins and fats. The symptoms that the patient has in common with this disease are elevated urinary carboxylic acid. However, this disease does not cause death in infancy or neonatal death.

+5.	Methylmalonic acidemia: This is an inherited disorder that affects the body's ability to break down certain proteins and fats. The symptoms that the patient has in common with this disease are elevated urinary carboxylic acid. However, this disease does not cause death in infancy or neonatal death.

It is important to note that the symptoms provided do not necessarily indicate a specific disease, and further testing would be needed to make a definitive diagnosis. Additionally, the symptoms of death in infancy and neonatal death are not present in any of the above diseases, and it is important to consider other potential causes for these symptoms."
['Carbamoyl-phosphate synthetase 1 deficiency']," +1. Urea Cycle Disorders (UCDs): The patient has Hyperammonemia, which is a symptom of UCDs. However, the patient does not show symptoms such as seizures, vomiting, or coma which are commonly associated with UCDs.

+2. Maple Syrup Urine Disease (MSUD): The patient has Lethargy and Drowsiness, which are symptoms of MSUD. However, the patient does not show symptoms such as maple syrup odor in urine, episodes of vomiting, or developmental delays which are commonly associated with MSUD.

+3. Nonketotic Hyperglycinemia (NKH): The patient has Lethargy and Drowsiness, which are symptoms of NKH. However, the patient does not show symptoms such as seizures, hiccups, or apnea which are commonly associated with NKH.

+4. Phenylketonuria (PKU): The patient does not show any symptoms that are commonly associated with PKU.

+5. Homocystinuria: The patient does not show any symptoms that are commonly associated with Homocystinuria.

+6. Glutaric Acidemia Type I (GA-I): The patient does not show any symptoms that are commonly associated with GA-I.

+7. Methylmalonic Acidemia (MMA): The patient does not show any symptoms that are commonly associated with MMA.

+8. Propionic Acidemia (PA): The patient does not show any symptoms that are commonly associated with PA.

+9. Isovaleric Acidemia (IVA): The patient does not show any symptoms that are commonly associated with IVA.

+10. Citrullinemia: The patient does not show any symptoms that are commonly associated with Citrullinemia.

+11. Argininosuccinic Aciduria (ASA): The patient does not show any symptoms that are commonly associated with ASA.

+12. Tyrosinemia Type I: The patient does not show any symptoms that are commonly associated with Tyrosinemia Type I.

+13. Tyrosinemia Type II: The patient does not show any symptoms that are commonly associated with Tyrosinemia Type II.

+14. Tyrosinemia Type III: The patient does not show any symptoms that are commonly associated with Tyrosinemia Type III.

+15. Galactosemia: The patient does not show any symptoms that are commonly associated with Galactosemia.

+16. Hereditary Fructose Intolerance (HFI): The patient does not show any symptoms that are commonly associated with HFI.

+17. Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD): The patient does not show any symptoms that are commonly associated with G6PD.

+18. Pyruvate Dehydrogenase Deficiency (PDH): The patient does not show any symptoms that are commonly associated with PDH.

+19. Mitochondrial Disorders: The patient does not show any symptoms that are commonly associated with Mitochondrial Disorders.

+20. Leigh Syndrome: The patient does not show any symptoms that are commonly associated with Leigh Syndrome.

+21. Pelizaeus-Merzbacher Disease (PMD): The patient has Spastic"
['Vitamin B12-unresponsive methylmalonic acidemia']," +1. Methylmalonic acidemia: This is a genetic disorder in which the body is unable to properly break down certain proteins and fats. Symptoms can include death in infancy or childhood, metabolic acidosis, and decreased methylmalonyl-CoA mutase activity. However, not all patients with methylmalonic acidemia will have all of these symptoms.

+2. Propionic acidemia: This is a genetic disorder in which the body is unable to properly break down certain proteins and fats. Symptoms can include death in infancy or childhood, metabolic acidosis, and decreased methylmalonyl-CoA mutase activity. However, not all patients with propionic acidemia will have all of these symptoms.

+3. Isovaleric acidemia: This is a genetic disorder in which the body is unable to properly break down certain proteins. Symptoms can include metabolic acidosis and death in infancy or childhood. Decreased methylmalonyl-CoA mutase activity is not typically associated with this disorder.

+4. Multiple carboxylase deficiency: This is a genetic disorder that affects the body's ability to use certain vitamins. Symptoms can include metabolic acidosis and death in infancy or childhood. Decreased methylmalonyl-CoA mutase activity is not typically associated with this disorder.

It is important to note that this is not an exhaustive list of potential diagnoses, and that further testing and evaluation would be necessary to confirm any diagnosis. It is also important to note that some of these disorders can be managed with dietary changes and supplements, while others may require more intensive medical treatment. It is essential that the patient consult with a healthcare professional for an accurate diagnosis and treatment plan."
[]," Based on the symptoms you have provided, here are some potential diseases that the patient may have:

+1. Phenylketonuria (PKU): PKU is a genetic disorder characterized by a deficiency of the enzyme phenylalanine hydroxylase, which leads to an accumulation of phenylalanine in the body. This can cause brain damage and intellectual disability if left untreated. Symptoms can include hyperactivity, seizures, and behavioral problems. However, PKU does not typically cause spasticity, anemia, or metabolic acidosis.

+2. Maple syrup urine disease (MSUD): MSUD is a genetic disorder caused by a deficiency of the enzyme branched-chain keto acid dehydrogenase complex. This leads to an accumulation of branched-chain amino acids in the body, which can cause neurological problems and intellectual disability. Symptoms can include hyperactivity, seizures, and behavioral problems. However, MSUD does not typically cause anemia, metabolic acidosis, or increased bilirubin.

+3. Homocystinuria: Homocystinuria is a genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. This leads to an accumulation of homocysteine in the body, which can cause neurological problems, intellectual disability, and vascular complications. Symptoms can include hyperactivity, seizures, and behavioral problems. However, homocystinuria does not typically cause anemia, metabolic acidosis, or increased bilirubin.

+4. Glutaric acidemia type I: Glutaric acidemia type I is a genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. This leads to an accumulation of glutaric acid in the body, which can cause neurological problems and intellectual disability. Symptoms can include hyperactivity, seizures, and behavioral problems. However, glutaric acidemia type I does not typically cause anemia, metabolic acidosis, or increased bilirubin.

+5. Galactosemia: Galactosemia is a genetic disorder caused by a deficiency of the enzyme galactose-1-phosphate uridylyltransferase. This leads to an accumulation of galactose in the body, which can cause neurological problems and intellectual disability. Symptoms can include hyperactivity, seizures, and behavioral problems. However, galactosemia does not typically cause anemia, metabolic acidosis, or increased bilirubin.

+6. Porphyria: Porphyria is a group of genetic disorders caused by a deficiency of enzymes in the heme biosynthesis pathway. This can lead to the accumulation of porphyrins and their precursors in the body, which can cause neurological problems, skin symptoms, and abdominal pain. Symptoms can include increased circulating porphyrin concentration and abnormal circulating porphyrin concentration. However, porphyria does not typically cause spasticity, anemia, or metabolic acidosis.

+7. Leukodystrophy: Leukodystrophies are a group of genetic disorders that affect the white matter of the brain. Symptoms can include spasticity, intellectual disability, and neurological problems. However, le"
['Neonatal intrahepatic cholestasis due to citrin deficiency']," +1. Neonatal citrullinemia: This is a genetic disorder caused by a deficiency of the enzyme argininosuccinate synthetase. Symptoms may include death in infancy, premature birth, hyperammonemia, respiratory distress, apnea, neonatal death, respiratory acidosis, and elevated plasma citrulline. However, hypoxemia is not a typical symptom of this disease.

+2. Urea cycle disorder: This is a group of genetic disorders that affect the body's ability to remove ammonia from the blood. Symptoms may include death in infancy, premature birth, hyperammonemia, respiratory distress, apnea, neonatal death, and respiratory acidosis. Elevated plasma citrulline and hypoxemia are not typical symptoms of this disease.

+3. Maple syrup urine disease: This is a genetic disorder caused by a deficiency of the enzyme branched-chain keto acid dehydrogenase. Symptoms may include death in infancy, premature birth, and respiratory distress. Hyperammonemia, respiratory acidosis, apnea, neonatal death, elevated plasma citrulline, and hypoxemia are not typical symptoms of this disease.

+4. Organic acidemias: This is a group of genetic disorders that affect the body's ability to break down certain amino acids. Symptoms may include death in infancy, premature birth, hyperammonemia, respiratory distress, apnea, neonatal death, and respiratory acidosis. Elevated plasma citrulline and hypoxemia are not typical symptoms of this disease.

+5. Pyruvate dehydrogenase deficiency: This is a genetic disorder that affects the body's ability to convert pyruvate to acetyl-CoA. Symptoms may include death in infancy, premature birth, and respiratory distress. Hyperammonemia, respiratory acidosis, apnea, neonatal death, elevated plasma citrulline, and hypoxemia are not typical symptoms of this disease.

It is important to note that these are only potential diagnoses based on the symptoms provided and further testing is needed to confirm any diagnosis. It is also important to note that these are rare genetic disorders and it is important to consult with a geneticist or a metabolic specialist for further evaluation and management."
[]," Based on the symptoms you have provided, here are some potential diseases that the patient may have:

+1. Autism Spectrum Disorder: The patient has autistic behavior, which is a core symptom of Autism Spectrum Disorder. However, the patient does not have any other symptoms that are commonly associated with this disorder, such as difficulty with social communication and restricted interests.

+2. Hypertension: The patient has hypertension, which is defined as sustained high blood pressure. This can lead to complications such as heart disease, stroke, and kidney damage if left untreated.

+3. Edema: The patient has edema, which is swelling caused by the accumulation of fluid in the body. This can be a symptom of a variety of underlying conditions, including heart failure, kidney disease, and liver disease.

+4. Intellectual Disability: The patient has intellectual disability, which is characterized by below-average intelligence or mental ability and a lack of skills necessary for day-to-day living. This can be caused by genetic conditions, brain injury, or other factors.

+5. Epilepsy: The patient has seizures, which can be a symptom of epilepsy. Epilepsy is a neurological disorder characterized by recurrent seizures.

+6. Coma: The patient has a coma, which is a state of deep unconsciousness. This can be caused by a variety of underlying conditions, including brain injury, infection, and metabolic disorders.

+7. Hypotonia: The patient has generalized hypotonia, which is decreased muscle tone. This can be a symptom of a variety of underlying conditions, including neurological disorders and metabolic disorders.

+8. Pancreatitis: The patient has pancreatitis, which is inflammation of the pancreas. This can be caused by a variety of factors, including gallstones, alcohol abuse, and certain medications.

+9. Leukopenia: The patient has leukopenia, which is a decreased white blood cell count. This can be a symptom of a variety of underlying conditions, including viral infections and certain medications.

+10. Anemia: The patient has anemia, which is a decreased red blood cell count. This can be caused by a variety of factors, including iron deficiency, vitamin deficiency, and chronic disease.

+11. Acute Kidney Injury: The patient has acute kidney injury, which is the sudden loss of kidney function. This can be caused by a variety of factors, including dehydration, sepsis, and certain medications.

+12. Hyperammonemia: The patient has hyperammonemia, which is an elevated level of ammonia in the blood. This can be caused by a variety of underlying conditions, including liver disease and certain genetic disorders.

+13. Gout: The patient has gout, which is a type of arthritis caused by the buildup of uric acid crystals in the joints. This can be caused by a variety of factors, including diet, genetics, and certain medications.

+14. Vomiting: The patient has vomiting, which can be a symptom of a variety of underlying conditions, including gastrointestinal infections, food poisoning, and migraines.

+15. Hyperuricemia: The patient has hyperuricemia, which is an elevated level of uric acid in the blood. This can be caused by a variety of factors, including diet, genetics"
['Dihydropteridine reductase deficiency'], +1
[]," Based on the symptoms you have provided, here are some potential diseases:

+1. Erythema Toxicum Neonatorum: This is a common skin condition in newborns that is characterized by a rash made up of small red bumps or pustules. It typically appears within the first few days of life and resolves on its own within a week or two. The rash can appear anywhere on the body, but it is most commonly found on the face, chest, and diaper area. The other symptoms you have listed are not typically associated with this condition.

+2. Maple Syrup Urine Disease: This is a genetic disorder that affects the way the body breaks down certain amino acids. It is characterized by the presence of sweet-smelling urine, which is caused by the buildup of certain acids in the body. Other symptoms can include feeding difficulties, vomiting, seizures, and developmental delays. The skin rash, glycosuria, and ethylmalonic aciduria you have described are not typically associated with this condition.

+3. Mitochondrial Disease: This is a group of disorders that affect the mitochondria, which are the energy-producing structures in cells. Symptoms can vary widely, but they often include muscle weakness, fatigue, and developmental delays. The skin rash, glycosuria, and ethylmalonic aciduria you have described are not typically associated with this condition, but cytochrome C oxidase-negative muscle fibers can be a sign of mitochondrial disease.

+4. Nonketotic Hyperglycinemia: This is a genetic disorder that affects the way the body breaks down the amino acid glycine. It is characterized by an abnormal accumulation of glycine in the body, which can cause a range of symptoms including seizures, developmental delays, and low muscle tone. The skin rash, glycosuria, and ethylmalonic aciduria you have described are not typically associated with this condition, but an abnormal circulating glycine concentration is a key feature of nonketotic hyperglycinemia.

+5. Peutz-Jeghers Syndrome: This is a genetic disorder that is characterized by the development of benign growths (polyps) in the digestive tract. It is also associated with the development of pigmented spots on the skin and mucous membranes. The skin rash, glycosuria, and ethylmalonic aciduria you have described are not typically associated with this condition.

+6. Zellweger Syndrome: This is a rare genetic disorder that affects the development of the brain, liver, and kidneys. It is characterized by a number of symptoms including feeding difficulties, seizures, and developmental delays. The skin rash, glycosuria, and ethylmalonic aciduria you have described are not typically associated with this condition.

I hope this information is helpful. It is important to note that this is just a list of potential diseases based on the symptoms you have provided, and further testing would be needed to make a definitive diagnosis."
['Carbamoyl-phosphate synthetase 1 deficiency']," Based on the symptoms you have provided, here are some potential diseases:

+1. Urea Cycle Disorders (UCDs): UCDs are a group of genetic disorders that affect the body's ability to remove ammonia from the blood. Symptoms can include hyperammonemia, cerebral edema, seizures, and death in infancy. However, UCDs do not typically cause cyanosis, fasciculations, or oroticaciduria.

+2. Maple Syrup Urine Disease (MSUD): MSUD is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include seizures, hyperammonemia, and neonatal death. However, MSUD does not typically cause cyanosis, fasciculations, or oroticaciduria.

+3. Citrullinemia: Citrullinemia is a genetic disorder that affects the body's ability to remove ammonia from the blood. Symptoms can include hyperammonemia, cerebral edema, seizures, and neonatal death. However, citrullinemia does not typically cause cyanosis, fasciculations, or oroticaciduria.

+4. Argininosuccinic Aciduria (ASA): ASA is a genetic disorder that affects the body's ability to remove ammonia from the blood. Symptoms can include hyperammonemia, cerebral edema, seizures, and neonatal death. However, ASA does not typically cause cyanosis, fasciculations, or oroticaciduria.

+5. Homocystinuria: Homocystinuria is a genetic disorder that affects the body's ability to process the amino acid methionine. Symptoms can include seizures, hypoargininemia, and death in infancy. However, homocystinuria does not typically cause cyanosis, fasciculations, or oroticaciduria.

+6. Nonketotic Hyperglycinemia (NKH): NKH is a genetic disorder that affects the body's ability to break down the amino acid glycine. Symptoms can include seizures, hypotonia, and developmental delays. However, NKH does not typically cause cyanosis, fasciculations, or oroticaciduria.

+7. Pyridoxine-Dependent Epilepsy (PDE): PDE is a genetic disorder that affects the body's ability to process the vitamin pyridoxine (also known as vitamin B6). Symptoms can include seizures and developmental delays. However, PDE does not typically cause cyanosis, fasciculations, or oroticaciduria.

It is important to note that these are potential diagnoses based on the symptoms you have provided, and further testing would be needed to confirm any diagnosis. Additionally, some of these disorders may have overlapping symptoms, and it is possible that a patient may have multiple conditions."
['Canavan disease']," Based on the symptoms you have provided, here are some potential diseases:

+1. Urea Cycle Disorders (UCDs): Hyperammonemia, Neonatal death, Aminoaciduria, Abnormal circulating glycine concentration, Abnormal circulating aspartate family amino acid concentration. UCDs are a group of genetic disorders that affect the body's ability to remove ammonia from the blood. Symptoms can include vomiting, seizures, and developmental delays.

+2. Erythrodermic Psoriasis: Skin rash, Erythematous plaque, Erythematous macule, Erythematous papule. Erythrodermic psoriasis is a rare and severe form of psoriasis that affects the entire body. Symptoms can include redness, itching, and skin shedding.

+3. Dravet Syndrome: Seizure, Death in infancy. Dravet syndrome is a rare and severe form of epilepsy that begins in the first year of life. Symptoms can include prolonged seizures, developmental delays, and behavioral problems.

+4. Maple Syrup Urine Disease (MSUD): Hyperammonemia, Aminoaciduria, Abnormal circulating glycine concentration, Abnormal circulating aspartate family amino acid concentration. MSUD is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms can include sweet-smelling urine, vomiting, and seizures.

+5. Neonatal Lupus: Skin rash, Neonatal death. Neonatal lupus is a rare condition that affects newborns of mothers with lupus. Symptoms can include a skin rash, anemia, and liver problems.

It is important to note that this is not an exhaustive list and further testing and evaluation by a healthcare professional is necessary to make a definitive diagnosis."
['Maple syrup urine disease']," Based on the symptoms you have provided, here are some potential diseases that the patient may have:

+1. Maple Syrup Urine Disease: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms can include seizures, respiratory insufficiency, opisthotonus, and feeding difficulties. However, this disease does not typically cause death in infancy or neonatal death.

+2. Nonketotic Hyperglycinemia: This is a genetic disorder that affects the metabolism of the amino acid glycine. Symptoms can include seizures, respiratory insufficiency, opisthotonus, and feeding difficulties. However, this disease does not typically cause hypervalinemia, hyperleucinemia, or hyperisoleucinemia.

+3. Phenylketonuria (PKU): This is a genetic disorder that affects the metabolism of the amino acid phenylalanine. Symptoms can include seizures, respiratory insufficiency, and feeding difficulties. However, this disease does not typically cause death in infancy, neonatal death, or hypervalinemia, hyperleucinemia, or hyperisoleucinemia.

+4. Homocystinuria: This is a genetic disorder that affects the metabolism of the amino acid methionine. Symptoms can include seizures, respiratory insufficiency, and feeding difficulties. However, this disease does not typically cause death in infancy, neonatal death, or hypervalinemia, hyperleucinemia, or hyperisoleucinemia.

+5. Isovaleric Acidemia: This is a genetic disorder that affects the metabolism of the amino acid leucine. Symptoms can include seizures, respiratory insufficiency, opisthotonus, and feeding difficulties. However, this disease does not typically cause death in infancy, neonatal death, or hypervalinemia, hyperleucinemia, or hyperisoleucinemia.

+6. Glutaric Acidemia Type I: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms can include seizures, respiratory insufficiency, opisthotonus, and feeding difficulties. However, this disease does not typically cause death in infancy, neonatal death, or hypervalinemia, hyperleucinemia, or hyperisoleucinemia.

+7. Methylmalonic Acidemia: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms can include seizures, respiratory insufficiency, and feeding difficulties. However, this disease does not typically cause death in infancy, neonatal death, or hypervalinemia, hyperleucinemia, or hyperisoleucinemia.

+8. Propionic Acidemia: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms can include seizures, respiratory insufficiency, opisthotonus, and feeding difficulties. However, this disease does not typically cause death in infancy, neonatal death, or hypervalinemia, hyperleucinemia, or hyperisoleucinemia.

It is important to note that these are potential diseases based on the symptoms provided, and further testing would be needed to confirm a diagnosis. Additionally, some of these diseases"
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Trisomy 13: Also known as Patau syndrome, this genetic disorder is characterized by abnormalities in prenatal development, including intellectual disability, physical abnormalities, and organ defects. However, it does not typically cause obesity or abnormal carnitine or 3-hydroxyacyl-CoA dehydrogenase levels.

+2. Prader-Willi Syndrome: This genetic disorder is characterized by obesity, intellectual disability, and abnormal muscle tone. It can also cause short stature, small hands and feet, and distinctive facial features. However, it does not typically cause abnormal prenatal development, neonatal or childhood death, or abnormal carnitine or 3-hydroxyacyl-CoA dehydrogenase levels.

+3. Zellweger Syndrome: This genetic disorder affects the body's ability to metabolize certain fats and can cause abnormal prenatal development, intellectual disability, physical abnormalities, and liver and kidney problems. It can also cause decreased levels of 3-hydroxyacyl-CoA dehydrogenase. However, it does not typically cause obesity or abnormal carnitine levels.

+4. Medium-chain acyl-CoA dehydrogenase deficiency (MCAD): This genetic disorder affects the body's ability to metabolize certain fats and can cause hypoglycemia, lethargy, and seizures, especially during periods of fasting or illness. It can also cause decreased levels of 3-hydroxyacyl-CoA dehydrogenase and abnormal carnitine levels. However, it does not typically cause abnormal prenatal development, obesity, or neonatal or childhood death.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing and evaluation may be necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'], +1
['Wilson disease']," +1. Wilson's disease: The patient has splenomegaly, hepatomegaly, elevated circulating hepatic transaminase concentration, decreased circulating ceruloplasmin concentration, increased urinary copper concentration, copper accumulation in liver. The patient does not have death in childhood or adolescence.

+2. Hepatitis: The patient has splenomegaly, hepatomegaly, elevated circulating hepatic transaminase concentration. The patient does not have death in childhood or adolescence, decreased circulating ceruloplasmin concentration, increased urinary copper concentration, copper accumulation in liver.

+3. Menkes disease: The patient has generalized hypotonia, decreased circulating copper concentration, abnormal circulating aspartate family amino acid concentration, abnormal circulating alanine concentration, copper accumulation in liver. The patient does not have death in childhood or adolescence, splenomegaly, hepatomegaly, elevated circulating hepatic transaminase concentration, decreased circulating ceruloplasmin concentration, increased urinary copper concentration.

+4. Cirrhosis: The patient has splenomegaly, hepatomegaly, elevated circulating hepatic transaminase concentration, and may have decreased circulating ceruloplasmin concentration, increased urinary copper concentration, copper accumulation in liver. The patient does not have death in childhood or adolescence, generalized hypotonia.

+5. Hemochromatosis: The patient has hepatomegaly, elevated circulating hepatic transaminase concentration, and may have decreased circulating ceruloplasmin concentration, increased urinary copper concentration, copper accumulation in liver. The patient does not have death in childhood or adolescence, generalized hypotonia, splenomegaly.

+6. Alpha-1 antitrypsin deficiency: The patient has hepatomegaly, elevated circulating hepatic transaminase concentration, and may have decreased circulating ceruloplasmin concentration, increased urinary copper concentration, copper accumulation in liver. The patient does not have death in childhood or adolescence, generalized hypotonia, splenomegaly.

It's important to note that these are potential diagnoses based on the symptoms provided and further testing would be needed to confirm any diagnosis."
['PMM2-CDG']," Based on the symptoms you have provided, here are some potential diseases that the patient may have:

+1. Congenital Fiber Type Disproportion (CFTD)::
The patient has generalized hypotonia and cerebellar atrophy, which are common symptoms of CFTD. However, the patient does not have respiratory distress or feeding difficulties, which are also common symptoms of CFTD.

+2. Joubert Syndrome::
The patient has cerebellar atrophy and intellectual disability, which are common symptoms of Joubert Syndrome. However, the patient does not have the characteristic ""molar tooth sign"" on brain imaging, which is a hallmark of Joubert Syndrome.

+3. Pelizaeus-Merzbacher Disease (PMD)::
The patient has cerebellar atrophy and ataxia, which are common symptoms of PMD. However, the patient does not have nystagmus or tremors, which are also common symptoms of PMD.

+4. Pontocerebellar Hypoplasia (PCH)::
The patient has cerebellar atrophy, intellectual disability, and generalized hypotonia, which are common symptoms of PCH. However, the patient does not have microcephaly or seizures, which are also common symptoms of PCH.

+5. Cohen Syndrome::
The patient has strabismus and intellectual disability, which are common symptoms of Cohen Syndrome. However, the patient does not have retinal dystrophy or intermittent neutropenia, which are also common symptoms of Cohen Syndrome.

+6. Marinesco-Sjgren Syndrome::
The patient has cerebellar atrophy, intellectual disability, and generalized hypotonia, which are common symptoms of Marinesco-Sjgren Syndrome. However, the patient does not have cataracts or hypoparathyroidism, which are also common symptoms of Marinesco-Sjgren Syndrome.

+7. Ataxia Telangiectasia (AT)::
The patient has ataxia and cerebellar atrophy, which are common symptoms of AT. However, the patient does not have oculocutaneous telangiectasia or immunodeficiency, which are also common symptoms of AT.

These are just a few potential diseases that the patient may have, and further testing and evaluation would be needed to make a definitive diagnosis. It is important to note that many of these diseases have overlapping symptoms, and a patient may have features of multiple different diseases."
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms include abnormality of prenatal development or birth, hyperphenylalaninemia, and if left untreated, can lead to death in infancy or adolescence. However, this disorder does not typically cause neonatal death.

+2. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include abnormality of prenatal development or birth, hyperphenylalaninemia, and if left untreated, can lead to death in infancy or adolescence. However, this disorder does not typically cause neonatal death or hypertyrosinemia.

+3. Homocystinuria: This is a genetic disorder that affects the body's ability to process the amino acid methionine. Symptoms include abnormality of prenatal development or birth, hyperphenylalaninemia, and if left untreated, can lead to death in infancy or adolescence. However, this disorder does not typically cause neonatal death or hypertyrosinemia.

+4. Tyrosinemia type I: This is a genetic disorder that affects the body's ability to process the amino acid tyrosine. Symptoms include abnormality of prenatal development or birth, hypertyrosinemia, and if left untreated, can lead to death in infancy or adolescence. However, this disorder does not typically cause neonatal death or hyperphenylalaninemia.

+5. Nonketotic hyperglycinemia: This is a genetic disorder that affects the body's ability to break down the amino acid glycine. Symptoms include abnormality of prenatal development or birth, and if left untreated, can lead to death in infancy. However, this disorder does not typically cause hypertyrosinemia, hyperphenylalaninemia, neonatal death or death in adolescence.

It is important to note that these are only potential diagnoses based on the symptoms provided and further testing would be needed to confirm any diagnosis."
['Glutaryl-CoA dehydrogenase deficiency']," +1. Megalencephaly-capillary malformation syndrome: The patient has macrocephaly and abnormal cerebral morphology. However, this syndrome does not typically present with generalized hypotonia, death in infancy, increased circulating lactate concentration, hypercalcemia, glutaric aciduria, abnormal circulating lysine concentration, or abnormal circulating carnitine concentration.

+2. Alexander disease: The patient has macrocephaly and abnormal cerebral morphology. However, this disease does not typically present with generalized hypotonia, death in infancy, increased circulating lactate concentration, hypercalcemia, glutaric aciduria, abnormal circulating lysine concentration, or abnormal circulating carnitine concentration.

+3. Canavan disease: The patient has macrocephaly and abnormal cerebral morphology. However, this disease does not typically present with generalized hypotonia, death in infancy, increased circulating lactate concentration, hypercalcemia, glutaric aciduria, abnormal circulating lysine concentration, or abnormal circulating carnitine concentration.

+4. Glutaric acidemia type I: The patient has increased circulating lactate concentration and abnormal circulating lysine concentration. However, this disease does not typically present with macrocephaly, generalized hypotonia, death in infancy, hypercalcemia, glutaric aciduria, or abnormal circulating carnitine concentration.

+5. Carnitine transporter deficiency: The patient has abnormal circulating carnitine concentration. However, this disease does not typically present with macrocephaly, generalized hypotonia, death in infancy, increased circulating lactate concentration, hypercalcemia, glutaric aciduria, or abnormal circulating lysine concentration.

+6. Hypercalcemia of infancy: The patient has hypercalcemia. However, this condition does not typically present with macrocephaly, generalized hypotonia, death in infancy, increased circulating lactate concentration, glutaric aciduria, abnormal circulating lysine concentration, or abnormal circulating carnitine concentration.

+7. Lactic acidosis: The patient has increased circulating lactate concentration. However, this condition does not typically present with macrocephaly, generalized hypotonia, death in infancy, hypercalcemia, glutaric aciduria, abnormal circulating lysine concentration, or abnormal circulating carnitine concentration.

It is important to note that this is not an exhaustive list of potential diagnoses and that further evaluation and testing would be necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, PKU does not typically cause death in infancy or childhood.

+2. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, MSUD does not typically cause death in infancy or childhood.

+3. Homocystinuria: This is a genetic disorder that affects the body's ability to process the amino acid methionine. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, homocystinuria does not typically cause death in infancy or childhood.

+4. Tyrosinemia type I: This is a genetic disorder that affects the body's ability to break down the amino acid tyrosine. Symptoms include abnormality of prenatal development or birth, neonatal death, hyperphenylalaninemia, and hypertyrosinemia. However, tyrosinemia type I does not typically cause death in childhood.

+5. Isovaleric acidemia: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, isovaleric acidemia does not typically cause hypertyrosinemia or death in infancy or childhood.

It is important to note that these are just potential diagnoses based on the symptoms provided. Further testing and evaluation would be necessary to confirm any diagnosis."
['Phenylketonuria']," +1. Primary Microcephaly: The patient has Microcephaly, which is a primary symptom of this disease. However, the patient does not show any other specific symptoms associated with Primary Microcephaly.

+2. Patau Syndrome: The patient has Microcephaly and Abnormality of prenatal development or birth. Additionally, the patient has Small for gestational age and Neonatal death, which are common symptoms of Patau Syndrome.

+3. Edwards Syndrome: The patient has Abnormality of prenatal development or birth, Small for gestational age, Neonatal death, and Death in childhood. However, the patient does not have Microcephaly, which is not a common symptom of Edwards Syndrome.

+4. Down Syndrome: The patient has Abnormality of prenatal development or birth and Small for gestational age. However, the patient does not have Microcephaly, which is not a common symptom of Down Syndrome.

+5. Congenital Disorder of Glycosylation (CDG): The patient has Microcephaly, Abnormality of prenatal development or birth, and Severe short stature. However, the patient does not have Pericardial effusion, Pleural effusion, or Hypertyrosinemia, which are not common symptoms of CDG.

+6. Non-ketotic Hyperglycinemia: The patient has Microcephaly, Abnormality of prenatal development or birth, and Hypertyrosinemia. However, the patient does not have Pericardial effusion, Pleural effusion, Severe short stature, Neonatal death, or Death in childhood, which are not common symptoms of Non-ketotic Hyperglycinemia.

+7. Phenylketonuria (PKU): The patient has Hyperphenylalaninemia and Hypertyrosinemia. However, the patient does not have Microcephaly, Abnormality of prenatal development or birth, Pericardial effusion, Pleural effusion, Severe short stature, Neonatal death, or Death in childhood, which are not common symptoms of PKU.

+8. Maple Syrup Urine Disease (MSUD): The patient has Hypertyrosinemia. However, the patient does not have Microcephaly, Abnormality of prenatal development or birth, Pericardial effusion, Pleural effusion, Severe short stature, Neonatal death, or Death in childhood, which are not common symptoms of MSUD.

+9. Homocystinuria: The patient has Hypertyrosinemia. However, the patient does not have Microcephaly, Abnormality of prenatal development or birth, Pericardial effusion, Pleural effusion, Severe short stature, Neonatal death, or Death in childhood, which are not common symptoms of Homocystinuria.

+10. Isovaleric Acidemia: The patient has Hypertyrosinemia. However, the patient does not have Microcephaly, Abnormality of prenatal development or birth, Pericardial effusion, Pleural effusion, Severe short stature, Neonatal death, or Death in childhood, which are not common symptoms of Isovaleric Acidemia.

+11. Glutaric Acidemia Type I: The patient has Hypertyrosinemia. However, the patient does not have Microceph"
['Ornithine transcarbamylase deficiency']," +1. Hyperammonemia: This condition is characterized by an excess of ammonia in the blood. The patient has this symptom.

+2. Hyperglutaminemia: This is a condition where there are high levels of glutamine in the blood. The patient has this symptom.

+3. Oroticaciduria: This is a rare genetic disorder that affects the body's ability to process certain proteins and nucleotides, resulting in an increased excretion of orotic acid in the urine. The patient has this symptom.

+4. Urea Cycle Disorders: This is a group of genetic disorders that affect the body's ability to remove ammonia from the blood. The patient has Hyperammonemia which is a symptom of this disorder.

+5. Organic Acidemias: This is a group of genetic disorders that affect the body's ability to break down certain amino acids and proteins. The patient has Oroticaciduria which is a symptom of this disorder.

+6. Maple Syrup Urine Disease: This is a genetic disorder that affects the body's ability to break down certain amino acids. The patient does not have this symptom.

+7. Homocystinuria: This is a genetic disorder that affects the body's ability to process the amino acid methionine. The patient does not have this symptom.

+8. Phenylketonuria (PKU): This is a genetic disorder that affects the body's ability to process the amino acid phenylalanine. The patient does not have this symptom.

+9. Isovaleric Acidemia: This is a genetic disorder that affects the body's ability to break down certain amino acids. The patient does not have this symptom.

+10. Glutaric Acidemia Type I: This is a genetic disorder that affects the body's ability to break down certain amino acids. The patient does not have this symptom.

+11. Tyrosinemia Type I: This is a genetic disorder that affects the body's ability to process the amino acid tyrosine. The patient does not have this symptom.

+12. Methylmalonic Acidemia: This is a genetic disorder that affects the body's ability to process certain proteins and amino acids. The patient does not have this symptom.

+13. Propionic Acidemia: This is a genetic disorder that affects the body's ability to process certain proteins and amino acids. The patient does not have this symptom.

+14. Citrullinemia: This is a genetic disorder that affects the body's ability to process certain amino acids. The patient does not have this symptom.

+15. Argininosuccinic Aciduria: This is a genetic disorder that affects the body's ability to process certain amino acids. The patient does not have this symptom.

+16. Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome: This is a genetic disorder that affects the body's ability to process certain amino acids. The patient has Hyperammonemia which is a symptom of this disorder.

+17. N-Acetylglutamate Synthase (NAGS) Deficiency: This is a genetic disorder that affects the"
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder that affects the metabolism of an amino acid called phenylalanine. Symptoms include abnormality of prenatal development or birth, obesity, hyperphenylalaninemia, and abnormal circulating tyrosine concentration. However, PKU does not typically cause death in infancy, neonatal death, elevated urinary carboxylic acid, or death in early adulthood.

+2. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include abnormality of prenatal development or birth, elevated urinary carboxylic acid, and hyperphenylalaninemia. However, MSUD does not typically cause obesity, death in infancy, neonatal death, or death in early adulthood.

+3. Homocystinuria: This is a genetic disorder that affects the metabolism of the amino acid methionine. Symptoms include obesity, hyperphenylalaninemia, and abnormal circulating tyrosine concentration. However, homocystinuria does not typically cause abnormality of prenatal development or birth, death in infancy, neonatal death, or elevated urinary carboxylic acid.

+4. Tyrosinemia type I: This is a genetic disorder that affects the metabolism of the amino acid tyrosine. Symptoms include hyperphenylalaninemia, abnormal circulating tyrosine concentration, and elevated urinary carboxylic acid. However, tyrosinemia type I does not typically cause abnormality of prenatal development or birth, obesity, death in infancy, or neonatal death.

+5. Trimethylaminuria: This is a genetic disorder that affects the metabolism of the amino acid choline. Symptoms include abnormal circulating tyrosine concentration and elevated urinary carboxylic acid. However, trimethylaminuria does not typically cause abnormality of prenatal development or birth, obesity, death in infancy, neonatal death, or hyperphenylalaninemia.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing and evaluation would be necessary to confirm any diagnosis. Additionally, some of these symptoms can be caused by a variety of factors, and not all cases of these symptoms are due to the specific genetic disorders listed."
['Pearson syndrome']," Based on the symptoms you have provided, I will list some potential diseases that could match. Please note that this is not a definitive diagnosis and further testing would be needed to confirm.

+1. Mitochondrial disorders: A group of diseases caused by dysfunction of the mitochondria, the energy-producing structures in cells. Symptoms can include lethargy, coma, hypoglycemia, increased circulating lactate concentration, and death in infancy or childhood.

+2. Zellweger syndrome: A rare genetic disorder affecting the development of the brain, eyes, liver, and kidneys. Symptoms can include enlarged kidney, lethargy, coma, generalized hypotonia, death in infancy, and characteristic facial features.

+3. Fanconi anemia: A genetic disorder that affects the bone marrow, leading to decreased production of all types of blood cells. Symptoms can include thrombocytopenia, neutropenia, anemia, and increased susceptibility to infections.

+4. Maple syrup urine disease: A genetic disorder affecting the metabolism of certain amino acids. Symptoms can include lethargy, coma, hypoglycemia, increased circulating lactate concentration, and abnormal circulating monocarboxylic acid concentration.

+5. Nephrotic syndrome: A group of disorders that cause the kidneys to leak large amounts of protein into the urine. Symptoms can include enlarged kidney, hypoglycemia, and chronic kidney disease.

+6. Medullary cystic kidney disease: A genetic disorder affecting the kidneys, characterized by the formation of cysts in the medulla of the kidneys. Symptoms can include enlarged kidney, chronic kidney disease, and increased circulating lactate concentration.

+7. Pearson syndrome: A rare genetic disorder affecting the mitochondria and bone marrow. Symptoms can include lethargy, coma, generalized hypotonia, anemia, thrombocytopenia, neutropenia, and death in infancy or childhood.

+8. Carnitine palmitoyltransferase II deficiency: A genetic disorder affecting the metabolism of fatty acids. Symptoms can include lethargy, coma, generalized hypotonia, hypoglycemia, increased circulating lactate concentration, decreased plasma free carnitine, and abnormal circulating monocarboxylic acid concentration.

+9. Pyruvate dehydrogenase deficiency: A genetic disorder affecting the metabolism of pyruvate. Symptoms can include lethargy, coma, hypoglycemia, increased circulating lactate concentration, and increased serum pyruvate.

+10. Lowe syndrome: A genetic disorder affecting the eyes, brain, and kidneys. Symptoms can include ptosis, photophobia, congestive heart failure, exocrine pancreatic insufficiency, and renal Fanconi syndrome.

Please note that this is not an exhaustive list and further testing would be needed to confirm a diagnosis."
['Smith-Lemli-Opitz syndrome']," Based on the symptoms you have provided, here are some potential diseases that the patient may have:

+1. Smith-Lemli-Opitz syndrome: This is a genetic disorder that affects the metabolism of cholesterol. The symptoms include a broad philtrum, anteverted nares, syndactyly, generalized hypotonia, feeding difficulties, and elevated circulating 7-dehydrocholesterol concentration. However, this condition does not typically cause death in infancy or neonatal death.

+2. CHARGE syndrome: This is a genetic disorder that affects multiple organ systems. The symptoms include a broad philtrum, anteverted nares, generalized hypotonia, feeding difficulties, and sometimes syndactyly. However, this condition does not typically cause death in infancy or neonatal death, and it does not cause elevated circulating 7-dehydrocholesterol concentration.

+3. Down syndrome: This is a genetic disorder caused by an extra copy of chromosome 21. The symptoms include a broad philtrum, hypotonia, and feeding difficulties. However, this condition does not typically cause death in infancy or neonatal death, and it does not cause elevated circulating 7-dehydrocholesterol concentration or syndactyly.

+4. Fetal alcohol syndrome: This is a condition that can occur in a fetus if the mother drinks alcohol during pregnancy. The symptoms include a long philtrum, anteverted nares, hypotonia, and feeding difficulties. However, this condition does not typically cause death in infancy or neonatal death, and it does not cause elevated circulating 7-dehydrocholesterol concentration or syndactyly.

+5. Zellweger syndrome: This is a rare genetic disorder that affects the metabolism of fats. The symptoms include a broad philtrum, hypotonia, feeding difficulties, and neonatal death. However, this condition does not typically cause death in infancy, and it does not cause elevated circulating 7-dehydrocholesterol concentration or syndactyly.

+6. Smith-McCort dysplasia: This is a rare genetic disorder that affects the development of bones and cartilage. The symptoms include a broad philtrum, hypotonia, and feeding difficulties. However, this condition does not typically cause death in infancy or neonatal death, and it does not cause elevated circulating 7-dehydrocholesterol concentration or syndactyly.

Please note that this is not an exhaustive list of potential diagnoses, and further testing and evaluation may be necessary to determine the underlying cause of the patient's symptoms."
['Acute intermittent porphyria']," +1. Food poisoning: The patient has vomiting and abdominal pain, which are common symptoms of food poisoning. However, food poisoning usually does not cause death in childhood or recurrent viral infections.

+2. Gastroenteritis: The patient has vomiting and abdominal pain, which are common symptoms of gastroenteritis. However, gastroenteritis does not typically cause death in childhood or recurrent viral infections.

+3. Inflammatory bowel disease (IBD): The patient has vomiting and abdominal pain, which can be symptoms of IBD. However, IBD does not typically cause death in childhood or recurrent viral infections.

+4. Intestinal obstruction: The patient has vomiting and abdominal pain, which are common symptoms of intestinal obstruction. However, intestinal obstruction does not typically cause death in childhood or recurrent viral infections.

+5. Meckel's diverticulum: The patient has vomiting and abdominal pain, which can be symptoms of Meckel's diverticulum. However, Meckel's diverticulum does not typically cause death in childhood or recurrent viral infections.

+6. Appendicitis: The patient has vomiting and abdominal pain, which are common symptoms of appendicitis. However, appendicitis does not typically cause death in childhood or recurrent viral infections.

+7. Intussusception: The patient has vomiting and abdominal pain, which are common symptoms of intussusception. However, intussusception does not typically cause death in childhood or recurrent viral infections.

+8. Hirschsprung's disease: The patient has vomiting and abdominal pain, which can be symptoms of Hirschsprung's disease. However, Hirschsprung's disease does not typically cause death in childhood or recurrent viral infections.

+9. Celiac disease: The patient has vomiting and abdominal pain, which can be symptoms of celiac disease. However, celiac disease does not typically cause death in childhood or recurrent viral infections.

+10. Cystic fibrosis: The patient does not have any symptoms that are typically associated with cystic fibrosis.

+11. Primary immunodeficiency: The patient has recurrent viral infections, which can be a symptom of primary immunodeficiency. However, primary immunodeficiency does not typically cause vomiting, abdominal pain, or death in childhood.

+12. Acute lymphoblastic leukemia (ALL): The patient does not have any symptoms that are typically associated with ALL.

+13. Hodgkin's lymphoma: The patient does not have any symptoms that are typically associated with Hodgkin's lymphoma.

+14. Non-Hodgkin's lymphoma: The patient does not have any symptoms that are typically associated with non-Hodgkin's lymphoma.

+15. Burkitt's lymphoma: The patient does not have any symptoms that are typically associated with Burkitt's lymphoma.

+16. Wilms' tumor: The patient does not have any symptoms that are typically associated with Wilms' tumor.

+17. Neuroblastoma: The patient does not have any symptoms that are typically associated with neuroblastoma.

+"
['Citrullinemia type I']," Based on the symptoms you have provided, here are some potential diseases:

+1. Citrullinemia Type I: This is a genetic disorder caused by a deficiency of the enzyme argininosuccinate synthetase. The disease can present in infancy or childhood and is characterized by hyperammonemia, metabolic acidosis, and elevated plasma citrulline. Other symptoms can include death in infancy, hyperglutaminemia, and hyperglycinuria.

+2. Citrullinemia Type II: This is a genetic disorder caused by a deficiency of the enzyme argininosuccinate lyase. The disease can present in infancy or childhood and is characterized by hyperammonemia, metabolic acidosis, and elevated plasma citrulline. Other symptoms can include neonatal death, hyperglutaminemia, and hyperglycinuria.

+3. Argininosuccinic aciduria: This is a genetic disorder caused by a deficiency of the enzyme argininosuccinate lyase. The disease can present in infancy or childhood and is characterized by hyperammonemia, metabolic acidosis, and elevated plasma citrulline. Other symptoms can include neonatal death, hyperglutaminemia, and hyperglycinuria.

Based on the symptoms you have provided, here are some potential diseases:

+1. Citrullinemia Type I: This is a genetic disorder caused by a deficiency of the enzyme argininosuccinate synthetase. The disease can present in infancy or childhood and is characterized by hyperammonemia, metabolic acidosis, and elevated plasma citrulline. Other symptoms can include death in infancy, hyperglutaminemia, and hyperglycinuria.

+2. Citrullinemia Type II: This is a genetic disorder caused by a deficiency of the enzyme argininosuccinate lyase. The disease can present in infancy or childhood and is characterized by hyperammonemia, metabolic acidosis, and elevated plasma citrulline. Other symptoms can include neonatal death, hyperglutaminemia, and hyperglycinuria.

+3. Argininosuccinic aciduria: This is a genetic disorder caused by a deficiency of the enzyme argininosuccinate lyase. The disease can present in infancy or childhood and is characterized by hyperammonemia, metabolic acidosis, and elevated plasma citrulline. Other symptoms can include neonatal death, hyperglutaminemia, and hyperglycinuria.

Based on the symptoms you have provided, here are some potential diseases:

+1. Citrullinemia Type I: This is a genetic disorder caused by a deficiency of the enzyme argininosuccinate synthetase. The disease can present in infancy or childhood and is characterized by hyperammonemia, metabolic acidosis, and elevated plasma citrulline. Other symptoms can include death in infancy, hyperglutaminemia, and hyperglycinuria.

+2. Citrullinemia Type II: This is a genetic disorder caused by a deficiency of the enzyme argininosuccinate lyase. The disease can present in infancy or childhood and is characterized by hyperammonemia, metabolic acidosis, and elevated plasma citrulline. Other symptoms can include neonatal death, hyperglut"
[]," Based on the symptoms you have provided, I will list some potential diseases that could match. Please note that this is not a definitive diagnosis and medical examination and testing are necessary for accurate diagnosis.

1. + Pitt-Hopkins syndrome: Delayed speech and language development, generalized hypotonia, and possible death in infancy. However, this syndrome does not typically present with dehydration, hyperammonemia, hyperhomocystinemia, or methylmalonic acidemia.
2. + Prader-Willi syndrome: Delayed speech and language development, generalized hypotonia, lethargy, and possible death in infancy. However, this syndrome does not typically present with dehydration, hyperammonemia, hyperhomocystinemia, methylmalonic acidemia, or methylmalonic aciduria.
3. + Nonketotic hyperglycinemia: Delayed speech and language development, lethargy, generalized hypotonia, and possible death in infancy. This disorder can also present with hyperammonemia and drowsiness. However, it does not typically present with dehydration, hyperhomocystinemia, or methylmalonic acidemia.
4. + Maple syrup urine disease: Delayed speech and language development, lethargy, generalized hypotonia, and possible death in infancy. This disorder can also present with dehydration, hyperammonemia, and methylmalonic acidemia. However, it does not typically present with hyperhomocystinemia.
5. + Methylmalonic acidemia: Delayed speech and language development, lethargy, generalized hypotonia, dehydration, hyperammonemia, methylmalonic acidemia, and methylmalonic aciduria. However, this disorder does not typically present with hyperhomocystinemia.
6. + Homocystinuria: Delayed speech and language development, lethargy, generalized hypotonia, hyperhomocystinemia, and possible death in infancy. However, this disorder does not typically present with dehydration, hyperammonemia, or methylmalonic acidemia.

Again, this is not a definitive diagnosis and medical examination and testing are necessary for accurate diagnosis."
['Very long chain acyl-CoA dehydrogenase deficiency']," Based on the symptoms you have provided, I will list some potential diseases that the patient may have. Please note that this is not a definitive diagnosis and medical tests are required to confirm the presence of any disease.

1. +1 Citrullinemia: This is a genetic disorder caused by a deficiency of the enzyme argininosuccinate synthetase. Symptoms include hyperammonemia, lethargy, poor feeding, vomiting, and developmental delay. The patient does not have decreased plasma free carnitine or abnormal circulating aspartate family amino acid concentration.
2. +2 Argininosuccinic aciduria: This is a genetic disorder caused by a deficiency of the enzyme argininosuccinate lyase. Symptoms include hyperammonemia, lethargy, poor feeding, vomiting, seizures, and developmental delay. The patient does not have decreased plasma free carnitine or abnormal circulating aspartate family amino acid concentration.
3. +3 Maple syrup urine disease: This is a genetic disorder caused by a deficiency of the enzyme branched-chain keto acid dehydrogenase. Symptoms include hyperammonemia, lethargy, poor feeding, vomiting, maple syrup odor in urine, and developmental delay. The patient does not have decreased plasma free carnitine or abnormal circulating aspartate family amino acid concentration.
4. +4 Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: This is a genetic disorder caused by a deficiency of the enzyme ornithine translocase. Symptoms include hyperammonemia, lethargy, poor feeding, vomiting, seizures, and developmental delay. The patient does not have decreased plasma free carnitine or abnormal circulating aspartate family amino acid concentration.
5. +5 Isovaleric acidemia: This is a genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. Symptoms include hyperammonemia, lethargy, poor feeding, vomiting, seizures, and developmental delay. The patient does not have decreased plasma free carnitine or abnormal circulating aspartate family amino acid concentration.
6. +6 Glutaric acidemia type I: This is a genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. Symptoms include hyperammonemia, lethargy, poor feeding, vomiting, seizures, and developmental delay. The patient does not have decreased plasma free carnitine or abnormal circulating aspartate family amino acid concentration.
7. +7 Carnitine palmitoyltransferase II (CPT II) deficiency: This is a genetic disorder caused by a deficiency of the enzyme carnitine palmitoyltransferase II. Symptoms include hypotonia, lethargy, poor feeding, vomiting, seizures, and developmental delay. The patient has decreased plasma free carnitine and abnormal circulating creatine kinase concentration.
8. +8 Mitochondrial disorders: This is a group of genetic disorders caused by defects in the mitochondria, the energy-producing structures in cells. Symptoms include hypotonia, lethargy, poor feeding, vomiting, seizures, and developmental delay. The patient does not"
['Phenylketonuria']," +1. Trisomy 13 (Patau Syndrome): This is a genetic disorder caused by the presence of all or part of a third copy of chromosome 13. It can result in abnormalities of prenatal development or birth, including severe intellectual disability and physical abnormalities. However, it typically does not cause upper airway obstruction or hyperphenylalaninemia.

+2. Trisomy 18 (Edwards Syndrome): This is a genetic disorder caused by the presence of all or part of a third copy of chromosome 18. It can result in abnormalities of prenatal development or birth, including severe intellectual disability and physical abnormalities. It can also cause neonatal death and hyperphenylalaninemia, but it typically does not cause upper airway obstruction.

+3. Trisomy 21 (Down Syndrome): This is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It can result in abnormalities of prenatal development or birth, including intellectual disability and physical abnormalities. However, it typically does not cause upper airway obstruction, hyperphenylalaninemia, or neonatal death.

+4. Pierre Robin Sequence: This is a congenital condition characterized by a small lower jaw and a tongue that falls back in the throat, causing upper airway obstruction. It can also result in abnormalities of prenatal development or birth. However, it typically does not cause hyperphenylalaninemia or neonatal death.

+5. Phenylketonuria (PKU): This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, which leads to an accumulation of the amino acid phenylalanine in the body. This can result in hyperphenylalaninemia, intellectual disability, and other neurological problems. However, it typically does not cause abnormalities of prenatal development or birth, upper airway obstruction, or neonatal death.

+6. Cystic Fibrosis: This is a genetic disorder that affects the respiratory, digestive, and reproductive systems. It can result in chronic pulmonary obstruction, recurrent respiratory infections, and difficulty gaining weight. However, it typically does not cause abnormalities of prenatal development or birth, upper airway obstruction, hyperphenylalaninemia, or neonatal death.

+7. Congenital Diaphragmatic Hernia: This is a birth defect in which the diaphragm does not form properly, allowing the abdominal organs to move into the chest and causing upper airway obstruction. It can also result in abnormalities of prenatal development or birth and neonatal death. However, it typically does not cause hyperphenylalaninemia.

+8. Mucopolysaccharidosis: This is a group of genetic disorders caused by the absence or malfunctioning of enzymes needed to break down complex sugars called mucopolysaccharides. These disorders can result in a variety of symptoms, including abnormalities of prenatal development or birth, intellectual disability, physical abnormalities, and chronic pulmonary obstruction. However, they typically do not cause hyperphenylalaninemia or neonatal death.

+9. Neonatal Respiratory Distress Syndrome: This is a condition that affects"
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Metabolic disorder: This category of diseases includes problems with the body's ability to process nutrients properly. The patient's symptoms of decreased plasma free carnitine and decreased 3-hydroxyacyl-CoA dehydrogenase level suggest a possible metabolic disorder. However, the symptoms of spasticity, premature birth, ileus, neonatal death, and death in childhood suggest against this diagnosis.

+2. Iron deficiency anemia: This condition is caused by a lack of iron in the body, leading to a decrease in the production of red blood cells. The patient's symptom of decreased circulating ferritin concentration supports this diagnosis. However, the symptoms of spasticity, ileus, neonatal death, and death in childhood argue against this diagnosis.

+3. Sepsis: This is a serious infection that can lead to organ failure and death. The patient's symptom of hypoxemia supports this diagnosis. However, the symptoms of spasticity, premature birth, ileus, neonatal death, and death in childhood argue against this diagnosis.

+4. Congenital heart disease: This is a heart condition that is present at birth. The patient's symptom of hypoxemia supports this diagnosis. However, the symptoms of spasticity, premature birth, ileus, neonatal death, and death in childhood argue against this diagnosis.

+5. Respiratory distress syndrome: This is a condition that affects newborns and can cause difficulty breathing. The patient's symptom of hypoxemia supports this diagnosis. However, the symptoms of spasticity, premature birth, ileus, neonatal death, and death in childhood argue against this diagnosis.

+6. Inflammatory bowel disease: This is a group of conditions that cause inflammation in the digestive tract. The patient's symptom of ileus supports this diagnosis. However, the symptoms of spasticity, premature birth, neonatal death, and death in childhood argue against this diagnosis.

+7. Hypoxic-ischemic encephalopathy: This is a brain injury caused by a lack of oxygen to the brain. The patient's symptom of hypoxemia supports this diagnosis. However, the symptoms of spasticity, premature birth, ileus, neonatal death, and death in childhood argue against this diagnosis.

+8. Neonatal alloimmune thrombocytopenia: This is a condition that affects newborns and can cause bleeding due to a low platelet count. The patient's symptom of peritoneal effusion supports this diagnosis. However, the symptoms of spasticity, premature birth, ileus, neonatal death, and death in childhood argue against this diagnosis.

+9. Maple syrup urine disease: This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptom of decreased plasma free carnitine supports this diagnosis. However, the symptoms of spasticity, premature birth, ileus, neonatal death, and death in childhood argue against this diagnosis.

+10. Medium-chain acyl-CoA dehydrogenase deficiency: This is a genetic disorder that affects the body's ability to break down certain fats. The patient's symptom of decreased plasma free carnitine supports this diagnosis. However, the symptoms of spasticity, premature birth, ileus, neonatal death,"
['Phenylketonuria']," +1. Tyrosinemia type I: This is a genetic disorder caused by a deficiency of the enzyme fumarylacetoacetase, which is needed to break down the amino acid tyrosine. Symptoms can include death in infancy or childhood, hypertyrosinemia, and hyperphenylalaninemia. However, this disease would not explain the recurrent viral infections.

+2. Phenylketonuria (PKU): This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, which is needed to break down the amino acid phenylalanine. Symptoms can include hyperphenylalaninemia and can lead to intellectual disability if left untreated. However, PKU would not explain the death in infancy, childhood, or adolescence, or the recurrent viral infections.

+3. Primary Immunodeficiency Diseases (PIDDs): This is a group of disorders caused by genetic defects in the immune system. Symptoms can include recurrent viral infections. However, PIDDs would not explain the death in infancy, childhood, or adolescence, or the hypertyrosinemia and hyperphenylalaninemia.

+4. Liver failure: This can be caused by a variety of factors, including genetic disorders, infections, and exposure to toxins. Symptoms can include death in infancy, childhood, or adolescence. However, liver failure would not explain the hypertyrosinemia, hyperphenylalaninemia, or recurrent viral infections.

It is important to note that this is not an exhaustive list of potential diagnoses, and additional testing and evaluation would be necessary to confirm any of these diagnoses. Additionally, the patient's symptoms may be caused by a combination of different conditions. A healthcare professional should be consulted for further evaluation and treatment."
['3-methylcrotonyl-CoA carboxylase deficiency']," +1. Maple Syrup Urine Disease: This is a genetic disorder that affects the way the body breaks down certain amino acids (leucine, isoleucine, and valine). The disease gets its name from the characteristic sweet odor of the patient's urine. The symptoms you mentioned, aminoaciduria and elevated urinary carboxylic acid, align with this disease. However, death in infancy and abnormal circulating glycine concentration are not typically associated with Maple Syrup Urine Disease.

+2. Nonketotic Hyperglycinemia: This is a genetic disorder that affects the body's ability to break down the amino acid glycine. The symptom of abnormal circulating glycine concentration matches with this disease. However, death in infancy, aminoaciduria, and elevated urinary carboxylic acid are not typically associated with Nonketotic Hyperglycinemia.

+3. Isovaleric Acidemia: This is a genetic disorder that affects the body's ability to break down the amino acid leucine. The symptoms of aminoaciduria and elevated urinary carboxylic acid align with this disease. However, death in infancy and abnormal circulating glycine concentration are not typically associated with Isovaleric Acidemia.

Please note that these are potential diagnoses based on the symptoms you provided and further testing would be needed to confirm. It is also important to consider that these symptoms can be associated with other medical conditions and it is crucial to consult with a healthcare professional for an accurate diagnosis."
['Succinic semialdehyde dehydrogenase deficiency']," +1. Phenylketonuria (PKU): This is a genetic disorder in which the body cannot break down an amino acid called phenylalanine. Symptoms can include delayed speech and language development, motor delay, and generalized hypotonia. However, PKU does not typically cause hyperactivity, seizure, ataxia, or elevated urinary carboxylic acid.

+2. Maple syrup urine disease (MSUD): This is a genetic disorder in which the body cannot break down certain amino acids. Symptoms can include delayed speech and language development, motor delay, and elevated urinary carboxylic acid. However, MSUD does not typically cause hyperactivity, seizure, ataxia, or generalized hypotonia.

+3. Pelizaeus-Merzbacher disease (PMD): This is a genetic disorder that affects the nervous system and causes problems with muscle control and coordination. Symptoms can include delayed speech and language development, ataxia, motor delay, and generalized hypotonia. However, PMD does not typically cause seizure or elevated urinary carboxylic acid.

+4. Rett syndrome: This is a genetic disorder that affects brain development, primarily in girls. Symptoms can include delayed speech and language development, hyperactivity, and ataxia. However, Rett syndrome does not typically cause seizure, motor delay, generalized hypotonia, or elevated urinary carboxylic acid.

+5. Angelman syndrome: This is a genetic disorder that affects the nervous system and causes problems with speech and movement. Symptoms can include delayed speech and language development, hyperactivity, and seizure. However, Angelman syndrome does not typically cause ataxia, motor delay, generalized hypotonia, or elevated urinary carboxylic acid.

+6. Glutaric acidemia type I (GA-I): This is a genetic disorder in which the body cannot break down certain amino acids. Symptoms can include delayed speech and language development, motor delay, and elevated urinary carboxylic acid. However, GA-I does not typically cause hyperactivity, seizure, or ataxia.

+7. Mitochondrial disorders: These are a group of genetic disorders that affect the energy production in cells. Symptoms can include delayed speech and language development, motor delay, and generalized hypotonia. However, mitochondrial disorders do not typically cause seizure, ataxia, or elevated urinary carboxylic acid.

+8. Leigh syndrome: This is a rare inherited disorder that affects the nervous system. Symptoms can include delayed speech and language development, motor delay, and generalized hypotonia. However, Leigh syndrome does not typically cause seizure, ataxia, or elevated urinary carboxylic acid.

It is important to note that this is not an exhaustive list of potential diagnoses, and further evaluation and testing would be necessary to determine the underlying cause of the patient's symptoms."
['Argininosuccinic aciduria']," +1. Congenital Heart Defects: This condition refers to a problem with the structure of the heart that is present at birth. It can cause symptoms such as tachycardia (rapid heart rate), tachypnea (rapid breathing), and neonatal death. However, it would not typically cause symptoms such as death in infancy, metabolic acidosis, vomiting, hepatomegaly.

+2. Inborn Errors of Metabolism: These are genetic disorders that affect the body's ability to convert food into energy. They can cause a wide range of symptoms, depending on the specific disorder. Some possible symptoms include metabolic acidosis (a buildup of acid in the body), vomiting, and hepatomegaly (enlarged liver). However, they would not typically cause symptoms such as death in infancy, tachycardia, tachypnea, neonatal death.

+3. Sepsis: This is a life-threatening condition that can occur when the body's response to an infection injures its own tissues and organs. It can cause symptoms such as tachycardia, tachypnea, and death in infancy. However, it would not typically cause symptoms such as metabolic acidosis, vomiting, hepatomegaly, neonatal death.

+4. Respiratory Distress Syndrome: This is a condition that affects newborns, especially those born prematurely. It occurs when the baby's lungs don't produce enough surfactant, a substance that helps keep the air sacs in the lungs open. It can cause symptoms such as tachypnea, and neonatal death. However, it would not typically cause symptoms such as death in infancy, metabolic acidosis, vomiting, hepatomegaly, tachycardia.

+5. Meningitis: This is an inflammation of the membranes that cover the brain and spinal cord. It can be caused by a bacterial or viral infection. It can cause symptoms such as tachycardia, tachypnea, and death in infancy. However, it would not typically cause symptoms such as metabolic acidosis, vomiting, hepatomegaly, neonatal death.

It's important to note that this is not an exhaustive list and the symptoms presented could be caused by other medical conditions as well. A proper diagnosis should be made by a healthcare professional."
['Gyrate atrophy of choroid and retina']," Based on the symptoms you have provided, I will list some potential diseases that could match. Please note that this is not a definitive diagnosis and further medical testing is required.

1. + Leigh Syndrome: This is a mitochondrial disorder that can cause blindness, anemia, and severe short stature. However, it typically does not cause hyperammonemia, malabsorption, or hyperglycinemia.
2. + Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome: This genetic disorder can result in hyperammonemia, hyperornithinemia, and abnormal circulating serine concentration. However, it does not typically cause blindness, anemia, or severe short stature.
3. + Propionic Acidemia: This metabolic disorder can lead to hyperammonemia, malabsorption, and severe short stature. However, it does not typically cause blindness, anemia, or hypoargininemia.
4. + Non-ketotic Hyperglycinemia: This genetic disorder can result in hyperglycinemia, hypoargininemia, and abnormal circulating serine concentration. However, it does not typically cause blindness, anemia, or severe short stature.
5. + Maple Syrup Urine Disease: This metabolic disorder can lead to malabsorption, severe short stature, and death in childhood. However, it does not typically cause blindness, anemia, or hyperglycinemia.
6. + Urea Cycle Disorders: These genetic disorders can result in hyperammonemia, hypoargininemia, and death in childhood. However, they do not typically cause blindness, anemia, or malabsorption.
7. + Homocystinuria: This genetic disorder can lead to severe short stature, death in childhood or early adulthood, and abnormal circulating serine concentration. However, it does not typically cause blindness, anemia, or hyperammonemia.

Please consult with a medical professional for further evaluation and testing."
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder that causes an amino acid called phenylalanine to build up in the body. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, PKU does not typically cause death in infancy or childhood.

+2. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, MSUD does not typically cause death in infancy or childhood.

+3. Homocystinuria: This is a genetic disorder that affects the body's ability to process the amino acid methionine. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, homocystinuria does not typically cause death in infancy or childhood.

+4. Tyrosinemia type I: This is a genetic disorder that affects the body's ability to break down the amino acid tyrosine. Symptoms include abnormality of prenatal development or birth, neonatal death, hyperphenylalaninemia, and hypertyrosinemia. However, tyrosinemia type I does not typically cause death in childhood.

+5. Isovaleric acidemia: This is a genetic disorder that affects the body's ability to break down certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, isovaleric acidemia does not typically cause hypertyrosinemia or death in infancy or childhood.

It is important to note that these are just potential diagnoses based on the symptoms provided. Further testing and evaluation would be necessary to confirm any diagnosis."
['Carbamoyl-phosphate synthetase 1 deficiency']," +1. Urea Cycle Disorders (UCDs): This group of genetic disorders affects the body's ability to break down protein. Symptoms in common include hyperammonemia, cerebral edema, and neonatal death. Symptoms not in common include apathy and generalized hypotonia.

+2. Nonketotic Hyperglycinemia (NKH): A genetic disorder that affects the body's ability to process the amino acid glycine. Symptoms in common include hyperammonemia, cerebral edema, and neonatal death. Symptoms not in common include apathy, generalized hypotonia, and feeding difficulties.

+3. Maple Syrup Urine Disease (MSUD): A genetic disorder that affects the body's ability to break down certain amino acids. Symptoms in common include hyperammonemia, cerebral edema, and neonatal death. Symptoms not in common include apathy, generalized hypotonia, and feeding difficulties.

+4. Organic Acidemias: A group of genetic disorders that affect the body's ability to metabolize certain amino acids. Symptoms in common include hyperammonemia, cerebral edema, and neonatal death. Symptoms not in common include apathy, generalized hypotonia, and feeding difficulties.

+5. Mitochondrial Disorders: A group of genetic disorders that affect the body's ability to produce energy. Symptoms in common include generalized hypotonia and feeding difficulties. Symptoms not in common include apathy, hyperammonemia, cerebral edema, and neonatal death.

+6. Pompe Disease: A genetic disorder that affects the body's ability to break down glycogen. Symptoms in common include generalized hypotonia and feeding difficulties. Symptoms not in common include apathy, hyperammonemia, cerebral edema, and neonatal death.

+7. Prader-Willi Syndrome: A genetic disorder that affects the body's production of certain hormones. Symptoms in common include generalized hypotonia and feeding difficulties. Symptoms not in common include apathy, hyperammonemia, cerebral edema, and neonatal death.

+8. Smith-Lemli-Opitz Syndrome: A genetic disorder that affects the body's ability to produce cholesterol. Symptoms in common include generalized hypotonia and feeding difficulties. Symptoms not in common include apathy, hyperammonemia, cerebral edema, and neonatal death.

+9. Zellweger Syndrome: A genetic disorder that affects the body's ability to produce peroxisomes. Symptoms in common include generalized hypotonia and feeding difficulties. Symptoms not in common include apathy, hyperammonemia, cerebral edema, and neonatal death.

It is important to note that this is not an exhaustive list and that further testing is necessary to confirm a diagnosis."
['Canavan disease']," Based on the symptoms you have provided, I will list some potential diseases that could match, along with a brief description of each:

+1. Phenylketonuria (PKU): PKU is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. This leads to an accumulation of phenylalanine in the body, which can cause brain damage. Symptoms can include intellectual disability, seizures, behavioral problems, and motor delay. However, blindness, nystagmus, opisthotonus, neonatal death, and abnormal circulating aspartate family amino acid concentration are not typically associated with PKU.

+2. Maple syrup urine disease (MSUD): MSUD is a genetic disorder caused by a deficiency of the enzymes needed to break down certain amino acids. Symptoms can include seizures, motor delay, and hypotonia. However, blindness, nystagmus, opisthotonus, neonatal death, and abnormal circulating aspartate family amino acid concentration are not typically associated with MSUD.

+3. Non-ketotic hyperglycinemia (NKH): NKH is a genetic disorder caused by a deficiency of the enzyme needed to break down the amino acid glycine. Symptoms can include seizures, hypotonia, and developmental delay. However, blindness, nystagmus, opisthotonus, neonatal death, and abnormal circulating aspartate family amino acid concentration are not typically associated with NKH.

+4. Mohr-Tranebjaerg syndrome: This is a rare X-linked recessive disorder caused by mutations in the TIMM8A gene. Symptoms can include sensorineural deafness, dystonia, ataxia, and developmental delay. However, blindness, nystagmus, opisthotonus, and neonatal death are not typically associated with this syndrome.

+5. Pelizaeus-Merzbacher disease: This is a rare X-linked recessive disorder caused by mutations in the PLP1 gene. Symptoms can include nystagmus, ataxia, spasticity, and developmental delay. However, blindness, seizures, motor delay, hypotonia, and neonatal death are not typically associated with this disease.

+6. Glutaric aciduria type 1: This is a genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. Symptoms can include macrocephaly, seizures, hypotonia, and developmental delay. However, blindness, nystagmus, opisthotonus, neonatal death, and abnormal circulating aspartate family amino acid concentration are not typically associated with this disorder.

+7. Pyridoxine-dependent epilepsy: This is a rare genetic disorder caused by mutations in the ALDH7A1 gene. Symptoms can include seizures that are resistant to treatment with conventional anticonvulsant medications. However, blindness, nystagmus, motor delay, hypotonia, and neonatal death are not typically associated with this disorder.

+8. Leigh syndrome: This is a rare inherited neurometabolic disorder that affects the central nervous system. Symptoms can include hypotonia, developmental delay, and seizures. However, blindness, nystagmus, opisthotonus, neonatal"
"['Methylmalonic acidemia with homocystinuria, type cblC']"," +1. Hydrocephalus: The patient has this symptom, which is a buildup of fluid in the cavities (ventricles) deep within the brain. This can cause the ventricles to widen and put pressure on the brain.

+2. Microcephaly: The patient does not have this symptom, which is a condition where a person's head is much smaller than expected, often due to abnormal brain development.

+3. Strabismus: The patient has this symptom, which is a condition where the eyes are not aligned properly and point in different directions.

+4. Nystagmus: The patient has this symptom, which is a condition where the eyes make repetitive, uncontrolled movements.

+5. Intellectual disability: The patient has this symptom, which is a condition characterized by significant limitations in intellectual functioning and adaptive behavior.

+6. Death in infancy: The patient does not have this symptom, which is a condition where a person dies before their first birthday.

+7. Premature birth: The patient does not have this symptom, which is a condition where a baby is born before 37 weeks of pregnancy.

+8. Respiratory insufficiency: The patient has this symptom, which is a condition where the lungs are not able to provide the body with enough oxygen.

+9. Hyperhomocystinemia: The patient does not have this symptom, which is a condition where there are high levels of homocysteine in the blood.

+10. Neonatal death: The patient does not have this symptom, which is a condition where a baby dies within the first 28 days of life.

+11. Death in childhood: The patient does not have this symptom, which is a condition where a person dies before their 18th birthday.

+12. Abnormal circulating carnitine concentration: The patient does not have this symptom, which is a condition where there are abnormal levels of carnitine in the blood.

+13. Methylmalonic aciduria: The patient does not have this symptom, which is a rare genetic disorder that affects the body's ability to break down certain proteins and fats.

+14. Dyskinesia: The patient has this symptom, which is a condition where a person has difficulty controlling their movements.

It is important to note that this is just a list of potential diseases based on the symptoms provided and further testing would be needed to confirm a diagnosis. It is also possible that the patient's symptoms may be caused by a different condition."
['Medium chain acyl-CoA dehydrogenase deficiency']," +1. Trisomy 13: Also known as Patau syndrome, this genetic disorder is characterized by abnormalities in prenatal development or birth, and is often associated with neonatal death. However, it does not typically cause gastrointestinal inflammation, vomiting, or abnormal carnitine or 3-hydroxyacyl-CoA dehydrogenase levels.

+2. Necrotizing enterocolitis: This is a gastrointestinal disorder that primarily affects premature infants. It is characterized by inflammation and necrosis (tissue death) in the intestinal tract, which can lead to vomiting, abdominal distention, and in severe cases, death in infancy. However, it is not typically associated with abnormal prenatal development, neonatal death, or abnormal carnitine or 3-hydroxyacyl-CoA dehydrogenase levels.

+3. Medium-chain acyl-CoA dehydrogenase deficiency (MCADD): This is a genetic disorder that affects the body's ability to break down certain fats for energy. Symptoms can include vomiting, lethargy, and hypoglycemia, and in severe cases, can lead to death in infancy. However, MCADD is not typically associated with abnormal prenatal development, neonatal death, or gastrointestinal inflammation.

+4. Carnitine transporter deficiency: This is a genetic disorder that affects the body's ability to transport carnitine, a nutrient that helps the body convert fat into energy. Symptoms can include abnormal carnitine levels, hypoglycemia, and in severe cases, can lead to death in infancy. However, it is not typically associated with abnormal prenatal development, neonatal death, or gastrointestinal inflammation.

+5. 3-hydroxyacyl-CoA dehydrogenase deficiency: This is a genetic disorder that affects the body's ability to break down certain fats for energy. Symptoms can include hypoglycemia, lethargy, and in severe cases, can lead to death in infancy. However, it is not typically associated with abnormal prenatal development, neonatal death, or gastrointestinal inflammation.

It is important to note that this is not an exhaustive list of potential diagnoses, and that further testing and evaluation would be necessary to confirm any diagnosis. Additionally, some of these conditions may have overlapping symptoms, and it is possible that the patient's symptoms may be caused by a combination of factors."
['Biotinidase deficiency']," +1. Congenital lactic acidosis: This is a genetic disorder that affects energy production in the body. Symptoms include metabolic acidosis, hyperammonemia, and neonatal death. However, this condition does not typically cause generalized hypotonia or leukopenia.

+2. Maple syrup urine disease: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include metabolic acidosis, hyperammonemia, and neonatal death. However, this condition does not typically cause generalized hypotonia or leukopenia.

+3. Urea cycle disorders: This is a group of genetic disorders that affect the body's ability to remove ammonia from the blood. Symptoms include hyperammonemia, leukopenia, and neonatal death. However, this condition does not typically cause generalized hypotonia or metabolic acidosis.

+4. Nonketotic hyperglycinemia: This is a genetic disorder that affects the metabolism of the amino acid glycine. Symptoms include metabolic acidosis, hyperammonemia, and neonatal death. However, this condition does not typically cause generalized hypotonia or leukopenia.

+5. Pompe disease: This is a genetic disorder that affects the body's ability to break down glycogen, a type of sugar that is stored in muscles and other tissues. Symptoms include generalized hypotonia and neonatal death. However, this condition does not typically cause metabolic acidosis, hyperammonemia, or leukopenia.

+6. Spinal muscular atrophy: This is a genetic disorder that affects the nerves that control voluntary muscle movement. Symptoms include generalized hypotonia. However, this condition does not typically cause metabolic acidosis, hyperammonemia, leukopenia, or neonatal death.

It is important to note that this is not an exhaustive list of potential diagnoses, and further testing would be needed to confirm any of these possibilities. Additionally, it is possible that the patient's symptoms are caused by a combination of different conditions. A healthcare professional would be able to provide a more accurate diagnosis based on a thorough evaluation of the patient's medical history, physical examination, and test results."
['Tyrosinemia type 2']," +1. Blepharitis: The patient has no reported symptoms of inflamed eyelids, so this may not be the correct diagnosis.

+2. Conjunctivitis: The patient has reported symptoms of conjunctivitis, including redness and discomfort of the eye. However, the patient also has keratitis, which is not typically associated with conjunctivitis.

+3. Dacryocystitis: The patient has reported symptoms of epiphora, or excessive tearing, which can be a symptom of dacryocystitis. However, this condition typically involves infection or inflammation of the tear sac, which is not listed among the patient's symptoms.

+4. Herpes simplex keratitis: The patient has reported symptoms of keratitis, or inflammation of the cornea. Herpes simplex keratitis is a possible cause of keratitis, particularly if the patient has a history of cold sores or fever blisters. However, the patient does not report any symptoms of photophobia or pain, which are commonly associated with herpes simplex keratitis.

+5. Keratoconjunctivitis: The patient has reported symptoms of both keratitis and conjunctivitis, which can be indicative of keratoconjunctivitis. This condition can be caused by a variety of factors, including viral or bacterial infections, allergies, or exposure to irritants.

+6. Meibomian gland dysfunction: The patient has reported symptoms of epiphora, which can be a symptom of meibomian gland dysfunction. This condition involves blockage or dysfunction of the meibomian glands, which produce oils that help keep the tears from evaporating. However, the patient does not report any symptoms of dry eye, which is commonly associated with meibomian gland dysfunction.

+7. Ocular rosacea: The patient has reported symptoms of keratitis and photophobia, which can be indicative of ocular rosacea. This condition is characterized by inflammation of the eyelids and surrounding tissues, and can cause a variety of symptoms, including redness, burning, and grittiness. However, the patient does not report any symptoms of rosacea on the skin, which is commonly associated with ocular rosacea.

+8. Pterygium: The patient has reported symptoms of photophobia, which can be a symptom of pterygium. This condition involves growth of a fleshy tissue over the cornea, and can cause a variety of symptoms, including redness, irritation, and tearing. However, the patient does not report any symptoms of vision changes, which are commonly associated with pterygium.

+9. Retinoblastoma: The patient has reported symptoms of leukocoria, or white pupil, which can be indicative of retinoblastoma. This is a rare form of eye cancer that typically affects young children. However, the patient does not report any symptoms of strabismus, or crossed eyes, which is commonly associated with retinoblastoma.

+10. Seborrheic dermatitis: The patient has reported symptoms of hyperkeratosis, or thickening of the skin, which can be indicative of seborrheic dermatitis. This condition is characterized by inflammation and scaling of the skin, and can affect various parts of the body, including the scalp, face, and eyelids. However, the patient does not report any symptoms of itching or flaking, which are commonly"
['Phenylketonuria']," +1. Phenylketonuria (PKU): This is a genetic disorder that affects the metabolism of an amino acid called phenylalanine. Symptoms include abnormality of prenatal development or birth, neonatal death, hyperphenylalaninemia, and abnormal circulating tyrosine concentration. However, PKU does not typically cause death in early adulthood.

+2. Maple syrup urine disease (MSUD): This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include abnormality of prenatal development or birth, neonatal death, and hyperphenylalaninemia. However, MSUD does not typically cause death in early adulthood or abnormal circulating tyrosine concentration.

+3. Homocystinuria: This is a genetic disorder that affects the metabolism of an amino acid called methionine. Symptoms include abnormality of prenatal development or birth, hyperphenylalaninemia, and abnormal circulating tyrosine concentration. However, homocystinuria does not typically cause death in infancy or neonatal death.

+4. Tyrosinemia type I: This is a genetic disorder that affects the metabolism of the amino acid tyrosine. Symptoms include abnormal circulating tyrosine concentration, hyperphenylalaninemia, and death in early adulthood. However, tyrosinemia type I does not typically cause abnormality of prenatal development or birth or neonatal death.

+5. Nonketotic hyperglycinemia: This is a genetic disorder that affects the metabolism of the amino acid glycine. Symptoms include abnormality of prenatal development or birth and death in infancy. However, nonketotic hyperglycinemia does not typically cause hyperphenylalaninemia, abnormal circulating tyrosine concentration, or death in early adulthood.

It is important to note that these are just potential diagnoses based on the symptoms provided, and further testing would be needed to confirm any diagnosis. It is also possible that the patient's symptoms may be caused by a combination of different conditions or by factors unrelated to genetic disorders."
[]," +1. Cyanoalbuminemia: This condition is characterized by the presence of cyanosis, which is a bluish discoloration of the skin and mucous membranes due to poor oxygenation of the blood. However, this condition does not typically cause seizures, death in infancy, hyperammonemia, neonatal death, or 3-hydroxydicarboxylic aciduria.

+2. Urea cycle disorders: This group of genetic disorders can cause hyperammonemia, which is an excess of ammonia in the blood. Symptoms can include seizures, lethargy, and coma. However, urea cycle disorders do not typically cause cyanosis, death in infancy, neonatal death, or 3-hydroxydicarboxylic aciduria.

+3. Maple syrup urine disease: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms can include seizures, lethargy, and maple syrup-like odor in the urine. However, this condition does not typically cause cyanosis, death in infancy, neonatal death, or 3-hydroxydicarboxylic aciduria.

+4. Organic acidemias: This is a group of genetic disorders that affect the metabolism of certain organic acids. Symptoms can include seizures, vomiting, and metabolic acidosis. However, organic acidemias do not typically cause cyanosis, death in infancy, neonatal death, or hyperammonemia.

+5. Isovaleric acidemia: This is a specific type of organic acidemia that is characterized by the accumulation of isovaleric acid in the body. Symptoms can include seizures, vomiting, and a sweaty, cheese-like odor. However, this condition does not typically cause cyanosis, death in infancy, neonatal death, or hyperammonemia.

+6. Glutaric acidemia type I: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms can include seizures, movement disorders, and metabolic acidosis. However, this condition does not typically cause cyanosis, death in infancy, neonatal death, or hyperammonemia.

+7. Propionic acidemia: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms can include seizures, vomiting, and metabolic acidosis. However, this condition does not typically cause cyanosis, death in infancy, neonatal death, or hyperammonemia.

+8. Methylmalonic acidemia: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms can include seizures, vomiting, and metabolic acidosis. However, this condition does not typically cause cyanosis, death in infancy, neonatal death, or hyperammonemia.

+9. Multiple carboxylase deficiency: This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms can include seizures, skin rashes, and metabolic acidosis. However, this condition does not typically cause cyanosis, death in infancy, neonatal death, or hyperammonemia.

+10. Citrullinemia: This is a genetic disorder that affects the metabolism of certain"
['Alkaptonuria']," I am an artificial intelligence and I cannot actually examine or diagnose a patient. However, based on the symptoms you have provided, here are some potential diseases that a real doctor might consider:

+1. Sudden Infant Death Syndrome (SIDS): This is a diagnosis of exclusion, which means that it is made when all other possible causes of death in infancy have been ruled out. It is typically only diagnosed in infants under one year of age.

+2. Pyloric Stenosis: This is a condition that affects the muscle at the opening of the stomach, causing vomiting after feeding. It is more common in infants than in older children or adults.

+3. Urinary Tract Infection (UTI): This is an infection that can occur in any part of the urinary system, including the kidneys, bladder, or urethra. Dark urine can be a symptom of a UTI, although it is more commonly associated with other symptoms such as a strong, persistent urge to urinate, a burning sensation while urinating, and cloudy or strong-smelling urine.

Please note that this is not an exhaustive list of potential diagnoses, and that a real doctor would need to consider many other factors in order to make an accurate diagnosis. It is important to seek medical attention if you or someone else is experiencing these symptoms."
['Maple syrup urine disease']," Based on the symptoms you have provided, here are some potential diseases:

+1. Maple Syrup Urine Disease (MSUD): This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include seizures, lethargy, growth delay, death in infancy, metabolic acidosis, hyperammonemia, drowsiness, sleep abnormality, and elevated urinary carboxylic acid. However, MSUD does not typically cause feeding difficulties or severe hearing impairment.

+2. Nonketotic Hyperglycinemia (NKH): This is a genetic disorder that affects the metabolism of the amino acid glycine. Symptoms include seizures, lethargy, growth delay, death in infancy, metabolic acidosis, hyperammonemia, drowsiness, sleep abnormality, and elevated urinary carboxylic acid. However, NKH does not typically cause hypervalinemia, hyperleucinemia, hyperisoleucinemia, feeding difficulties, or severe hearing impairment.

+3. Isovaleric Acidemia (IVA): This is a genetic disorder that affects the metabolism of the amino acid leucine. Symptoms include seizures, lethargy, growth delay, death in infancy, metabolic acidosis, hyperammonemia, drowsiness, sleep abnormality, and elevated urinary carboxylic acid. However, IVA does not typically cause hypervalinemia, hyperleucinemia, hyperisoleucinemia, feeding difficulties, or severe hearing impairment.

+4. Propionic Acidemia (PA): This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include seizures, lethargy, growth delay, death in infancy, metabolic acidosis, hyperammonemia, drowsiness, sleep abnormality, and elevated urinary carboxylic acid. However, PA does not typically cause hypervalinemia, hyperleucinemia, hyperisoleucinemia, feeding difficulties, or severe hearing impairment.

+5. Glutaric Acidemia Type I (GA-I): This is a genetic disorder that affects the metabolism of certain amino acids. Symptoms include seizures, lethargy, growth delay, death in infancy, metabolic acidosis, hyperammonemia, drowsiness, sleep abnormality, and elevated urinary carboxylic acid. However, GA-I does not typically cause hypervalinemia, hyperleucinemia, hyperisoleucinemia, feeding difficulties, or severe hearing impairment.

+6. Citrullinemia Type I: This is a genetic disorder that affects the metabolism of the amino acid arginine. Symptoms include seizures, lethargy, growth delay, death in infancy, metabolic acidosis, and hyperammonemia. However, citrullinemia Type I does not typically cause drowsiness, sleep abnormality, hypervalinemia, hyperleucinemia, hyperisoleucinemia, feeding difficulties, severe hearing impairment, or elevated urinary carboxylic acid.

It is important to note that these are potential diagnoses based on the symptoms provided, and further testing would be needed to confirm any diagnosis. Additionally"
['Ornithine transcarbamylase deficiency']," +1. Obsolete Eczematoid Dermatitis: The patient has presented with a skin rash, which is a common symptom of this condition. However, the patient has also shown symptoms such as coma, generalized hypotonia, hypoglycemia, fever, hyperammonemia, vomiting, cerebral edema, athetosis, hyperglutaminemia, oroticaciduria, aminoaciduria, neonatal death, death in childhood, gastrointestinal inflammation, recurrent viral infections, abnormal circulating proline concentration, abnormal circulating arginine concentration, death in adolescence, elevated plasma citrulline, uraciluria, myocarditis, and abnormal circulating creatine kinase concentration, which are not typically associated with eczematoid dermatitis.

+2. Maple Syrup Urine Disease: The patient has presented with elevated plasma citrulline, uraciluria, and abnormal circulating proline and arginine concentrations, which are common symptoms of this condition. However, the patient has not shown symptoms such as maple syrup-smelling urine, which is a hallmark of this disease.

+3. Urea Cycle Disorders: The patient has presented with hyperammonemia, which is a common symptom of urea cycle disorders. However, the patient has also shown symptoms such as coma, generalized hypotonia, hypoglycemia, fever, vomiting, cerebral edema, athetosis, hyperglutaminemia, oroticaciduria, aminoaciduria, neonatal death, death in childhood, gastrointestinal inflammation, recurrent viral infections, abnormal circulating proline concentration, abnormal circulating arginine concentration, death in adolescence, elevated plasma citrulline, uraciluria, myocarditis, and abnormal circulating creatine kinase concentration, which are not typically associated with urea cycle disorders.

+4. Non-ketotic Hyperglycinemia: The patient has presented with hypoglycemia, which is a common symptom of non-ketotic hyperglycinemia. However, the patient has also shown symptoms such as coma, generalized hypotonia, fever, hyperammonemia, vomiting, cerebral edema, athetosis, hyperglutaminemia, oroticaciduria, aminoaciduria, neonatal death, death in childhood, gastrointestinal inflammation, recurrent viral infections, abnormal circulating proline concentration, abnormal circulating arginine concentration, death in adolescence, elevated plasma citrulline, uraciluria, myocarditis, and abnormal circulating creatine kinase concentration, which are not typically associated with non-ketotic hyperglycinemia.

+5. Organic Acidemias: The patient has presented with uraciluria, which is a common symptom of organic acidemias. However, the patient has also shown symptoms such as coma, generalized hypotonia, hypoglycemia, fever, hyperammonemia, vomiting, cerebral edema, athetosis, hyperglutaminemia, oroticaciduria, aminoaciduria, neonatal death, death in childhood, gastrointestinal inflammation, recurrent viral infections, abnormal circulating proline concentration"
